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Volumetric protein production yields in Escherichia coli fermentations have 
improved with development of fed-batch high cell density cultures.  The use of high 
cell densities has introduced need to obtain a better understanding of intercellular 
quorum sensing signals, glucose feeding strategies, and endotoxin removal during 
protein purification.  The high purity of inclusion bodies (IBs) makes their extraction 
from host cell proteins in the cell lysate a standard procedure to simplify purification.  
The extraction is typically performed with centrifugation or tangential flow filtration, 
which are dependent on the IBs’ size, density, and shape.  The isolated IBs are then 
denatured, but the degree to which they are denatured can be dependent on their 
compactness.  These qualities of IBs can all be influenced with fermentation growth 
conditions, but little research on this topic has been published. 
A synthetic version of melanoma antigen A (Syn-Melan-A) was produced in 
high cell density E. coli cultures in complex medium under various temperatures, 
inducer concentrations, and feeding strategies.  IBs produced at 30 ºC, 37 ºC, and 42 
ºC were 316, 215, and 231 nm in size and had densities of 1.26, 1.30, and 1.31 g/cm3, 
respectively.  No significant changes in IB size or density were detected in 
fermentations using inducer in the range of 0.05 to 0.50 mM.  Changing from a pH-
stat feeding method that prevented glucose accumulation to an overfed culture could 
  
increase IB size to 340 nm and IB density to 1.31 g/cm3 at 37 ºC.  Similar results were 
obtained in a statistical design experiment in chemically defined medium. 
Scanning electron microscopy was used to show that Syn-Melan-A IBs were 
amorphous when produced at 30 ºC, granulated at 37 ºC, and smooth at 42 ºC.  
Coomassie dye was used to show that these IBs had a 62%, 65%, and 68% 
accessibility, respectively, as determined by Bradford reaction.   
Different fermentation temperatures were used also to determine their 
influence on the IB characteristics of Melan-A, SSX-2, NY-ESO-1, and enhanced 
green fluorescent protein (EGFP).  Different temperatures were only effective in 
altering IB characteristics of Syn-Melan-A.  This susceptibility is associated with 
slower production rate of Syn-Melan-A compared to natural Melan-A. 
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CHAPTER 1 
 
INCLUSION BODY FORMATION DURING RECOMBINANT PROTEIN 
PRODUCTION IN ESCHERICHIA COLI 
 
1.1 Introduction 
The biotechnology-based therapeutic market was $9.2 billion in 2007 and is 
projected to continue its rapid growth to $16.1 billion by 2011.  Recombinant proteins 
account for 68% of this market share; the remainder is divided between monoclonal 
antibodies and vaccines [1].  The most commonly used expression system for 
marketed recombinant protein fermentations in 2009 is still the bacterium Escherichia 
coli, which is the system of choice for proteins that do not require eukaryotic-type 
processing, such as N-linked glycosylation [2].  Important therapeutics produced in E. 
coli include insulin, interferon alpha, interferon beta 1b, interferon gamma 1b, human 
growth hormone, bovine growth hormone, insulin growth factor-1 (IGF-1), 
keratinocyte growth factor, anti-VEGF (Fab), human granulocyte colony stimulating 
factor (G-CSF), and interleukin 2.  Recombinant human insulin alone has a $900 
million market [1]. 
 Bioprocess engineers have refined the processes designed to produce and 
purify these proteins to improve process yields.  Yield improvements are important 
because they minimize the number of production campaigns needed to produce a 
required amount of protein which makes production more cost and time efficient and 
generally increases product consistency.  There are still unexplored issues of E. coli 
protein production and purification that are in need of investigation that can likely 
result in further yield improvements throughout the industry. 
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 Inclusion body (IB) extraction is a common purification procedure that has not 
been studied in detail.  Even though equipment for such a procedure has been 
optimized, IB extraction can be facilitated and made more predictable by altering the 
physical characteristics of IBs.  IBs also need to be solubilized to be purified and 
refolded, so their resistance to denaturant is also a relevant factor to consider for 
improving process yields.  These IB qualities can be adjusted with changes to the E. 
coli fermentation during protein production. 
 Evaluation of IB characteristics has grown popularity in the last five years.  
The major findings are described in section 1.5.  The findings, however, are anecdotal 
and have inconsistent design variables, such as different production strains and various 
culture conditions.  Section 1.2 provides a review of different E. coli strains and 
promoters.  Section 1.3 details relevant information in E. coli fermentations, and 
Section 1.4 summarizes general IB research over the last two decades. 
 
1.2. Protein expression in Escherichia coli 
 
1.2.1. Recombinant DNA technology 
 Extracting specific proteins of interest from natural sources or synthesizing 
them chemically typically generates low yields.  Recombinant deoxyribonucleic acid 
(DNA) technology provides a more practical alternative for synthesizing these 
proteins.  This technique was first demonstrated in E. coli over three decades ago [3] 
and is used commercially today for the production of a wide range of proteins. 
 Plasmids are extra-chromosomal DNA molecules that permit horizontal gene 
transfer amongst bacteria.  With the advent of restriction enzymes [4], scientists have 
been able to splice foreign DNA into plasmids and insert them back into bacteria.  A 
simple way to introduce plasmids into a bacterium is through chemical competence, a 
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treatment of highly-concentrated calcium ions and rapid temperature shifts.  A 
selective marker on the plasmid, commonly antibiotic resistance, makes isolation of 
transformants possible.  The plasmid is replicated as the cell replicates and uses the 
cell’s machinery to overexpress its coded protein.   
It should be noted that there are complications with producing a human antigen 
with a bacterial expression system.  For example, a DNA sequence has to be modified 
by adding a ribosome binding site and removing any original intron sequences since 
prokaryotic cells lack the same messenger ribonucleic acid (mRNA) processing ability 
that eukaryotic cells have.   
In addition to bacteria, certain yeast species, such as Saccharomyces 
cerevisiae, can also utilize plasmids.  In other yeast species, such as Pichia pastoris, 
and in mammalian cell lines, such as Chinese Hamster Ovary (CHO) cells, a stable 
transfection is needed [5].  Foreign DNA must be introduced into the cell and then 
integrate into the host chromosome.  Otherwise the foreign protein production will be 
transient and cease after the first cell division. 
 
1.2.2. The bacterium Escherichia coli 
For pharmaceutical production, fermentations with bacteria are often used 
instead of other general host systems because they are robust, relatively inexpensive to 
grow, and can produce large quantities of desired material in short periods of time.  E. 
coli is frequently used as a host organism for these processes because it is 
humankind’s most well-characterized organism, both in terms of physiology and 
genetics [6].  In 2003, 80% of the proteins submitted to the protein data bank to solve 
three-dimensional structures were prepared in E. coli [7]. 
A drawback of using a recombinant bacterial system is there are limitations to 
the complexity of bacterial products since E. coli will not perform any post-
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translational processing that some proteins require to be functional.  There are also 
many purification challenges because bacteria mainly overexpress target proteins 
intracellularly, which makes the protein’s purification more troublesome compared to 
if the protein were secreted.  These overexpressed proteins are often not folded 
properly and form IBs, insoluble protein aggregates, within the cell [8]. 
 
1.2.3. Promoter selection 
Polypeptide synthesis requires that the DNA be used as a template to 
synthesize mRNA that is translated at a ribosome.  To determine which specific 
section of DNA is expressed, promoters serve as non-coding regions of DNA that 
regulate the initiation of mRNA synthesis.  Constitutive promoters are used for 
essential housekeeping genes and express their proteins at a constant rate.  When 
selective markers include a code for antibiotic resistance, such a non-regulated 
promoter is standard.  Overexpressed proteins instead utilize promoters that can be 
regulated.  In addition to creating a metabolic burden, overexpressed proteins can also 
be toxic to the cell and their expression requires inducible activation. 
Inducible promoters that are compatible with E. coli are plentiful, but few are 
suitable for industrial protein production.  The promoters for ara and tet operons, for 
example, are not tightly regulated and will express basal levels of protein even in an 
uninduced state [9].  Promoters for tac and trc can only overexpress proteins to 
become 15-30% of the total cellular protein [10].  Even though the pH promoter can 
produce levels that are 40-50% of the total cellular protein, it is not well characterized 
[11].  The most commonly used promoter for industrial production is the 
bacteriophage T7 RNA polymerase expression system in pET vectors from Novagen 
(Darmstadt, Germany), making up 90% of the 2003 submissions to the protein data 
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bank [7].  Using this expression system, the protein of interest can account for 50% or 
more of the total cellular protein [12].   
The T7 promoter comes from bacteriophage, a virus that infects bacteria.  The 
promoter is tightly regulated because it is unrelated to other E. coli DNA sequences.  
This is a very strong promoter because T7 RNA polymerase is very specific to its own 
promoter and it elongates RNA chains over five times faster than E. coli’s native RNA 
polymerase [13].  When activated, so much of the cells resources become dedicated to 
the synthesis of the protein of interest that the expression of the target protein is 
typically much larger than the expression of any host proteins and cell growth 
commonly stops.  Lysogens have been formed by infecting cells with a lambda phage 
and integrating its DNA into the E. coli chromosome as a prophage, a dormant form of 
the virus that will not kill its host cell.  A lysogen, which is controlled by a lacUV5 
promoter that can be induced by lactose or the nonhydrolyzable lactose analog 
isopropyl-beta-D-thiogalactopyranoside (IPTG), is used to provide T7 RNA 
polymerase because it will only introduce one copy of the T7 polymerase gene into the 
bacteria.  Otherwise there will be too much T7 polymerase in the cell during the un-
induced state. 
 
1.2.4. Co-expression 
 Multiple proteins can be overexpressed in a single cell by introduction of 
multiple plasmids or by the inclusion of multiple protein codes on a single plasmid.  
For industrial applications, the goal is rarely to simultaneously produce multiple 
products, but co-expression is implemented to assist in the production of a single 
protein of interest.  Common examples of this are plasmids that code for uncommon 
transfer ribonucleic acid (tRNA) molecules and plasmids that code for folding 
chaperones. 
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Codon biases need to be considered when producing large amount of 
heterologous protein.  The DNA code is degenerate because different codons 
commonly code for the exact same amino acid.  A unique tRNA molecule is needed to 
match codons with the proper amino acid.  E. coli are prokaryotic organisms, but they 
are often used to produce eukaryotic proteins.  The bacterium is populated with tRNA 
molecules that match up with codons proportionate to common bacterial proteins and 
may not be able to supply more eukaryotic-common codons needed for efficient 
heterologous protein translation.  The lack of these uncommon tRNA forms is the 
main cause of a stringent response in E. coli fermentation [14].  This problem can be 
addressed by creating a synthetic code for the protein of interest, adjusting the DNA 
sequence for more efficient bacterial translation while leaving the final peptide 
sequence unchanged.  Another approach is to co-express the uncommon tRNA 
molecules in a pRARE plasmid (see Rosetta “strain”) [15]. 
 Besides draining cellular resources, protein overexpression also overloads the 
cell’s protein folding machinery.  Molecular chaperones are also known as stress or 
heat shock proteins (HSP) because they are upregulated under such conditions to aid 
in proper protein folding.  When a polypeptide that requires folding assistance is 
initially formed, it will commonly become associated with Trigger Factor (TF) or 
DnaK.  DnaK binding and release are regulated by the DnaJ and GrpE co-chaperones, 
respectively.  DnaK-DnaJ-GrpE together are known as the Hsp70 system.  Although a 
protein folding intermediate can release and rebind to these initial chaperones, it may 
also be transferred to GroEL/GroES (Hsp60) for further folding assistance.  Aside 
from these folding chaperones, the cell also ultilizes holdases, particularly under stress 
conditions, to stabilize partially folded intermediates until folding chaperones become 
available.  In cases where the foldases and holdases have both been saturated, protein 
aggregates can form.  At this point, there are still deaggregating chaperones, such as 
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ClpB, that can reintroduce intermediate proteins back to DnaK.  The co-expression of 
any one or more of these chaperones is discussed later in section 1.4.4. 
 
1.2.5. Strain selection 
The firm understanding of the E. coli genome and current molecular biology 
techniques allow for chromosomal changes that create custom strains.  PEP 
carboxylase, for example, has been overexpressed in a specific E. coli mutant to 
convert PEP directly to oxaloacetate, ultimately preventing acetate accumulation [16].  
The thioredoxin pathway can be altered to permit disulfide formation in the cytoplasm 
(see Origami and AD494 strains) [11].  Modifications have even allowed N-linked 
glycosylation to occur in E. coli [17].  More general strains include E. coli O157:H7, a 
pathogenic strain that can result in lethal food poisoning, and E. coli K-12, commonly 
used in basic laboratory studies.  Among each major strain, there are also additional 
variations.  Some variants of the K-12 strain are C600 and MC4100 [18], which have 
been used in IB studies (see Table 1.1). 
 
Table 1.1. Sample strains and vectors used to produce proteins for inclusion body 
studies.  Inclusion body data has been generated from different E. coli strains and 
vectors.  Le Thanh, used a tac promoter. 
source strain vector protein 
Hoffman BL26 pNF β-galactosidase 
Kang C600 pBV TRAIL 
Le Thanh MC4100 tac α-glucosidase 
Margreiter K12 HMS174 pET30a β-lactamase 
Vera BL21(DE3) pET21b(+) GFP 
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The most common production strains of E. coli, however, do not have so much 
variation.  After a collective analysis of 10,000 proteins, several groups came to a 
consensus that recombinant protein expression should be attempted using a T7 
promoter in a derivative of BL21(DE3) E. coli by default [19].   This strain is useful 
because it does not code for the Lon and OmpT proteases which ultimately increases 
protein expression yields.  BLR strains are derived from BL21 strains and also lack 
RecA.  RecA is a protein that repairs DNA, and its absence is helpful for plasmid 
stability.  Its recombinase properties can alter plasmids, or even insert antibiotic 
resistance into the bacterial chromosome.  BL26 is a derivative of BL21 that lacks 
LacZ which will prevent natural β-galactosidase activity.   
Another BL21 derivative is the C41 strain (see Walker strain).  The C41(DE3) 
strain continues to grow and does not experience a stress response after induction.  
This strain functions by limiting the accumulation of mRNA of the overexpressed 
protein, decreasing an mRNA overload [20].  The entire genetic difference is two 
mutations in the lacUV5 promoter, dampening T7 polymerase production [21].  These 
strains are advertised as optimized for making soluble proteins from IB-prone proteins 
and membrane proteins [7].  Since C41 E. coli are derived from BL21, they also lack 
the ability to produce the Lon and OmpT proteases.  It has also been shown that such 
strains of bacteria will ultimately produce less sigma-32, DnaK, and ClpB in response 
to stress conditions when compared to HB101, TOP10, or JM105 strains [22].  These 
proteins aid in protein folding and de-aggregation. 
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1.3. Bioprocess Development 
 
1.3.1. Medium Selection 
 The two major categories of fermentation medium are complex media, which 
are made up of natural compounds such as yeast extract, and chemically defined 
media, which are completely made up from a known chemical composition.  Although 
complex media often offer a surplus of needed growth and protein production 
components, cultures grown in defined media are better controlled and exhibit 
reproducible behavior. 
Defined media are typically made up a pH buffer, carbon source, nitrogen 
source, and trace metals.  The trace metals must be dissolved in a highly acidic 
solution to stay in solution.  Chemically defined medium permits higher cell densities 
and reduces the formation of acetate, a toxic by-product of metabolism [23].  On the 
manufacturing scale, there has also been concern with products that originate from 
animal sources, making chemically defined media a more attractive choice than most 
complex media. 
 
1.3.2. High cell density cultures 
High cell density cultures (HCDC) are roughly defined as 50 g of dry cell 
weight per liter or above, some reaching as high as 115 g/L [24].  This can be 
compared to E. coli grown in Luria broth (LB) which reach a peak dry cell weight of 
about 1 g/L.  Even though the protein titer is not directly proportional to the cell 
density [25], the volumetric productivity is still much higher in HCDC.  In one typical 
example, increasing a non-HCDC culture’s cell density by 60% resulted in an 
approximate 12% drop in cellular specific productivity.  The result was still an 
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increase of the volumetric productivity by 40% [26].  To maximize productivity, 
industrial processes that grow E. coli are regularly performed with HCDC. 
To achieve a HCDC, enough resources (i.e. carbon, nitrogen, oxygen) must be 
provided to the cells.  The controlled introduction of these nutrients to the culture is 
also critical.  High levels of metals can be toxic, and high levels of oxygen can lead to 
unwanted oxidation.  A common carbon source in E. coli fermentation is glucose, and 
even high levels of it will indirectly harm the growth of a HCDC.  High levels of 
glucose accumulate as pyruvate and saturate the cell’s tricarboxylic acid (TCA) cycle.  
When this happens, the remaining pyruvate is converted to acetate.  Acetate 
accumulation, which is very common in production fermentations [27], ultimately 
becomes toxic to the cells because undissociated forms of acetate can diffuse into the 
cells and lower internal pH [28].   
 For controlled introduction of nutrients, a fed-batch type of fermentation is the 
most practical [29].  Feedback control feeding strategies, which adjust feed rates based 
on available online measurements, are common because of their ease of use.  A pH-
stat control increases the feeding rate of a glucose-saturated medium to the bioreactor 
in response to rises in pH [30]; a dissolved oxygen (DO) -stat control calculates feed 
rates based on oxygen consumption responses to pauses of feed [31].  Both feedback 
control methods indirectly detect cell lysis that occurs upon complete glucose 
starvation.  Upon the initiation of cell death, the medium pH increases since alkaline 
intracellular space is released, and dissolved oxygen rises because there are fewer cells 
left to use the supplied oxygen.  Thus these strategies keep the cells in a constant near-
death state.  More complicated DO-stat controls have evolved by determining feed 
rates based on oxygen consumption during glucose pulses [32]. 
Other feeding protocols based on specific growth rate or maintenance of 
glucose levels are more gentle on the cells, but they often cannot keep glucose levels 
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at an absolute minimum.  Feeding at the industrial scale may sometimes even just be a 
constant feed rate for ease of operation.  These feeding profiles result in acetate 
accumulation early in the fermentation and cell starvation at the end.  A linear feed 
rate or a step feed try to maintain the operational simplicity of a constant feed while 
alleviating the major stresses a constant feed rate creates. 
 
1.3.3. Purification schemes 
 Cell isolation is a typical first step after a fermentation has reached completion.  
The bacteria are separated from their growth medium via centrifugation.  Intracellular 
protein is released by breaking open the cells.  Although this can be performed 
chemically or with sonication, the most practical method for large culture volumes is 
performed with high pressure homogenization. 
After cell lysis, soluble and insoluble protein fractions can be separated.  
Insoluble protein in E. coli forms aggregates known as IBs which are discussed in 
section 1.4.  These aggregates are large enough to be separated by tangential flow 
filtration (TFF) [33] or centrifugation [34].  A more recently studied technique is 
sedimentation flow-field fractionation [35], but it is difficult to scale-up and the 
separation principle is the same as centrifugation.  Isolated IBs must then be 
solubilized in chaotropic agents, such as urea or guanidine [36], before further 
processing. 
Once in a solubilized state, protein can be purified using column 
chromatography.  Protein solution is passed through functionalized resin beads that 
have specific affinities.  For example, an anion exchange column has positively charge 
beads and will only bind negative proteins.  Different concentrations of salt solution, a 
salt gradient, or even changes in buffer pH can be used to elute the bound protein.  
Some proteins may be produced with a gene modified to encode for an amino acid tag 
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to facilitate such purification.  A His tag is commonly an additional six histidine 
residues synthesized at either terminus of a protein.  It specifically binds to nickel in 
immobilized metal affinity chromatography (IMAC) and can be eluted with imidazole. 
 Solubilized protein must be refolded during the course of the purification 
process by the removal of the introduced chaotropic agent.  Precautions are taken to 
prevent protein aggregation during refolding [37].  Refolding can be done as a final 
step through dilution, followed by concentration.  The chaotropic agent can also be 
washed out while the protein is bound on a chromatography column. 
 
1.4. Inclusion bodies 
 
1.4.1. IB formation 
 Inclusion bodies (IBs) are insoluble protein aggregates that routinely form 
during heterologous protein overexpression.  There are two explanations, possibly 
synergistic, for why IBs are formed.  First, recombinant proteins that serve as human 
therapeutics are naturally made in mammalian cells.  This eukaryotic environment is 
non-reducing and allows for disulfide bonds to form.  The intracellular space of E. coli 
is reducing and will not allow any disulfides to form.  If a disulfide bond is necessary 
for the structure of a given protein, then it will not be able to fold properly in the E. 
coli cytosol.  Second, protein production aims to overexpress target proteins within the 
cell.  These levels can reach an unnatural 50% of the total cellular protein [38].  This 
product overwhelms the cell’s ability to fold it properly.  It should be noted that there 
is still some mystery in IB formation – some mammalian proteins have no thiol groups 
and still form IBs in low concentrations; some recombinant proteins can be expressed 
in a soluble form [39]. 
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More specifically, IBs are dynamic structures whose size is dependent on 
protein production rates, chaperone folding, and protease degradation rates.  A nascent 
protein may also have the fate to be transported out of the cell, but this would require a 
proper secretory sequence.  Based on this simplified  model (see Figure 1.1), IBs will 
only form when protein production exceeds the rate that the E. coli cell can properly 
fold the protein into a stable, soluble form or degrade it.  This frequently happens with 
the overexpression of recombinant proteins [38].  So even native E. coli proteins, such 
as β-galactosidase can form IBs. 
 
1.4.2. Disadvantages 
IB formation has been criticized as the main bottleneck in protein production 
[40], and many therapeutics have not been marketed as a result of them [41].  Proteins 
become insoluble and aggregate because they are not folded properly.  Aside from 
making much of the protein inaccessible because it is aggregated, misfolded protein 
loses functionality and would then be considered of no therapeutic or enzymatic use.  
Although misfolded protein can be denatured with chaotropic agents and refolded, this 
process can be inefficient and costly [42]. 
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Figure 1.1. Simplified diagram of formation and degradation of soluble protein 
and inclusion bodies.   
Nascent polypeptides are produced at the bacteria’s ribosome.  The protein 
intermediate then has several fates, depending on if it encounters a chaperone, 
protease, or neither. Double arrows indicate iterative steps.  Dotted arrows represent 
unconfirmed steps. 
 
More recent findings have suggested that there is some organized protein 
folding in IBs.  There have been several reports of IBs that have been found to be a 
collection of β-sheets connected by hydrogen bonds, not dissimilar to amyloid 
aggregates.  Although these β-sheets typically replace α-helices found in the soluble 
structure, such as in β-lactamase [43], the protein in IBs does have activity, 
particularly the embedded regions in the core of the aggregate [44].  Because IBs are 
very porous, this trend suggests that some IBs can at least be used as catalysts [41].  It 
is unknown whether this feature applies to all IBs.  Regardless of their activity, 
however, proteins must be solubilized to be subjected to conventional 
chromatographic techniques necessary for purification.  A biochemical and 
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biophysical characterization of the protein cannot be performed until the protein is 
isolated in a soluble and monodispersed form [45]. 
To compound matters, IB formation is the norm in recombinant production 
processes [39].  Insulin-like growth factor-I [46] and leptin [47] are two of the very 
limited number of cases where protein has been produced in large soluble quantities 
within E. coli.  In these cases, the protein was transported to the periplasmic space of 
the cell. 
 
1.4.3. Advantages 
 There are actually key positive qualities of IBs that make them helpful in 
protein production.  Because IB formation is typically unavoidable, it stands to reason 
that processes should take advantage of these positive qualities.  As aggregates, the 
protein will be less accessible.  This isolation of recombinant proteins is useful when 
manufacturing unstable proteins because they are protected from proteases [48].  In 
the case of producing proteins that may be toxic to the cell, the cell is then protected 
since these proteins are not functional [49].  Another very attractive feature of IBs is 
their ability to aid in purification processes. 
IBs themselves are comprised almost exclusively of recombinant protein, with 
purities that can reach over 90% [42].  The remainder of the protein is largely 
chaperones and proteases that were associated with these recombinant proteins as they 
aggregated [50].  It has been shown, in fact, that mixtures of two different protein 
folding intermediates, P22 tail spikes and coat proteins, will not randomly aggregate, 
but they will instead selectively form pure aggregates [51].  Thus if the IBs of an E. 
coli fermentation can be isolated, much of the purification work has already been 
completed.  IB isolation is a relatively simple process because IBs are much larger 
than all other cellular contaminants.   
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The general form for particle settling velocity in a centrifuge is analogous to 
the well-established equation for solid particle settling: 
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where Uo is the settling velocity, g is the gravitational force, Dp is the particle 
diameter, ρp and ρf are the densities of the particles and fluid, and µ is the viscosity of 
the fluid.  In the case of centrifugation, the g value can be substituted with an applied 
gravity force, which is 5,000-12,000g for IBs [39].  Unfortunately, the density of IBs 
(~1.3 g/ml) is only slightly higher than water [52] and the viscosity of cell lysate can 
be rather high.  Fortunately, there is an exponential dependence on particle size that 
dictates that larger particles are easier to separate than smaller particles. 
 There are several different types of filters used for IB isolation.  These 
ultrafiltration processes are all strongly dependent on particle size.  IB structures have 
been determined to be very porous and in cylindrical and ovoid shapes [53].  Because 
protein is typically pushed through filters at high pressures, the compressibility and 
shape of IBs become an issue.  One type of filter is a depth filter.  Like a centrifuge, 
depth filters that act as a molecular sieve have a strong dependence on particle size 
and some influence from particle density and fluid viscosity.  The other common type 
of filter, anisotropic membranes, has a thin porous layer on top that ideally has fixed 
pore sizes that particles must be smaller than to pass through.  If large IBs are 
obtained, the pore sizes can be correspondingly large, which will permit the removal 
of more contaminants.  In addition, a cake layer forms to inhibit flux through the 
membrane, and the resistance of this cake is decreased when particle size is larger.  
Just as in the case of centrifugation, filtration is also made more efficient when IB 
particles are larger. 
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1.4.4. Chaperone co-expression 
 Some of the main evidence that IBs form from protein folding intermediates is 
the identity of the impurities found in IBs.  Some of these proteins are the elongation 
factor EF-Tu and the large ribosomal subunits L7, L12, and L13, suggesting IB 
formation is associated with protein synthesis [50].  Furthermore, research has shown 
that manipulating the levels of folding chaperones in the cell can affect IB formation. 
 The most dramatic and extensive results using chaperones for IB manipulation 
has been performed with DnaK and GroEL.  It has been suggested that the effects 
caused by other chaperones in IB formation have limited effect in comparison to these 
two chaperones [54].  In vitro experiments have shown that high DnaK concentrations 
can decrease insoluble protein levels by 90%.  GroEL, HtpG, IbpB, and BSA could 
not decrease insoluble protein by more than 25% in these same experiments [55].  
When immunolabeling was performed for these main chaperones in E. coli sections, it 
was found that DnaK is localized at the periphery of IBs and GroEL is located 
throughout the cell, including inside the protein aggregate [56].  A conclusion that 
could be made is that folding intermediates in contact with DnaK do not 
simultaneously aggregate.  Instead, DnaK becomes associated with aggregated 
protein, which is understandable because it works in combination with the 
deaggregation role of ClpB [55].  Meanwhile, GroEL can be trapped within IBs, and it 
may even possibly play a role in their formation and structure. 
It has been shown that coexpressing DnaJK or GroESL can increase yields of 
active protein.  Nishihara used E. coli strain MG1655 to produce Cryj2, an allergen of 
Japanese cedar pollen [57]. Thomas used E. coli strain JM105 to produce preS2-S’-B-
galactosidase and got identical results [58].  Both groups found that coexpressing 
DnaJK or GroESL could increase soluble levels of their target protein 3-6 fold and 4 
fold, respectively.  These experiments were all done at 30°C.  Thomas also showed 
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that DnaK coexpression maintained its effect at 37°C and 42°C, but GroEL had no 
effect at these elevated temperatures.  It was also shown that coexpressing σ32, a 
transcription factor that promotes the synthesis of DnaK, DnaJ, GrpE, GroEL, and 
GroES, could cause a 2-3 fold increase in soluble protein.   
It has been noted, however, that these chaperone coexpressions are not able to 
increase the solubility for many specific proteins.  Coexpressing chaperones to 
increase soluble protein levels appear to succeed on a “trial-and-error” basis [59].  
Also, less aggregated protein does not mean that there will be more soluble protein 
available.  One group found that GroEL would break apart human basic fibroblast 
growth factor IBs but that this protein is proteolysed instead of being introduced into 
the soluble fraction [60].  In other cases where more soluble protein was made, 
GroESL caused severe proteolysis [61]. 
 
1.4.5. Chaperone deletion 
Knocking out dnaJ and dnaK resulted in higher total expression of 
recombinant protein and much higher aggregation of Cryj2.  GroEL and groES 
mutants produced slightly lower amounts of total protein and produced more unstable 
Cryj2, but there was no noticeable difference in aggregation percentages [57].  In 
another study that used the protein VP1LAC as a model, it was agreed that knocking 
out dnaK results in larger IBs, but groEL removal resulted in numerous small protein 
aggregates with a much higher soluble protein fraction.  GroES knockouts did not 
show these phenomena [54].   
These results can be explained by additional findings about the roles of these 
chaperones.  When protein production is stopped, which can be done with the proper 
antibiotic, cytoplasmic IBs can be degraded in a matter of hours [62].  As such, even if 
net production is slow, there is always a rapid rate of protein synthesis and degradation 
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at play within the cell.  If DnaK is not present to assist in IB deaggregation, then IB 
formation will be effectively irreversible and the total amount of recombinant protein 
and its percentage in IBs will increase appreciably, as observed.  Meanwhile, the 
complete absence of GroEL has been shown to increase IB instability [54].  This may 
seem contradictory since both the overexpression and deletion of GroEL both cause 
decreased aggregation.  A possible explanation is that GroEL is an integral part of the 
natural IB structure, and its overabundance aids in disaggregation.  This may explain 
the dual roles of GroEL in supporting IB formation in the wildtype and increasing 
solubility at higher concentrations when it is coexpressed.  
The rpoH gene encodes for the σ32 factor.  Levels of this transcription factor 
are directly proportional to levels of DnaK, DnaJ, GrpE, GroEL, and GroES.  A 
∆rpoH mutant produced several fold more protein, all in the insoluble fraction [57].  It 
should be noted, however, that there are consequences for using such knockout 
mutants.  Particularly, removing rpoH causes severe growth defects and such cells can 
only be grown at 20°C [63].  Even operating at low levels of DnaK or GroEL has been 
shown to have cytotoxic effects that may influence IB kinetics indirectly [64]. 
 Further caution should be taken when interpreting data from these studies 
because chaperone levels are interconnected.  For example, clpA mutants have higher 
levels of DnaK and GroEL.  When DnaK accumulates in the cell, sigma-32 production 
is inhibited; GroEL accumulation does not have this effect [65].  It has also been 
shown that when GroE levels are reduced in the cell, σ32 expression increases to 
compensate [66].  This may simply be a response to accumulated unfolded protein 
within the cell. 
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1.4.6. Process conditions 
There have been numerous strategies developed to minimize IB formation on 
the fermentation scale.  Lowering temperature is the most common method to increase 
the percentage of soluble protein [67].  These low growth temperatures have also been 
shown to improve the solubility of the protein in IBs [68].  Similarly, better protein 
folding has been shown to be a result of slower feeding [69] and decreased promoter 
induction [70].  These methods likely decrease the rate of protein synthesis so that the 
available folding chaperones are not titrated.  Increasing medium osmolarity with 
certain salts, such as betaine and proline, also aid in folding [71].  Salts have been 
shown to complement the folding ability of GroEL [72].  For some proteins, site 
directed mutagenesis has been able to greatly enhance the amount of properly folded 
protein produced in the cell [73].   
 IB formation can be increased by increasing temperature, which has been 
demonstrated for temperatures up to 44ºC, or by decreasing the pH of growth medium, 
as low as 5.5. [74].  The amount of acetate accumulation permitted during 
fermentation is relevant since it will influence the pH.   
Different types of medium will also influence IB formation.  An enriched 
medium has been shown to increase soluble protein [75].  It has also been observed for 
β-galactosidase that IB formation can be avoided by growth in a complex medium 
[76].  Complex media avoid a stringent response commonly caused by using defined 
media [77].  On the other hand, it has also been shown with microarray analysis that 
the metabolic burden caused by growing cells at high cell densities is decreased in a 
chemically defined medium [78]. 
Other growth conditions have given inconsistent results in terms of IB 
formation.  Low dissolved oxygen levels, for example, can cause more or less IB 
formation depending on the promoter and vector used [79].  Adding ethanol (3% v/v) 
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to cultures increases IB formation for some proteins but has the opposite effects for 
others [80].   
 There has been some work connecting fermentation conditions with levels of 
sigma-32 expression.  Production of this factor is induced by high temperatures, 
starvation conditions [81], and damaged protein [82].  Damaged protein can be 
induced by alcohol (ethanol), heavy metals (CdCl2), antibiotics (novobiocin), and 
hydrogen peroxide.  Adding dithiothreitol (DTT) to cause a reducing stress increases 
DnaK levels and decreases that of GroEL [83].   
 
1.5. Tailoring IB physical and chemical characteristics 
 
1.5.1. IB classes 
At any given time, there is a distribution of IBs within a cell [84].  Using 
differential centrifugation, two groups of Vitreoscilla hemoglobin-like molecule 
(VHb) IBs were obtained from E. coli lysate.  One-dimensional and two-dimensional 
gel electrophoresis data suggested that the composition of these IB populations may be 
different [85].  A separate study of GFP-GST IBs suggested that there could be four 
different aggregation classes of those IBs, mainly inferred from different densities 
[86]. 
 
1.5.2. GFP studies 
 When induced in LB medium at an optical density of 0.5, insoluble GFP from 
cultures with plasmid pET21-b in BL21(DE3) E. coli was shown to be have more 
fluorescent activity at lower production temperatures.  This IB activity phenomenon 
was also observed in a fusion of GFP and a point mutant of Aβ42 Alzheimer peptide 
[87].  Additionally, it was found that GFP-Aβ42 IBs produced at higher temperatures 
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were more stable with respect to chemical denaturation when using proteinase K or 
guanidine hydrochloride.  It was also found, using phase contrast microscopy, that IBs 
produced at 18 ºC were 0.9 um in size while IBs produced from 25 ºC to 42 ºC were 
1.1 to 1.2 um in size. 
 Using a light scattering method, the size of GFP IBs was analyzed for cultures 
where different IPTG concentrations, temperatures, and time post-induction were used 
[88].  IBs produced at 37 ºC were in the size of 550-690 nm in 0.1 mM IPTG and 645-
715 nm in 2 mM IPTG.  IBs produced at 30 ºC spanned the range of 500-950 nm 
regardless of IPTG concentration. 
 
1.5.3. IPTG concentrations 
 Unlike GFP (Section 1.5.2), a study of a β-lactamase variant showed that 
increasing IPTG concentrations from 1 to 20 µmol per g dry cell weight decreased the 
diameter of inclusion bodies from 446 ± 50 to 371 ± 52 nm.  Size measurements were 
conducted using sedimentation field-flow fractionation [89]. 
 
1.5.4. Specific growth rates 
 Different-sized IBs were formed when apoptosis-inducing ligand 2 (Apo2L) 
was produced in E. coli with different specific growth rates immediately prior to 
induction in a complex medium [90].  Growing at 0.05 hr-1, Apo2L IBs were 0.28 um 
in size and had a trypsin digest half-time of 26 min.  The Apo2L IBs made when 
growing at 0.15 hr-1 at preinduction were 0.34 um in size, had a trypsin digest half-
time of 55 min, and were described as being more spherical.  The circular dichroism 
spectra of the first group of IBs more closely resembled the native spectra of soluble 
protein. 
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 Growth rates were limited during the production of α-galactosidase in a fed-
bacth E. coli fermentation.  IBs formed and α-galactosidase activity was low when the 
growth rate at induction was 0.2 hr-1.  No IBs were formed and activity was high at an 
induction growth rate of 0.06 hr-1.  At an induction growth rate of 0.12 hr-1, IBs did 
form and protein activity was not compromised, reinforcing the concept of different IB 
classes [91]. 
 
1.5.5. Fermentation Type 
IB formation has already been shown to be different in shake flasks instead of 
bioreactors.  Shake flask cultures tend to have more IB formation due to the lack of pH 
control [92]. 
Protein aggregation produced during fed-batch fermentations is different than 
batch fermentations.  The fibroblast growth factor hFGF-2, for example, forms IBs 
when grown in batch mode (OD600 = 0.4-0.6), but much of the protein becomes 
soluble when grown in a fed-batch fermentation (OD600 = 100) [76]. 
When switching from a complex medium in shake flasks to a defined medium in a 
fed-batch bioreactor, protein activity was found to be much higher for the production 
of α-galactosidase [91].  Although defined media typically favor IB formation, the use 
of a fed-batch fermentation outweighed this contribution. 
 
1.6. Conclusions 
IB formation is common in the production of recombinant proteins.  Most 
previous data has focused on decreasing the amount of insoluble protein in such 
productions.  The methods to do this, typically by adjusting chaperone levels, are 
complicated to practically implement and often partially effective at best.  These 
studies have also mostly been performed in shake flasks, but results will change if 
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protein is produced in a HCDC.  Previous studies also ignore the physical and 
chemical characteristic of IBs, although these qualities may affect final protein yields.  
This study aims to determine the effects of HCDC conditions on IB quality to suggest 
fermentation improvements to increase industrial process yields. 
As illustrated in Table 1.1, IB studies have been inconsistent at the cellular 
level with regards to the protein, plasmid, and E. coli strain studied.  These studies 
have also been inconsistent on the manufacturing level with regards to media 
composition, cell densities, and feeding strategies.  It is one of this study’s goals to 
summarize and discover new data on IB-dependence of fermentation conditions using 
a single, representative system of recombinant protein production. 
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CHAPTER 2 
 
FERMENTATION SETUP AND ASSAY DEVELOPMENT  
 
2.1. Background 
The goal of this project was to determine how fermentation conditions 
influenced the physical and chemical properties of IB formation during industrial-like 
protein production in E. coli.  Several enabling steps were necessary to gather this 
data.  First, cell banks had to be created with various IB-forming proteins.  Second, set 
of HCDC fermentation process had to be created that demonstrated standard variations 
in fermentation processes.  Third, techniques to measure the IB density, size, 
morphology, and chemical resistance had to be developed. 
 
2.2. Proteins used 
 Multiple proteins were used in this study to determine the generality of any 
phenomena observed.  A range of proteins were selected based on their likelihood to 
form IBs.  These were EGFP, SSX2, NY-ESO-1, and Melan-A.   
 
2.2.1. EGFP 
Enhanced Green Fluorescent Protein (EGFP) is a 29 kDa recombinant protein 
made of 265 amino acids.  There are His tags on both the N- and C- terminus.  It was 
selected as an ideal protein that exists as a soluble cytosolic protein when produced in 
E. coli.  EGFP differs from Green Fluorescent Protein (GFP) by a single point 
mutation.  Even though it has been demonstrated to have improved fluorescent 
properties [93], the excitation and emission spectra for EGFP are identical to GFP 
[94].  GFP has been used in the past in IB studies, particularly because its fluorescence 
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can be quantified to estimate proper protein folding [95].  According to a 
hydropathicity chart created by Vector NTI software (see Figure 2.1), EGFP is a very 
hydrophilic protein. 
 
Figure 2.1. Hydropathicity plot of proteins used in this study.  Values shown are 
calculated estimates from Vector NTI software based on protein sequence.  Positive 
values represent hydrophobic regions.  Negative values represent hydrophilic regions. 
 
EGFP DNA sequence: 
atggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcgacgtaaacggc
cacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcacca
ccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctacccc
gaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaag
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gacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaa
gggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctat
atcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtg
cagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctg
agcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccg
ccgggatcactctcggcatggacgagctgtacaagtag 
 
EGFP amino acid sequence: 
mvskgeelftgvvpilveldgdvnghkfsvsgegegdatygkltlkficttgklpvpwptlvttltygvqcfsrypd
hmkqhdffksampegyvqertiffkddgnyktraevkfegdtlvnrielkgidfkedgnilghkleynynshnv
yimadkqkngikvnfkirhniedgsvqladhyqqntpigdgpvllpdnhylstqsalskdpnekrdhmvllefvt
aagitlgmdelyk 
 
2.2.2. SSX2 
SSX2 is a cancer testis antigen that has been shown to activate both CD4 and 
CD8 T cells of the adaptive immune system against several different types of cancer, 
such as synovial sarcoma [96].  It is classified as a nuclear protein and is even more 
hydrophilic than EGFP (see Figure 2.1). 
 
SSX2 DNA sequence: 
atgaacggagacgacgcctttgcaaggagacccacggttggtgctcaaataccagagaagatccaaaaggccttcg
atgatattgccaaatacttctctaaggaagagtgggaaaagatgaaagcctcggagaaaatcttctatgtgtatatgaag
agaaagtatgaggctatgactaaactaggtttcaaggccaccctcccacctttcatgtgtaataaacgggccgaagact
tccaggggaatgatttggataatgaccctaaccgtgggaatcaggttgaacgtcctcagatgactttcggcaggctcca
gggaatctccccgaagatcatgcccaagaagccagcagaggaaggaaatgattcggaggaagtgccagaagcatc
tggcccacaaaatgatgggaaagagctgtgccccccgggaaaaccaactacctctgagaagattcacgagagatct
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ggacccaaaaggggggaacatgcctggacccacagactgcgtgagagaaaacagctggtgatttatgaagagatca
gcgaccctgaggaagatgacgagtaa 
 
SSX2 amino acid sequence: 
mngddafarrptvgaqipekiqkafddiakyfskeewekmkasekifyvymkrkyeamtklgfkatlppfmc
nkraedfqgndldndpnrgnqverpqmtfgrlqgispkimpkkpaeegndseevpeasgpqndgkelcppgk
pttsekihersgpkrgehawthrlrerkqlviyeeisdpeedde 
 
2.2.3. NY-ESO-1 
NY-ESO-1 is a cancer testis antigen expressed on over 50% of all cancer 
tumors, including esophageal cancer where it was initially isolated [97].  It also has 
been shown to activate both CD4 and CD8 T cells and is currently being tested in 
Phase I clinical trials.  NY-ESO-1 has a large hydrophobic region (see Figure 2.1). 
 
NY-ESO-1 DNA sequence: 
atgcaggccgaaggccggggcacagggggttcgacgggcgatgctgatggcccaggaggccctggcattcctgat
ggcccagggggcaatgctggcggcccaggagaggcgggtgccacgggcggcagaggtccccggggcgcagg
ggcagcaagggcctcggggccgggaggaggcgccccgcggggtccgcatggcggcgcggcttcagggctgaat
ggatgctgcagatgcggggccagggggccggagagccgcctgcttgagttctacctcgccatgcctttcgcgacac
ccatggaagcagagctggcccgcaggagcctggcccaggatgccccaccgcttcccgtgccaggggtgcttctga
aggagttcactgtgtccggcaacatactgactatccgactgactgctgcagaccaccgccaactgcagctctccatca
gctcctgtctccagcagctttccctgttgatgtggatcacgcagtgctttctgcccgtgtttttggctcagcctccctcagg
gcagaggcgctaa 
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NY-ESO-1 amino acid sequence: 
mrgshhhhhhgsmqaegrgtggstgdadgpggpgipdgpggnaggpgeagatggrgprgagaarasgpggg
aprgphggaasglngccrcgargpesrllefylampfatpmeaelarrslaqdapplpvpgvllkeftvsgniltirlt
aadhrqlqlsissclqqlsllmwitqcflpvflaqppsgqrr 
 
2.2.4. Melan-A 
Melanoma antigen A (Melan-A), also known as melanoma antigen recognized 
by T-cells 1 (MART-1), is a membrane protein that serves as a differentiation antigen 
[98].  The sequence was extracted from tumor-infiltrating lymphocytes in T-cells that 
act in cancer regression.  Able to stimulate CD4 and CD8 T cell responses, it is also 
hypothesized to function as a possible melanoma cancer vaccine.  There is evidence 
that this antigen is expressed in 80-90% of primary tumors [99].  Aside from a direct 
treatment, this antigen can also be used to assay antibodies that are being developed to 
target cancer cells directly.  It has a major hydrophobic domain (see Figure 2.1). 
 
Melan-A DNA sequence: 
atgccgcgcgaagatgcgcacttcatttatggttacccgaaaaaggggcatggccacagctacaccacggctgaaga
ggccgcgggtatcggcattctgaccgtgatcctgggagtcttactgctcattggctgttggtattgccgtcgccgtaacg
gttaccgcgcattgatggataaaagtcttcatgttggcactcagtgtgccttaacacgtcgctgcccgcaagaagggttt
gatcatcgggacagcaaagtatctctgcaggagaaaaactgcgaacctgtggttcccaatgcgccaccggcttatga
gaaactgtccgcagaacagtcgccgccaccttattcaccgtga 
 
Melan-A amino acid sequence: 
mpredahfiygypkkghghsyttaeeaagigiltvilgvllligcwycrrrngyralmdkslhvgtqcaltrrcpqe
gfdhrdskvslqekncepvvpnappayeklsaeqspppysp 
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2.3. Creation of research cell banks 
 
2.3.1. Design of synthetic DNA sequence 
 The primary protein used in this study was Melan-A.  A His-tag was added to 
this protein to aid in purification.  A synthetic version of this plasmid was designed to 
avoid stringent responses based on codon bias.  Graphical Codon Usage Analyzer 
(www.gcua.de) was used to determine the frequency of codons used in K-12 
Escherichia coli.  The data for this strain was readily available, and it was assumed 
that this strain would have a very similar codon usage compared to a C41 strain.  The 
genetic code of Melan-A was altered manually to match this codon bias as closely as 
possible.  The original DNA sequence and new DNA sequence listed in Table 2.1.   
 
Table 2.1. GCUA of natural Melan-A and Syn-Melan-A.  Codons and their 
frequency in K-12 E. coli are shown.  The frequency of each codon in the natural 
Melan-A DNA sequence is also shown with frequencies in an adjusted synthetic 
sequence.  
Amino Acid Codon K12 Melan-A Syn-Melan-A 
Alanine GCT 16.1% 41.7% 16.7% 
  GCC 27.0% 33.3% 25.0% 
  GCA 21.3% 16.7% 25.0% 
  GCG 35.6% 8.3% 33.3% 
          
Arginine AGA 3.6% 62.5% 0.0% 
  AGG 2.0% 0.0% 0.0% 
  CGT 38.2% 0.0% 37.5% 
  CGC 40.0% 12.5% 50.0% 
  CGA 6.4% 12.5% 0.0% 
  CGG 9.8% 12.5% 12.5% 
          
Asparagine AAT 44.9% 66.7% 33.3% 
  AAC 55.1% 33.3% 66.7% 
          
Aspartic Acid GAT 62.6% 50.0% 75.0% 
  GAC 37.4% 50.0% 25.0% 
          
Cysteine TGT 44.3% 80.0% 40.0% 
  TGC 55.7% 20.0% 60.0% 
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Table 2.1. (Continued) 
(Stop) TAA 64.5% 0.0% 0.0% 
  TAG 6.5% 0.0% 0.0% 
  TGA 29.0% 100.0% 100.0% 
          
Glutamine CAA 34.6% 75.0% 25.0% 
  CAG 65.4% 25.0% 75.0% 
          
Glutamic Acid GAA 69.0% 44.4% 66.7% 
  GAG 31.0% 55.6% 33.3% 
          
Glycine GGT 33.8% 10.0% 30.0% 
  GGC 40.5% 40.0% 40.0% 
  GGA 10.7% 20.0% 10.0% 
  GGG 14.9% 30.0% 20.0% 
          
Histidine CAT 57.1% 18.2% 54.5% 
  CAC 42.9% 81.8% 45.5% 
          
Isoleucine ATT 50.8% 0.0% 60.0% 
  ATC 42.1% 100.0% 40.0% 
  ATA 7.2% 0.0% 0.0% 
          
Leucine CTT 10.3% 18.2% 9.1% 
  CTC 10.4% 27.3% 9.1% 
  CTA 3.7% 0.0% 0.0% 
  CTG 49.8% 27.3% 54.5% 
  TTA 13.0% 18.2% 18.2% 
  TTG 12.8% 9.1% 9.1% 
          
Lysine AAA 76.6% 66.7% 83.3% 
  AAG 23.4% 33.3% 16.7% 
          
Methionine 
(Start) ATG 100.0% 100.0% 100.0% 
          
Phenylalanine TTT 57.2% 50.0% 50.0% 
  TTC 42.8% 50.0% 50.0% 
          
Proline CCT 15.9% 36.4% 18.2% 
  CCC 12.2% 18.2% 9.1% 
  CCA 19.0% 45.5% 18.2% 
  CCG 52.8% 0.0% 54.5% 
          
Serine AGT 15.1% 14.3% 8.3% 
  AGC 27.9% 14.3% 58.3% 
  TCT 14.5% 42.9% 8.3% 
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Table 2.1. (Continued) 
  TCC 14.9% 0.0% 8.3% 
  TCA 12.3% 28.6% 8.3% 
  TCG 15.4% 0.0% 8.3% 
          
Threonine ACT 16.5% 20.0% 0.0% 
  ACC 43.7% 20.0% 60.0% 
  ACA 13.0% 40.0% 0.0% 
  ACG 26.8% 20.0% 40.0% 
          
Tryptophan TGG 100.0% 100.0% 100.0% 
          
Tyrosine TAT 56.9% 57.1% 57.1% 
  TAC 43.1% 42.9% 42.9% 
          
Valine GTT 25.8% 33.3% 33.3% 
  GTC 21.6% 16.7% 16.7% 
  GTA 15.4% 0.0% 0.0% 
  GTG 37.1% 50.0% 50.0% 
 
Codons that were changed are shown in bold.  Added nucleotides are italicized. 
old sequence: 
atg cca cgc gag gac gct cac ttc atc tat ggt tac ccc aag aag ggg cac ggc cac tct  
tac acc acg gct gaa gag gcc gct ggg atc ggc atc ctg aca gtg atc ctg gga gtc tta ctg 
ctc atc ggc tgt tgg tat tgt aga aga cga aat gga tac aga gcc ttg atg gat aaa agt ctt cat 
gtt ggc act caa tgt gcc tta aca aga aga tgc cca caa gaa ggg ttt gat cat cgg gac agc 
aaa gtg tct ctt caa gag aaa aac tgt gaa cct gtg gtt ccc aat gct cca cct gct tat gag  
aaa ctc tct gca gaa cag tca cca cca cct tat tca cct gcg gcc gca ctc gag cac cac cac 
cac cac cac tga 
 
new sequence: 
cat atg ccg cgc gaa gat gcg cac ttc att tat ggt tac ccg aaa aag ggg cat ggc cac agc 
tac acc acg gct gaa gag gcc gcg ggt atc ggc att ctg acc gtg atc ctg gga gtc tta ctg 
ctc att ggc tgt tgg tat tgc cgt cgc cgt aac ggt tac cgc gca ttg atg gat aaa agt ctt cat 
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gtt ggc act cag tgt gcc tta aca cgt cgc tgc ccg caa gaa ggg ttt gat cat cgg gac agc 
aaa gta tct ctg cag gag aaa aac tgc gaa cct gtg gtt ccc aat gcg cca ccg gct tat gag 
aaa ctg tcc gca gaa cag tcg ccg cca cct tat tca ccg gcg gcc gca ctg gaa cac cat cac 
cat cac cat tga gga tcc 
 
In addition to the codon changes, the new sequence also contains additional 
nucleotides at both ends.  These sequences coded for restriction sites so that restriction 
enzymes could used to create sticky ends on the sequence.  Specifically, the CATATG 
sequence codes for NdeI and the GGATCC sequence codes for BamH1.   
The synthetic Melan-A (Syn-Melan-A) sequence with the improved codon bias 
for E. coli was synthesized by Integrated DNA Technologies (IDT, Coralville, IA).  
The DNA sequence was synthesized in a pZErO-2 vector.  The synthesized plasmid 
was resuspended to 124 ng/µl in DNase free water to create a working plasmid 
solution. 
 
2.3.2. Plasmid production 
 The pZErO-2 vectors were produced in Top10 E. coli cells.  A heat shock 
transformation was performed by adding 1 µl of the working plasmid solution to 50 µl 
of One Shot Top10 competent cells (Invitrogen, Carlsbad, California).  This solution 
was left on ice for 30 min.  The solution was then placed at 42°C for 35 seconds 
before being returned to ice for another 2 min.  The transformed cells were then 
diluted with 250 µl SOC medium (0.5 % (w/v) yeast extract, 2 % (w/v) tryptone, 8.6 
mM NaCl, 2.5 mM KCl, 20 mM MgSO4, 20 mM glucose) and put in a 37°C shaker 
for 1 hr.  50 µl of these cells were then spread on LB plates containing 100 µg/ml 
kanamycin and left in a 37°C incubator overnight. 
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 One of the colonies that formed was grown in 20 ml of LB medium 
supplemented with kanamycin overnight at 37°C.  Plasmid extraction was performed 
on these cultures with a Miniprep Kit (Qiagen, Valencia, CA) following the 
instructions in the kit without modification.  Using kit solutions, the cells were 
pelleted, resuspended, and lysed.  The lysis was neutralized with another solution and 
the precipitated protein was removed by centrifugation.  Supernatant containing the 
plasmids was run through the kit’s miniprep column, which was subsequently rinsed 
with kit wash buffer and eluted with DNase free water.   
 
2.3.3. Plasmid construction 
 Steps were taken to transfer the Syn-Melan-A sequence from its pZErO-2 
vector to a pET9a24a vector.  This plasmid, pET9a24a, was a combination of two 
commercially available plasmids (Novagen, Darmstadt, Germany).  The promoter and 
kanamycin resistance from the pET9a plasmid was conserved, and the multiple 
cloning site of pET24a was added (see Figure 2.2a).  The creation of this vector was 
performed by Dr. Todd Vannelli (Cornell University, Ithaca, NY). 
 NdeI and BamH1 restriction enzymes were obtained from New England 
Biosciences (NEB, Beverly, MA).  According to the manufacturer, these enzymes 
function with optimal activity in NEB Buffer 2 with added bovine serum albumin 
(BSA).  2 µg of the pZErO-2 plasmid was added to 5 µl of 10x NEB Buffer 2 and 0.5 
µl of 100x BSA.  Water was added to bring this volume up to 46 µl before 1 µl of 
NdeI and BamH1 enzymes were each added.  The digest was incubated at 37°C for 4 
hr.  The digestion was then set at 65°C for 10 min to deactivate the enzymes.  An 
identical digestion was also performed with the pET9a24a vector. 
 Digested pZErO-2 with Syn-Melan-A insert and pET9a24a vector were run on 
a 1% agarose gel in Tris-Acetate-EDTA (TAE) buffer.  Bands of the Syn-Melan-A 
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DNA insert and pET9a24a vector were cut out and purified using a Plasmid Maxi Kit 
(Qiagen, Valencia, CA).  Aliquots of 30 fmol of the purified digested vector and 90 
fmol of the insert were mixed together and diluted to 17 µl.  2 µl of ligation buffer and 
1 µl of ligase were added to this solution, and the solution was incubated at 16°C 
overnight.  The solution was then left at room temperature for 1 hr and then put on ice.  
Another transformation into One Shot Top10 cells was performed, and kanamycin 
resistant colonies were grown up overnight.  The Syn-Melan-A pET9a24a plasmid 
was extracted with a Miniprep.  The plasmid map, as displayed by Vector NTI 
software, is shown in Figure 2.2b. 
. 
 
Figure 2.2.  Plasmid maps of a) pET9a24a and b) Syn-Melan-A in vector 
pET9a24a.   
 
2.3.4. Research cell bank transformation 
C41(DE3) E. coli cells (Lucigen, Middleton, WI) were made chemically 
competent in the following way.  An aliquot of 250 µl of an overnight culture of C41 
a)                                                                   b) 
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cells were used to inoculate 25 ml of APS Luria Broth (LB) glycine medium (20 g/L 
APS LB, 1.1% glycine, 5 g/L NaCl) in a 125 ml baffled shake flask.  These cells were 
grown at 25°C until the opitcal density measured at 600 nm (OD600) reached 0.5.  This 
culture was then put on ice for 10 min.  The cells were pelleted in a HERMLE 
Z400_K refrigerated centrifuge (Labnet, Edison, NJ) at 4°C at 5,000g for 10 min and 
resuspended in 5 ml of ice cold transformation buffer (4 g/L HEPES, 15 ml 1 M 
CaCl2, 18.64 g/L KCl, 10.88 g/L MnCl2·4H2O, 25 µl/ml 1 M DTT).  The cell 
suspension was incubated on ice for another ten min before being pelleted again.  This 
pellet was reuspended in 0.93 ml of ice cold transformation buffer and 70 µL of 
DMSO.  The cell suspension was left on ice for an additional 10 min and then frozen 
in 100 ml aliquots at -80°C. 
A heat shock transformation with the Syn-Melan-A plasmid into the competent 
C41 cells was performed using the same protocol used for the Top10 cells and 
previous plasmid constructs.  The cells were grown in LB medium until they reached 
an OD600 of 1.5, which was representative of early exponential growth.  At this point, 
sterilized glycerol was added to a final concentration of 15% (v/v).  1 ml aliquots were 
frozen at -80°C.  This concluded the construction of the Syn-Melan-A research cell 
bank. 
 
2.3.5. Other plasmids 
 Like Syn-Melan-A, all proteins used in this study were present in pET9a24a 
plasmids in C41(DE3) E. coli.  The SSX2, EGFP, and NY-ESO-1 research cell banks 
were constructed, with analogous techniques as the Syn-Melan-A plasmid, by Chung-
Jr Huang, Dr. Nuttawee Niamsiri, and Dr. Todd Vannelli, respectively (Cornell 
University, Ithaca, NY).  The SSX2 and EGFP genes were not synthetic.  The NY-
ESO-1 DNA sequence was synthetic, but it was designed by only changing the rarely 
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used E. coli codons in the sequence to frequently used E. coli codons.  In Leucine, for 
example, the CTA codons (4% natural frequency) were changed to CTG (50% natural 
frequency), but the TTA codons (11% natural frequency) were unchanged regardless 
of frequency present in the protein code.   
 In the case of SSX2 and NY-ESO-1, a second transformation was performed.  
These transformed cell banks were individually made chemically competent, and a 
pRARE plasmid (Novagen, Darmstadt, Germany) was inserted into each using a heat 
shock transformation.  Preparing chemically competent cells and heat shock 
transformation procedures were identical to those described above. Properly 
transformed cells were selected from plates of LB medium and agar that ultimately 
contained both 100 µg/ml kanamycin and 34 µg/ml chloramphenicol. 
 
2.4. Fermentation conditions 
 
2.4.1. Complex medium 
Two types of complex media were used for each fermentation.  A complex 
batch medium was used for the inoculum and initial bioreactor growth.  Once the 
dextrose in the complex batch medium was depleted, a complex feed medium was 
added to the fermentor at a controlled rate.   
The recipe for the complex batch medium used in this study was 3 g/L 
[NaPO3]6, 1.6 ml/L 2 M MgSO4·7H2O, 1.9 g/L Citrate·H2O, 2.1 g/L NH4Cl, 0.1 g/L 
FeSO4·7H2O, 15 g/L yeast extract, 20 g/L dextrose, 0.2 µg/L MnCl2·4H2O, pH 7.0.  
When grown in a bioreactor, 0.4 ml/L of Antifoam 204 was added.  The complex feed 
medium used was 3 g/L [NaPO3]6, 10.5 g/L MgSO4·7H2O, 2.6 g/L Na3Citrate·2H2O, 3 
g/L (NH4)2CO3, 0.1 g/L FeSO4·7H2O, 210 g/L yeast extract, 275 g/L dextrose, 2.4 
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µg/L MnCl2·4H2O.  Isopropyl-β-D-thiogalactopyranoside (IPTG) was also added to 
the feed medium, to a final fermentation concentration of 2.25 mM.   
The same complex medium was used for all proteins used in this study.  All 
media contained 100 µg/ml kanamycin for sterility and genetic stability.  34 µg/ml 
chloramphenicol was added to all SSX2 and NY-ESO-1 media.  Even though 
contamination in the feeding phase could not outgrow the HCDC culture, it was added 
with the intention to prevent any cells lacking plasmid to overtake the culture.  In 
BL21(DE3), plasmids can be stable throughout logarithmic phase but unstable during 
stationary phase [100].  
Ferrous sulfate, ammonium hydroxide, manganese chloride, ammonium 
carbonate, kanamycin, chloramphenicol, and Antifoam 204 were obtained from 
Sigma-Aldrich (St. Louis, MO).  Dextrose and ammonium chloride were obtained 
from Thermo Fisher Scientific.  Sodium hexametaphosphate, citric acid, magnesium 
sulfate, and sodium citrate were obtained from Mallincrodt Baker (Phillipsburg, NJ).  
Yeast extract and IPTG was obtained from EMD Biosciences (San Diego, CA). 
 
2.4.2. Chemically defined medium 
The transformed cells were adapted to a chemically defined medium recipe 
taken from the literature [101].  Modifications were made to the medium composition 
to better accommodate a high cell density process.  The final chemically defined batch 
medium composition was 14.6 g/L K2HPO4, 4.1 g/L NaH2PO4H2O, 8.0 g/L 
(NH4)2SO4, 40.0 g/L dextrose, 20.0ml/L 1 M MgSO4, 4.75 ml/L trace metals, 0.05 g/L 
CaCl2.  When grown in a bioreactor, 1.0 ml/L of Antifoam 204 was added to the 
chemically defined batch medium.  Chemically defined feed medium was 500 g/L 
dextrose, 10 g/L (NH4)2SO4, 50 ml/L 1 M MgSO4, and 10 ml/L trace metals.  The 
trace metal recipe was 260.0 g/L FeSO4·nH2O, 15.5 g/L CuSO4·5H2O, 21.1 g/L 
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CoCl2·6H2O, 45.0 g/L MnSO4·H2O, 21.1 g/L Na2MoO4·2H2O, 29.2 g/L ZnSO4·7H2O, 
5.26 g/L H3BO3, 26.3 ml/L H2SO4.  Dextrose was obtained from Thermo Fisher 
Scientific.  Curpic sulfate, cobalt chloride, and dibasic potassium phosphate were 
obtained from Sigma-Aldrich (St. Louis, MO).  All other chemicals were from 
Mallincrodt Baker (Phillipsburg, NJ). 
Transformed cells from a glycerol stock of complex medium were used to 
inoculate a 250 ml unbaffled shake flask of chemically defined medium.  Once the 
cells reached an optical density of 1.0, indicating entry into early exponential growth 
two days post-inoculation, they were also banked.  This process was repeated once 
more with the new bank to fully adapt the cells, minimizing the observed initial lag in 
growth.  To confirm the adaptation, the plasmids from the cells were extracted with a 
MiniPrep.  The restriction enzymes used to construct the original plasmids were used 
and the DNA fragments were run on an agarose gel; the respective restriction 
fragments matched (Figure 2.3).  These cells have also been grown in 2.5 L HCDC 
and shown to express Melan-A. 
An attempt to adapt these cells to a chemically defined medium containing 
[NaPO3]6 as the sole phosphate source failed.  Also known as phosphate glass, this 
hexametaphosphate is a polymeric chain that prevents precipitation with metals in 
media.  Unfortunately cells were not able to grow on it, suggesting that the usable 
phosphate source in the complex medium came solely from the yeast extract.  Cells 
could be grown in complex medium lacking the [NaPO3]6, but the original recipe was 
not changed to maintain consistency amongst all fermentations conducted. 
 
 
 
 
1     2       3      4 
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Figure 2.3. Agarose gel of Melan-A plasmids extracted from transformed cells.  
Lanes 1 and 2 show uncut and cut plasmids extracted from transformed cells, 
respectively.  Lanes 3 and 4 show uncut and cut plasmids extracted from chemically 
defined medium adapted cells. 
 
2.4.3. Fermentation conditions 
 Fermentations were conducted in a 2.5 L Bioflo 3000 fermentor (New 
Brunswick Scientific, Edison, NJ).  AFS-Biocommand Bioprocessing software 
version 2.6 (New Brunswick Scientific) was used for data acquisition and parameter 
control.  The pH of the medium was adjusted with the addition of 5 N sodium 
hydroxide.  The dissolved oxygen was maintained above 40 % air saturation with 
oxygen-enriched air.  Temperature was maintained with a jacketed base. 
One liter of batch medium was autoclaved per fermentation.  Two fermentor 
units were sterilized for 45 min at 121ºC.  Calibration of the pH probe was performed 
prior to sterilization with individually packed pH 4 and 7 standards (VWR, West 
Chester, PA).  A solution of 5 N sodium hydroxide was added to the fermentator to 
bring the pH to 7.0.  This operating pH was confirmed on an external pH meter.  
Filtered air entered the fermentor through a ring sparger located directly below the 
impeller at 2 L/min, 1 vvm of the final volume.  The two data points for dissolved 
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oxygen (DO) calibration were created by unplugging the probe and by allowing the 
medium to reach 100% air saturation.  DO started at 100% air saturation, and oxygen-
enriched air was added to keep the DO level at 40% air saturation in the latter stages 
of the fermentation.  Temperature of batch cultures were all 37°C, and agitation was 
1,000 rpm.  pH was maintained at 7.0.  An example profile is shown in Figure 2.4. 
 Some of the medium components were not autoclaved and instead filter 
sterilized through a 0.22 µm pore size vacuum filter (Nalgene Labware, Rochester, 
NY).  For the complex batch medium, dextrose, magnesium sulfate, manganese 
chloride, and antibiotics were added to the fermentor after reactor sterilization.  For 
the complex feed medium, yeast extract, sodium hexametaphosphate, ammonium 
carbonate, and IPTG were added after the other components were autoclaved.  For the 
chemically defined batch medium, only the potassium phosphate and sodium 
phosphate were autoclaved with the reactor.  All other components were added from 
filter-sterilized stocks.  The entire chemically defined feed medium was filter 
sterilized, and the filtered trace metals were added post-sterilization.  
 A 45 ml inoculum was grown for each fermentation in a 250 ml unbaffled 
shake flask.  Complex batch medium was used and inoculated with 45 µl of thawed 
research cell bank and grown at 37°C in a MaxQ 5000 shaker (Barnstead, Dubuque, 
Iowa).  After 7-9 hr, the OD600 was 2.5, suggesting cells were in mid-exponential 
growth phase, and 40 ml (4% v/v) of the inoculum was added to the fermentor.  After 
6 hr, the dextrose in the medium would be depleted, as indicated by a rise in pH.  
Feeding was initiated until the feed medium was depleted, typically 20-40 hr elapsed 
fermentation time.  Cell broth was collected in 500 ml centrifuge bottles (Corning, 
Corning, NY) and pelleted by centrifugation in a Sorvall RC-5B centrifuge using a 
SH-3000 rotor (Thermo Fisher Scientific, Waltham, MA) at 4°C for 40 min at 4,000 
rcf.  Supernatant was discarded and cell pellets were stored at -20°C. 
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Figure 2.4. Melan-A Fermentation profile during high cell density culture.  
Dissolved oxygen and pH were continuously monitored.  A pH spike at 6 hr elapsed 
fermentation time indicated that feeding needed to be initiated.  Optical density was 
measured from reactor samples. 
 
2.4.4. Feeding strategies 
 Various feeding strategies were used in this study’s fermentations.  The default 
feeding method performed was a pH-stat technique.  In this technique, feed medium 
was added to the fermentor in response to pH increases, which are a response to 
limited carbon.  Decreases in pH are created by acetic acid production as a subsequent 
result of feeding.  As a result, base addition is terminated once feeding begins. 
 Constant feeding techniques added feed medium to the reactor at a constant 
rate.  Values of 25, 45, and 80 ml/hr were used.  pH was maintained with 1 M 
phosphoric acid at the slowest feed rate and with 5 M sodium hydroxide at the higher 
two constant feed rates.  A step feed method started feeding 25 ml/hr, and this feed 
rate would increase by 10 ml/hr at every pH spike.  Base control with sodium 
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hydroxide was needed.  A linear feed also started at 25 ml/min and increased linearly 
at different rates. 
 It was also during feeding that protein production started because IPTG was 
included in the feed medium.  Therefore, any variables to be changed in the 
fermentation, such as temperature, were initiated when feeding started. 
 
2.4.5. Statistical Design 
 Multiple fermentation parameters have been shown to influence IB formation.  
Statistical design of experiments allow us to evaluate factors independently while 
varying several factors simultaneously, ultimately reducing the number of experiments 
necessary to get accurate estimates.  These studies typical look at two-factor 
interactions which result in an equation for a response variable as shown [102]. 
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Here, Y is the response parameter, such as inclusion body size or density.  Xi 
are the design parameters, such as fermentation temperature, that influence the 
response parameter.  All other variables are coefficients or intercepts.  A factorial 
design explores the main effects of each factor (Xi) on two levels (-1, +1).  The 
number of experiments needed are 2X.  When the factors are too numerous, then a 
fractional factorial design is used that reduces the total number of experiments, while 
still generating enough data to get estimates of main effects.  A central composite 
design uses three (-1, 0, +1) or more levels to see generate response surface designs. 
  SAS-JMP software was used to design a central composite design of 
experiment (DOE) to analyze various fermentation parameters on IB formation.  
Relevant parameters were temperature, feeding rate, growth rate, IPTG concentration, 
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Figure 2.5. Simple experimental design using central composite design of 
experiment.  Two factors, temperature and feed rate, are tested over three levels each.  
One experiment is performed in duplicate to determine the error variation.  
Experiments designed for 36ºC were performed at 37ºC. 
 
and pH.  Because growth rate could be considered a dependent variable, it was 
observed, but it was not included in the experimental design.  Various linear feed rates 
were used in this experimental design, but the design does not accommodate different 
feeding strategies, so these set of experiments were conducted outside the statistical 
experimental set.  IPTG concentration and pH were not included in the experimental 
design to keep a manageable number of necessary experiments.  The final design, after 
randomization, is shown in Figure 2.5. 
 
2.5. Fermentation Measurements 
 
2.5.1. Feeding Rate Calibration 
 The Biocommand Software constantly monitored a unitless pump rate (0-125) 
for the addition of feed medium to the bioreactor.  This pump rate had to be calibrated 
to determine the actual amount of feed added to the fermentor at any given time.  This 
was done by manually weighing feed medium reservoir and calculating the amount of 
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feed removed at various time points.  For simplicity, these measurements were done 
during constant feeding pump rates.  Results are summarized in Figure 2.6. 
At a constant feeding rate of 8.0, 55.5 g of complex feed medium was added 
per hr.  This rate was 109.0 g/hr for a constant feeding rate of 16.0.  For a single pump 
rate unit, the constant feed rates of 8.0 and 16.0 added 6.812 and 6.813 g/hr, 
respectively.  The complex feed medium density of 1.176 g/ml was determined by 
measuring the mass of a 50 ml sample.  Each pump unit was therefore equivalent to 
5.793 ml/hr. 
 
Figure 2.6. Feed rates at different feed pump settings.  The amount of feed added at 
pump setting 8 and 16 are shown.  Also indicated on the secondary axis the actual feed 
rate at various timepoints. 
 
2.5.2. Cell Density Measurements 
 Optical density was the primary value measured to determine the cell density 
at any given time throughout the fermentation.  Measurements were performed on an 
Ultrospec 2000 spectrophotometer (General Electric Healthcare, Piscataway, NJ).  
Measurements were performed at a wavelength of 600 nm.  The spectrophotometer 
was blanked with 800 ml of phosphate buffered saline (PBS) in a 1.5 ml polymethyl 
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Figure 2.7. Optical density and dry cell weight correlation.  Fermentation broth 
samples were taken throughout a fermentation.  Optical density samples were 
measured using a spectrophotometer and dry cell weights were measured from cell 
pellets from 1 ml broth. 
 
methacrylate semi-micro disposable cuvette (Brand, Wertheim, Germany).  A five 
hundred-fold serial dilution was performed in PBS.  A 100 µl aliquot of fermentation 
broth was mixed with 900 µl of PBS, and 100 µl of this mixture was mixed with 
another 900 µl aliquot of PBS.  Finally, 200 µl of this mixture was added and mixed 
with the PBS in the cuvette, and a measurement was taken. 
 A method for measuring dry cell weights is described in Section 2.11.  Values 
for optical density and dry cell weight were compared to determine a correlation 
(Figure 2.7).  For the spectrophotometer and cells used in this study, this correlation 
value was approximately 0.34 g/ml per optical density unit.  An absorbance of 1.0 at 
600 nm is roughly equivalent to 5 x 108 to 109 cells/ml [100]. 
 
2.5.3. Protein Production Measurements 
 Samples were taken at various timepoints throughout all fermentation runs 
performed in this study.  Cells were pelleted in a HERMLE Z200_M/U non-
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refrigerated centrifuge (Labnet, Edison, NJ) for 3 min at 12,000 rcf in 1 ml aliquots.  
The supernatant was removed and the cell pellet was stored at -20°C. 
 Cell pellets were lysed using a chemical lysis buffer (100 µl/ml bugbuster 
(Novagen, Darmstadt, Germany), 1 µl/ml lysozyme, 50 mM Tris, 1 mM EDTA, 1 mM 
β-mercaptoethanol).  The cell pellets were thawed and suspended in this buffer.  For 
the cell masses used in this study, it was necessary to leave the suspensions shaking 
overnight.  Soluble and insoluble fractions were separated using centrifugation for 10 
min at 12,000 rcf. 
 The samples were subjected to sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE).  All gels and reagents were purchased from Invitrogen 
(Carlsbad, CA).  An aliquot of 10 µl of each protein fraction was added to 60 ul 8 M 
urea, 25 µl NuPAGE 4x lithium dodecyl sulphate (LDS) buffer, and 5 µl β-
mercaptoethanol.  This sample was heated at 65°C for 10 min, cooled to room 
temperature, and centrifuged at 1,000 rcf briefly.  Sample were then loaded onto 
NuPAGE 10% Bis-Tris gels.  For 10, 12, and 15 well gels, 10, 7.5, and 5 ml of sample 
was loaded into each well.  Gels were run in a Novex Mini Cell box at 200 V for 38 
min.  After rinsing the gel for 5 min in deionized water three times, it was stained in 
SimplyBlue Safestain overnight.  The stained gel was destained in deionized water for 
at least 2 hr.  Western blots were performed using reagents from a WesternBreeze kit 
(Invitrogen, Carlsbad, CA).  The transfer was performed at 30 V for 90 min. 
 Gels were scanned on a Stylus CX4200 scanner (Epson, Long Beach, CA).  
Images were subjected to analysis using Image J densitometry software (National 
Institutes of Health, Bethesda, MD).  Without a standard, Image J software can be 
used to compare pixel counts of protein bands on the same gel based on area and color 
density.  The software is primarily used for rough estimates only.  Protein fractions 
can be compared to determine percentages of protein in the soluble or insoluble 
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fractions.  Protein bands from different fermentations can also be compared to 
determine relative increases or decreases in production.   
 
2.6. Inclusion body isolation 
 Frozen cell pellets were restored to their original 450 ml broth volumes in 20 
mM Tris buffer, pH 8.0.  The cell pellets were permitted to thaw in a 37°C water bath 
for 10-20 min.  Cell pellets were then resuspended and blended before being 
introduced to an Emulsiflex-C3 microfluidizer (Avestin, Ontario, Canada).  
Resuspended cell pellets were sent through the homogenizer three times at 12,000 
peak psi. 
 To obtain optimal separation, IBs were separated by centrifugation in the same 
centrifuge used in Section 2.5.3 for 10 min at 12,000 rcf in 1.5 ml aliquots.  
Supernatant was removed as the soluble protein fraction.  The pellet was resuspended 
in IB wash buffer (50 mM Tris, 1% Tween-20, 1 mM EDTA, 200 mM NaCl, 1 mM β-
mercaptoethanol, pH 8.0).  The resuspension was allowed to rock at room temperature 
for 10 min.  The wash, resuspension, and incubation with IB wash buffer was repeated 
once, and the IBs were then washed twice in 20 mM Tris. 
 It has been found that a significant amount of membrane proteins co-
precipitates with IBs during cell lysis [103].  These detergent washes are necessary to 
remove the membrane proteins.  In an ultracentrifugation sucrose gradient, it was 
found that if inclusion bodies were not washed, contaminating proteins would drag 
them into heavy fractions (see Figure 2.8). 
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Figure 2.8. Melan-A fractions after separation in sucrose ultracentrifugation.  
Cell lysate (top) and washed inclusion bodies (bottom) of Melan-A were separated in a 
continuous gradient of sucrose.  The Melan-A monomer is indicated by the arrows.  
Unwashed inclusion bodies in the cell lysate were pulled into heavier fractions by their 
contaminating proteins. 
 
2.7. Cesium chloride ultracentrifugation gradients 
 
2.7.1. Ultracentrifugation introduction 
 IBs have been shown to be separable by ultracentrifugation.  Preparative 
ultracentrifugation is performed in a centrifuge that runs under vacuum to minimize 
friction and reach very high rotational speeds.  It is typically coupled with a sucrose 
gradient to separate cell organelles.  Cesium chloride gradients have also been used to 
separate nucleic acids [104].  There is also precedence of using ultracentrifugation to 
Density (mg/ml): 1.08    1.20   1.32   1.44    1.56   1.65  1.74 
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determine the density of IBs.  The most recent work has gathered IBs between sucrose 
layers [105, 106].  
 
2.7.2. Cesium chloride solutions 
An improved chemical gradient to use for IB ultracentrifugation instead of 
sucrose is cesium chloride; the range of densities is more appropriate.  Published IB 
densities are 1,340 and 1,240 kg/m3 for IFN-gamma and prochymosin, respectively 
[107].  A separate study of 24 different proteins, not in IB form, resulted in densities 
ranging from 1.25 to 1.37 kg/m3 [108].  As a reference, 40% and 65% sucrose 
solutions have densities of 1,176 kg/m3 and 1,316 kg/m3, respectively.  Meanwhile 
34% and 70% solutions of cesium chloride have densities of 1,250 kg/m3 and 1520 
kg/m3, respectively.  Sucrose gradients are not in the proper range to measure the 
density of heavier IBs. 
Solution manageability, which improves assay consistency, is another 
advantage of cesium chloride.  Previous IB ultracentrifugation utilized a step gradient, 
so IBs settled at the interfaces of steps to suggest a density range.  For improved 
resolution, a continuous gradient can be poured, which would provide more precise 
densities, but sucrose viscosity makes this difficult.  A 40% solution of sucrose has a 
viscosity of 5.187 [109].  A digital paddle SV-10 sine-wave Vibro viscometer (KSV 
Instruments, Helsinki, Finland) was used to measure a 1.34 cP viscosity for a 34% 
solution of cesium chloride.  In addition to being relative dense, easily prepared, and 
having a low viscosity, homogeneous cesium chloride solutions will form a gradient 
during centrifugation.  Therefore pouring a step or continuous gradient is not 
necessary. 
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2.7.3. Ultracentrifugation experimental setup 
 The ultracentrifuge, rotor, and tubes used were from Beckman Coulter 
(Fullerton, CA).  A 34% cesium chloride solution (1.25 kg/m3) was used in all IB 
ultracentrifugation.  Beckman Coulter 14 x 89 mm polyallomer centrifuge tubes were 
used.  An aliquot of 11.4 ml of the homogeneous solution was added to each tube.  
100 µl of washed inclusion bodies solution was added to the top of each solution.  
This was less than 1% of the total volume, and small amounts of solutes do not disrupt 
the gradient formation [110].  The tubes were then centrifuged at 180,000g (38,000 
rpm) for 15 hr at 4°C on an SW 41 Ti rotor.  Since the IBs were clearly visible within 
the gradient (see Figure 2.9), the depth of the IBs could be directly measured. 
 
 
Figure 2.9. Inclusion body bands in cesium chloride gradients.  From left to right, 
inclusion body samples were cultured at 30°C, 37°C, and 42°C.  Bands that are denser 
travel farther down the cesium chloride gradient. 
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Figure 2.10. Cesium chloride density in an ultracentrifugation gradient.  a) 
Cesium chloride gradient density as a function of sample volume.  The variable w is 
the solute concentration and volume is measured from the top of the tube.  
Centrifugation durations were 2 (■), 5(▲), 10(●), and 71(▼) hr.  Solid lines represent 
simulation values [110].  b) This study’s measurements of density versus sample 
depth, also measured from top of the tube.  Centrifugation was performed for 15 hr. 
 
Fractions were removed by pumping a 50% cesium chloride solution, colored 
with bromophenol blue, into the bottom of the tube via a syringe.  These fractions 
were collected in pre-weighed eppendorf tubes.  Volumes collected in these tubes 
were measured using pipettemen.  The density of each fraction could then be 
determined.  Known volumes of water were added into an empty ultracentrifugation 
tube, and their depth from the rim of the tube was measured.  It was then possible to 
construct a correlation between sample depth and density (see Figure 2.10b).  The data 
comes from one run with 20 mM Tris buffer added and three runs with different 
batches of washed IBs.   
A similar density graph was created by Minton under different conditions 
[110].  In this case, the initial density of the cesium chloride gradient was 1.5 kg/m3 
and the centrifugation was performed at 40,000 rpm at 25°C.  The general trend of 
these graphs are similar (see Figure 2.10a).  It makes sense that as a gradient forms, 
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fractions at the top of the tube will get lighter, fractions at the bottom will get heavier, 
and middle fractions will be in steady-state flux with unchanged density values. 
 
2.7.4. Sedimentation equilibrium 
Sedimentation equilibrium experiments allow particles to travel through a 
gradient until they reach a point in the gradient that has an identical density.  This is 
different than sedimentation velocity experiments that measure the distance a particle 
travels in a viscous solution over time.  Sedimentation equilibration experiments were 
conducted so that IB density could be determined independent of IB size or shape.  It 
can be calculated that IBs reached equilibrium based on the sedimentation equation 
(Eq. 1). 
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This calculation means that for an inclusion body the size of 200 µm to travel the 
entire 8.5 cm length of the ultracentrifugation tube, it would have to have a density 
difference greater than the final value shown in Equation 3. 
 
2.8. Microscopy preparation and operation 
 
2.8.1. Light microscopy 
 A washed IB solution could be viewed under a light microscope only after the 
IBs were fluorescently stained.  Two different stains were used, 6-carboxyfluorescein 
succinimidyl ester (CFSE) and 1-anilinonaphthalene 8-sulfonate (ANS).  Both stains 
were obtained from Invitrogen (Carlsbad, CA) The CFSE stain, advertised as an amine 
binder, was self-fluorescent and had to be washed out of IB solutions with repeated 
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pelleting and resuspension in 20 mM Tris buffer.  The ANS stain, advertised as a lipid 
binder, only fluoresced after binding, so solutions were immediately usable under the 
microscope.  Images from both stains were visually identical.  Samples were filtered 
through a 0.8 µm filter.  Filtering through a 0.45 µm filter seemed to remove most of 
the particles. 
The microscope used had a 10x magnification on the eyepiece and a 100x 
magnification on the objective lens, providing a 1,000x magnified image.  The sample 
was 10 µl of IB solution after the addition 1 µl ANS stain.  The image was viewed 
through a film of oil over the cover slip.  Images of the ANS stain are shown in Figure 
2.11. 
 
 
Figure 2.11. Light microscopy image of fluorescently stained inclusion bodies.  
Images are at 1000x magnification after ANS stain a) without filtration and b) with 
filtration. 
 
2.8.2. Cell and IB fixation and dehydration 
 To prepare E. coli cells and IBs for electron microscopy, a fixation step was 
needed.  All fixation solutions were in 0.1 M sodium cacodylate buffer, pH 7.2.  Cells 
and IBs were pelleted using 12,000 rcf centrifugation for 3 and 10 min, respectively, 
using the centrifuge described in Section 2.5.3.  A 0.5 ml aliquot of fermentation 
harvest was pelleted and resuspended in 4% formaldehyde and 0.5% glutaraldehyde.  
a)                          b) 
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Washed IBs, as detailed in Section 2.6, were resuspended in 2.0% glutaraldehyde.  
Incubation in the fixatives was performed at 4°C overnight.  Glutaraldehyde has 
terminal aldehyde groups that are able to cross-link the lysine groups in adjacent 
proteins. 
Fixative was removed by pelleting and resuspending the IBs three times in 
buffer.  Each resuspension was incubated on ice for 10 min.  After washes, pellets 
were further fixed and stained with 0.1% osmium tetroxide.  Osmium tetroxide acts as 
a secondary fixative that reacts with lipid moieties.  Fixative was removed again with 
three 10 min washes with incubations on ice with 0.1 M sodium cacodylate. 
 The E. coli cells had an additional embedding step.  The fixed cell pellet was 
resuspended in a hot 1% agarose solution at approximately 50ºC.  Before the agarose 
solidified, cells were pelleted.  The cell pellet was extracted into 1 mm cubes with a 
razor blade. 
 Cell-enriched agarose cubes were incubated in 25% ethanol and rocked for 10 
min.  Fixed IB pellets were resuspended in 25% ethanol and rocked for 10 min.  These 
dehydration incubations were repeated for 50%, 75%, 95%, and 100% ethanol. 
 
2.8.3. Transmission electron microscopy of cells 
Transmission electron microscopy (TEM) works by shooting electrons at a 
sample.  These electrons undergo diffraction when they collide with the sample and 
are then focused through electromagnetic lenses to create an image.  Because of the 
short wavelengths of the X-rays generated from the impaction, very high 
magnifications and resolutions can be reached, which make TEM ideal for imaging 
mircostructures.  Inclusion bodies have been visualized by TEM in the past [111, 112].  
Cells were fixed with formaldehyde, glutaraldehyde, and osmium tetroxide, as 
described in Section 2.8.2.  They were then embedded in agarose and gradually 
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dehydrated in 100% ethanol, also described in Section 2.8.2.  The cells cubes were 
then incubated in a 2:1 ethanol:unicryl solution for 30 min.  The infiltration solution 
was then changed to 1:2 ethanol:unicryl and then unicryl only. 
 
Figure 2.12. TEM image of E. coli sections producing Melan-A as inclusion 
bodies.  a) Low magnification view of E. coli cells in TEM.  b) Inclusion bodies are 
labeled with gold nanoparticles.  c) Inclusion bodies are stained with osmium 
tetroxide. 
 
Single cell cubes were transferred to embedding capsules (BEEM, West 
Chester, PA) and then submerged in fresh unicryl.  The capsules were then incubated 
at 65°C for two days to polymerize the unicryl.  The cells could then be sectioned 
using a diamond knife in an ultramicrotome.  The thin slices (50 – 100 nm) were 
placed on nickel-gilded 300 mesh hex microscopy grids (Electron Microscopy 
Sciences, Hatfield, PA).  
a)                                                          
b) 
c) 
68 
These sections were viewed in Tecnai T-12 TEM (FEI, Hillsboro, OR).  Note 
that the some of the cells are elongated (see Figure 2.10a).  This is commonly seen in 
bacteria that overproduce protein [113]. 
 
2.8.4. Transmission electron microscopy of IBs 
 Instead of sectioning, washed IBs could be diluted to a concentration of 0.03 
mg/ml and directly placed on gold gilded nickel grids (Electron Microscopy Sciences) 
coated with formvar.  To confirm the presence of Melan-A in these bodies, 10 nm 
goat-anti-mouse IgG gold (Electron Microscopy Sciences) were used to label them.  
These gold nanoparticles were applied as a secondary antibody, much like how a 
western blot is performed.  Based on images obtained, IB sizes ranged from 0.1 µm to 
0.6 µm in diameter (see Figure 2.13).   
 
 
Figure 2.13. TEM image of washed inclusion bodies.  Inclusion bodies have been 
labeled with antibody-conjugated gold nanoparticles.  Image is taken at 26,000x 
magnification. 
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2.8.5. Scanning electron microscopy 
 Although IBs have been visualized with scanning electron microscopy in the 
past [105, 114], none of these images have gone beyond 20,000x magnification [115].  
This study examined IBs at up to 50,000x magnification to visualize finer details. 
 
 
Figure 2.14. SEM image of E. coli cell and inclusion body bed.  A suspected E. coli 
bacterium is shown (top) that survived homogenization, detergent washing, and IB 
SEM preparation.  In the background (bottom) are 300 µm inclusion bodies.  Dotted 
white line is the scale bar. 
 
 As described in Section 2.8.2, washed IBs were dehydrated to 100% ethanol 
after being fixed with glutaraldehyde and osmium tetroxide.  Each IB suspension was 
then syringed through a 0.2 µm nylon syringe filter (Thermo Fisher Scientific, 
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Waltham, MA).  A razor blade was used to slice open the filter casing and extract the 
filter paper that collected the IBs.  This filter was placed in 100% ethanol. 
The IBs were then dried using a Balzers Union CPD 020 critical point dryer 
(BAL-TEC, Balzers, Liechtenstein).  The 100% ethanol was washed out with liquid 
carbon dioxide.  The carbon dioxide was then sublimed at 31°C at 73.8 bar.  Dried 
samples were then given a 10 nm coat of gold palladium using a sputter coater 
(Technics Hummer V).  The IB samples were then viewed in a Hitachi 5900 SEM 
(Maidenhead, Berkshire, UK).  An example image is shown in Figure 2.14. 
 
2.8.6. Atomic Force Microscopy 
 Atomic Force Microscopy (AFM) brushes a probe along the surface of a 
sample.  The probe rests on the tip of a cantilever which is mounted on a piezo.   
A laser is used to detect deflections as the probe responses to changes in surface 
topography.   
 
Figure 2.15. AFM image of Melan-A inclusion bodies.  Images of inclusion bodies 
obtained from dry samples in tapping mode on the Dimension 3100 AFM (left) and a 
software generated 3-D representation (right).   
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Washed IB solution was filtered through a 0.8 µm filter and 10 µl was placed 
on a poly-d-lysine coated 35 mm glass bottom culture dish (MatTek, Ashland, MA).  
This solution was allowed to dry and analyzed on an Dimension 3100 AFM (Veeco, 
Plainview, NY).  Figure 2.15. shows an example image obtained in tapping mode 
using a silicon probe. 
 
 
Figure 2.16. SEM images of AFM probes after exposure to  inclusion bodies.  a) 
Wangsa’s image and b) this study’s image of an AFM probe after attempting to 
perform force measurements on inclusion bodies in solution. 
  
AFM imaging was also attempted on a Picoplus AFM (Agilent, Santa Clara, 
CA) with wet samples diluted into PBS.  A silicon nitride probe was used.  The probe 
analyzed these samples in contact mode.  Force measurements could be conducted on 
these particles based on Hooke’s Law:  
zkF ∆−=  (4) 
k is the cantilever spring constant, and ∆z is the deflection in the probe at the force F.  
Corrections must be made for piezo sensitivity.  Unfortunately force measurements 
continued to increase over time because the probe would get fouled.  This was 
confirmed by taking an SEM image of a used probe (see Figure 2.16b).  Interestingly, 
a)                                                               b) 
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this same type of image was obtained from a group that used AFM to measure IB 
force in the past [116] (see Figure 2.16a). 
 
2.9. Particle size distribution 
 For centrifugation, a particle size distribution is necessary to calculate accurate 
collection efficiencies.  When collection efficiencies are calculated based off average 
particle size alone, values are inflated.  For example, if 100% collection can be 
accomplished at the average particle size, this would not be true if there were a 
distribution of sizes.  Particles that were larger would still be collected, but particles 
that were smaller would not.  For filtration, pore sizes cannot simply match the 
average particle size because any smaller particles in the distribution will not be 
retained.  These are the very practical reasons for why it is necessary to know the 
particle size distribution. 
 
2.9.1. Size estimation with tangential flow filtration 
 Cell lysate has been routinely washed via tangential flow filtration (TFF).  
During a TFF process, a protein solution is re-circulated back into a reservoir while 
being pumped parallel to a filter membrane.  A portion of the solution passes through 
the membrane due to a pressure difference; particulates larger than the membrane’s 
pore size are retained.  IBs are washed using TFF using a detergent solution to remove 
bacterial membrane proteins because the tangential flow prevents IBs from fouling the 
filter membrane. 
In the instances when TFF was used to wash Melan-A IBs, no back pressure 
was applied and a membrane cassette (Pall, East Hills, NY) with 0.45 µm pores was 
used to retain the IBs.  If 10-20 psi transmembrane pressure was applied, there is some 
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Melan-A loss in the permeate.  These data suggest that there is a distribution of 
Melan-A IBs that span below and above 0.45 µm in diameter.   
 When NY-ESO-1 IBs were washed using the TFF unit, a 0.45 µm filter was 
not able to retain the inclusion bodies.  This problem was solved by using a 0.22 µm 
filter. 
 
2.9.2. Size estimation from electron microscopy 
 Although TEM is normally a very appropriate tool for measuring particle size, 
it was not applicable to IB measurements.  If IBs were measured from cell sections, 
there was no indication which plane of the IB was being measured.  The measurement 
would not be accurate unless the sectioning was done to obtain the widest cross-
section of the IB.  Measuring washed IBs in TEM was also unreliable since the objects 
were three-dimensional and difficult to focus as a result.  Inconsistencies in focusing 
would compromise the accuracy of the measurement.  The same issue applied to SEM 
imaging.  These techniques were all very good, however, at providing a size estimate 
for the IBs in this study.  For example, the IBs shown in Figure 2.10, 2.11, and 2.12 
were from Melan-A produced at 42°C using a pH stat feeding method.  The IBs 
produced under these conditions are about 300 µm. 
 
2.9.3. Dynamic light scattering 
 The size distribution of IBs was ultimately determined via measurements of 
their zeta potential.  Dynamic light scattering techniques have been shown to 
accurately measure particle sizes that span from nanometers to several microns in 
diameter [117].  A zetasizer instrument (Malvern, Worcestershire, UK) measures the 
fluctuations in light scattering.  Smaller particles are more susceptible to Brownian 
motion and give larger fluctuations. 
74 
 Washed IBs were filtered through a 0.8 µm filter and 10 µl was diluted into 0.5 
ml of Milli-Q water.  The filtration was necessary to remove IB aggregates as earlier 
demonstrated in Figure 2.9.  The ultrapure diluent was necessary because other buffers 
would give false particle measurements.  Samples were transferred to a 1.5 ml 
polystyrene semi-micro disposable cuvette (Perfector Scientific, Atascadero, CA) and 
measured in triplicate.  The refractive indices of water and protein were used to 
calculate particles sizes and assumed to be 1.33 and 1.45, respectively.  Calculated 
particle sizes of IBs ranged from 20 – 400 nm.  These measurements agreed with 
estimates obtained from TFF, SEM, TEM, and AFM. 
 
2.10. Bradford total protein assay 
 Coomassie dye reacts with all proteins, particularly lysine and arginine 
residues.  This change is colorimetric and can be quantified using spectroscopy at 595 
nm.  A 2 mg/ml BSA stock was diluted into standards with concentrations of 0.025, 
0.125, 0.25, 0.50, 0.75, 1.00, 1.25, and 1.50 mg/ml.  The dilutions used to make these 
standards is shown in Table 2.2.  A 10 µl aliquot of each standard was added in 
triplicate to wells in a 96-well plate.  A 10 µl aliquot of cell lysate, soluble protein, or 
IBs were also added in triplicate to the plate.  An additional 295 µl of refrigerated 
Pierce Coomassie dye (Thermo Fisher Scientific, Waltham, MA) was added to each 
well, and the samples were incubated at room temperature for 10 mintes.  A GENios 
plate reader (Tecan, Männedorf, Switzerland) was then used to measure the 
absorbance of each well at 595 nm.  The BSA samples were used as a standard curve, 
which is the most commonly used standard for the Bradford assay.  An example 
standard curve is shown in Figure 2.17. 
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Table 2.2. Bradford standard preparation dilutions.  Bovine serum albumin was 
diluted to various concentrations at regular intervals from 0 to 1.5 mg/ml.  The 
dilution order for how these standards were prepared is shown. 
Vial 
Water 
(ul) 
BSA  
(ul) 
Conc. 
mg/ml 
A 125 375 of Stock 1.500 
B 105 175 of Stock 1.250 
C 400 400 of Stock 1.000 
D 175 175 of A 0.750 
E 325 325 of C 0.500 
F 325 325 of E 0.250 
G 325 325 of F 0.125 
H 400 100 of G 0.025 
I 400 0 0.000 
 
 
 
 
Figure 2.17. Example Bradford standard curve.  The standard curve is made of 
freshly made dilutions of BSA in water.  All measurements are taken in triplicate. 
 
2.11 Dry weights 
 The dry weight of cells or IBs could be measured with the following 
procedure.  Eppendorf tubes were pre-weighed using an analytical balance.  A 1 ml 
aliquot of cell broth or washed IB solution were added to a tube and centrifuged at 
12,000 rcf in the same centrifuge described in Section 2.5.3.  Cells were pelleted for 3 
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min; IBs were pelleted for 10 min.  A pipetteman was used to remove the supernatant 
without disturbing the pellet.  Cells grown in a chemically defined medium pelleted 
with salts, so these pellets were resuspended in 20 mM Tris buffer and pelleted again 
three times.  The wet cell pellet was then placed on a 95°C heating block overnight.  
Dried pellets were re-weighed, correcting for the weight of the empty tube. 
 
2.12. IMAC chromatography 
 An IMAC column was used to capture selected batches of Melan-A protein.  
Two 1 ml solutions of washed Melan-A IBs for each selected condition were pelleted 
and resuspended in either 2, 4, or 8 M urea buffers containing 100 mM sodium 
phosphate, pH 7.5.  The solubilized inclusion bodies were added to a new 1 ml 
HisTrap column (General Electric Healthcare, Piscataway, NJ) that had been 
equilibrated with 3 column volumes (CV) of the respective urea buffer.  After the 
protein was loaded on the column, 3 CV this same urea buffer was used to chase the 
unbound protein off the column.  Another urea buffer with 85 mM imidazole was then 
loaded on the column for 3 CV to remove any non-specific binding protein.  3 CV of a 
third urea buffer with 500 mM imidazole was used to elute the protein.  This protein 
was quantified using a Bradford assay, as described in Section 2.10. 
 
2.13. Conclusion 
 Fermentation procedures were set up that varied temperature, IPTG 
concentration, oxygen levels, and feeding profiles for Melan-A producing E. coli.  
Runs with varying temperatures were also performed with HCDCs producing EGFP, 
SSX2, and NY-ESO-1.  IBs from all of these runs were collected. 
IB density was determined using cesium chloride gradients, IB sizes were estimated 
using dynamic light scattering, and IB protein accessibility was determined by 
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comparing Bradford protein values with dry weights.  The chemical stability of the 
IBs was tested with various levels of urea, and protein accessibility and IMAC 
recovery were measured. 
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CHAPTER 3 
 
THE DENSITY AND PARTICLE SIZE OF SYNTHETIC MELAN-A INCLUSION 
BODIES ARE DEPENDENT ON FERMENTATION CONDITIONS 
 
3.1. Introduction 
 High cell density cultures (HCDC) of E. coli were used to produce protein 
from a synthetic Melan-A plasmid.  Syn-Melan-A protein readily formed inclusion 
bodies (IBs) which could be extracted and measured for density and particle size using 
the techniques described in Chapter 2.  These IBs were produced in both complex and 
chemically defined media. 
 In complex medium experiments, the variables changed in the fermentations 
were feeding strategies, IPTG concentrations, and culture temperature.  In chemically 
defined medium experiments, a statistical design of experiment was used to examine 
the effects of feeding rate and temperature only. 
 
3.2. Inclusion body size and density trends from complex medium studies 
 
3.2.1. Feeding strategies 
 As detailed in Chapter 2, initial cell growth was done in a batch medium and 
feed medium was gradually added to the reactor upon glucose depletion.  One set of 
media contained yeast extract; the other set was completely chemically defined.  Both 
types of fermentations were confirmed to be glucose-limiting because the addition of 
only a glucose solution was able to reverse any rises in pH and dissolved oxygen 
(DO).   
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Various feeding strategies were used to grown synthetic Melan-A in complex 
medium.  These runs were all performed at 37°C and pH 7.0.  A pH-stat feeding 
method added feed medium in constant responses to rises in pH.  Since the pH-stat 
feeding profile was regularly reproducible, it was possible to calculate a linear feed 
rate to feed approximately at the same rate as the pH-stat feeding method.  It was also 
possible to create a step feed, which mimicked pH-stat feeding profile with five 
distinct feed rates.  Constant feed strategies were also employed with a different 
constant feed rate per run.  The total fermentation time of the constant feed 
fermentations varied, but the total amount of feed added was the same in all runs.  The 
feeding profiles are shown in Figure 3.1. 
 
Figure 3.1. Feed rate data for different feeding types.  Linear and step feeding 
profiles attempted to reproduce the pH-stat feeding profile.  Dotted lines represent 
constant feeding rates.  The low constant feed rate fermentation continued until 46 hr 
of elapsed fermentation time. 
  
Almost identical cell growth was observed between pH-stat, step, linear, and 
medium constant feeding rates (Figure 3.7).  Lower densities were reached with low 
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and high constant feed rates.  Despite the difference in cell density, volumetric 
productivity of protein was roughly equivalent in these fermentations (Figure 3.2). 
The density of IBs produced using different feeding methods varied (Table 
3.1).  The major trend for density was that higher feeding rates led to denser IBs.  
Even in the case of pH-stat versus linear and step feeds, IBs produced using a pH-stat 
feeding method had lower densities.  This agrees with the trend that limited  
Figure 3.2. Gel densitometry of Melan-A production under different feeding 
strategies.  a) SDS-PAGE of synthetic Melan-A insoluble fractions produced under 
fermentations using pH-stat, low constant feed, and high constant feed.  Melan-A 
protein is indicated by the arrow.  b) Image J gel densitometry analysis of gel shown. 
 
feed creates less dense IBs because pH-stat feeding feeds just under the amount the 
nutrients need to prevent starvation.  So although the feeding profiles of pH-stat, step, 
and linear feed seem very similar, the borderline starvation response allowed in pH-
stat feeding affects the IB density. 
 A trend in IB size based on feeding condition (Table 3.1) was also observed.  
Although not as obvious as the density trend, it appears that the size of IBs produced 
under pH-stat conditions at 37°C are 220 ± 16 nm, while IBs produced at 37°C with 
other feeding strategies are 299 ± 32 nm.  Again, this can be attributed to the 
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CF 
low 
CF 
high 
pH 
stat 
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starvation response triggered throughout a pH-stat fermentation.  If cell starvation is 
the cause, it is not immediately obvious why the lowest constant feeding rate 
fermentation did not also elicit a similar response as the pH-stat fermentations.  This 
may be attributed to the excess glucose present in the bioreactor at the start of all 
constant feed strategies.  It may also be possible that the lowered feed was able to slow 
down the bacterial growth rate, thus decreasing glucose demand. 
 
3.2.2. IPTG Effects 
 Four different concentrations of IPTG were used.  These concentrations in the 
complex feed medium were 0.1, 0.5, 1.0, and 4.5 mM.  The feed medium was 
gradually added to the fermentor, increasing the IPTG concentrations in the reactor to 
final values of 0.05, 0.25, 0.50, and 2.25 mM.  Although the latter values may seem 
high compared to the typical micromolar concentrations in E. coli studies [118],  
 
Figure 3.3. SDS-PAGE and Image J densitometry analysis of Melan-A fractions 
under different concentrations of IPTG.  Soluble (S) and insoluble (I) fractions of 
each sample are shown. 
  7069         2879          11795         7447          6728         12834       7887       17387 
0.05 mM          0.25 mM          0.50 mM        2.25 mM 
S         I           S          I           S         I           S          I 
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IPTG concentrations up to 3 mM are common in HCDC [119].  Indeed, as  
seen in Figure 3.3, a higher level of IPTG increases final Melan-A production.   
Focusing on only the insoluble protein fraction, which is primarily where Melan-A is 
located, 0.05, 0.25, and 0.50 mM IPTG respectively generate 17%, 43%, and 74% of 
the Melan-A generated with 2.25 mM IPTG. 
Another condition studied was the method of IPTG addition.  Instead of 
gradually adding IPTG to the culture with the feed medium, IPTG was added directly 
to the fermentor upon initiation of the feeding phase.  An amount of 4.5 ml 1 M IPTG 
solution was added to the vessel, creating an initial concentration of 4.5 mM in the 
reactor that was gradually diluted to a final concentration of 2.25 mM as feed was 
added to the vessel. 
The density of Syn-Melan-A IBs produced from any of the four concentrations 
of IPTG tested in this study was 1.294 ± 0.004 g/ml.  The particle sizes of these IBs 
were 221 ± 16 nm.  Even though using different IPTG concentrations did alter the 
amount of Melan-A produced in the fermentor, there was no noticeable difference in 
the density or particle size of the resultant IBs.  Even when IPTG was added directly 
to the fermentor, there was no effect on IB density, and IBs were only slightly larger at 
248 nm.  These observations suggest that the rate of Syn-Melan-A production does not 
alter IB properties.  Further discussion is provided in Section 5.1. 
 The growth curves of the cultures were identical regardless of the amount or 
method of IPTG added.  Therefore the IPTG concentrations did not need to be 
normalized per cell. 
 
3.2.3. Temperature Effects 
 Syn-Melan-A was grown at three different temperatures in complex medium 
using a pH-stat feeding method to a final concentration of 2.25 mM IPTG.  These 
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temperatures were 30°C, 37°C, and 42°C.  All fermentations were maintained at 37°C 
during the inoculum and batch phase.  When feeding was initiated, temperature was 
changed to 30°C or 42°C for the duration of the fermentation. 
 Although it is expected that more Syn-Melan-A would be produced in the 
soluble fraction at 30°C, this was not the case.  As seen in Figure 3.4, there is very 
little difference in Syn-Melan-A production when cultures were grown at 30°C or 
37°C.  There is less Syn-Melan-A produced at 42°C in the insoluble fraction.  This 
response was expected since proteases are very active during the heat shock response. 
 
Figure 3.4. SDS-PAGE and Image J densitometry analysis of Melan-A fractions 
under different fermentation temperatures.  Soluble (S) and insoluble (I) fractions 
of each sample are shown. 
 
 There is the largest disparity in IB density when producing cultures were 
grown at different temperatures.  The densities spanned from 1.258 to 1.308 g/ml.  
Particle sizes of IBs produced at 37°C and 42°C were about 223 ± 8 nm, and IBs 
    12923           27421            19242           27672            13198          16600 
      30°C                      37°C                       42°C 
    S             I             S              I               S             I        
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produced at 30°C were 316 ± 17.  IBs produced at 30°C were larger than those 
produced at 37°C, but they were also less dense.  IBs produced at 42°C were denser 
than their 37°C counterparts, but cultures at 42°C ultimately produced less. 
 
3.2.4. General trends 
 IB density and size data based on the fermentations performed in complex 
medium are summarized in Table 3.1.  
 
Table 3.1. Inclusion body density and size for synthetic Melan-A produced with 
different fermentation conditions in complex medium.   
 
Temp Feed Style IPTG conc IB density IB size 
°C  mM (g/ml) (nm) 
37 pH-stat 0.05 1.294 217 ± 9 
37 pH-stat 0.25 1.299 211 ± 1 
37 pH-stat 0.50 1.292 209 ± 9 
37 pH-stat 2.25* 1.294 248 ± 9 
37 pH-stat 2.25 1.296 215 ± 5 
30 pH-stat 2.25 1.258 316 ± 17 
42 pH-stat 2.25 1.308 231 ± 6 
37 const: low 2.25 1.276 296 ± 29 
37 const: med 2.25 1.296 273 ± 9 
37 const: high 2.25 1.310 340 ± 21 
37 linear 2.25 1.303 267 ± 9 
37 step 2.25 1.303 287 ± 31 
* In one set of conditions, IPTG was added directly to the fermentor 
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Figure 3.5. Inclusion body density as a function of feed rate and growth 
temperature in complex medium.  Vertical lines in the contour plot indicate that 
inclusion body density had a stronger dependence on temperature than feeding rate.  
The pH-stat, step, and linear feeding rates were inputted as medium feeding rate on 
this plot. 
 
Figure 3.6. Inclusion body size as a function of feed rate and growth temperature 
in complex medium.  Diagonal lines indicate that both feed rate and growth 
temperature contributed equally to the inclusion body size.  The pH-stat, step, and 
linear feeding rates were inputted as medium feeding rate on this plot. 
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The quantity and rate of IPTG addition did not affect IB density, but feed rates 
and growth temperatures did have an effect.  Feeding strategies that limited glucose 
levels during the fermentations resulted in less dense IBs.  Meanwhile, the feed rates 
that supplied more levels of glucose in excess of the cells’ needs produced denser IBs.  
Even more dramatic was the effect different growth temperatures had on IB density, as 
illustrated in Figure 3.5.  IB density increased proportionately with growth 
temperature. 
In terms of IB size, feeding profiles and growth temperatures, again, both had 
an influence, whereas IPTG concentration did not.  Larger IBs were produced when 
IPTG was added directly to the fermentor instead of being gradually added with the  
Figure 3.7. Growth curves of Syn-Melan-A in complex medium.  Cell density is 
measured by optical density at 600 nm.  Non-constant feed rates consist of pH-stat, 
linear, and step feeds.  All IPTG runs and runs with different temperatures were 
conducted using the pH-stat feeding method. 
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feed medium.  Aside from the direct addition of IPTG and the run at 30°C, all 
fermentations using a pH-stat feeding profile resulted in smaller inclusion bodies.  As 
a higher excess of glucose was inputted into the fermentor, IB size increased.   
An excess of IPTG is toxic to cells, and high levels of glucose in the fermentor 
lead to an accumulation of inhibitory levels of acetate.  Although it could be suspected 
that conditions with the direct addition of IPTG or with the highest constant feed rate 
could be responsible for larger IB size due to toxicity, a decrease in cell growth was 
only found in the fermentation with the highest constant feed rate (Figure 3.7).  The 
other factor that these two runs have in common is faster production rates.  On the 
other hand, the largest IBs were produced at 30°C and when the lowest constant feed 
rate was used.  As seen in Figure 3.7, both of these conditions retarded growth rates.  
Although it seems contradictory, this data suggests that larger IBs were created both 
when protein production speed was increased and decreased from the runs with 
standard growth temperature and feeding rate.   
 
3.2.5. Size distribution analysis 
 The size distributions of the complex medium studies are shown in Figure 3.8.  
When IBs were produced using a pH-stat feeding method at 37 ºC or 42 ºC, the 
calculated diameters of IBs were Gaussian distributions.  At 30 ºC, the IBs formed two 
populations, which were smaller and larger than the IBs produced at 37 ºC or 42 ºC.  
A similar distribution occurred when IBs were produced using a step feed or low 
constant feed protocol.  When the constant feed rate was increased, the smaller 
population was reduced, creating a shoulder.  When the highest constant feed rate was 
used, this smaller population was no longer detected. 
 Size distributions had previously been examined using sedimentation fast-flow 
fractionation [120].  In these studies, Gaussian distributions of IB size were  
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Figure 3.8. Inclusion body size distribution as determined by dynamic light 
scattering. 
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found at 37 ºC cultures and two distinct populations were generated during 30 ºC 
cultures.  A shoulder of smaller sized particles was detected when IPTG 
concentrations were reduced twenty-fold. 
 
3.3. Inclusion body size and density trends from chemically defined medium studies 
 
3.3.1. DOE set-up 
 A statistical experimental design was created to evaluate the effects of 
temperature and feeding rate on IB size and density.  IPTG was not listed as a factor 
because it did not have influence on IB size and density in complex medium studies.  
Constant, pH-stat, step, and linear feeding strategies were also used in complex 
medium studies.  Although these conditions were relevant, they were qualitative and 
could not be subjected to a quantitative statistical design.  As such, only a series of 
linear feed rates were used.  These feeding profiles are shown in Figure 3.9. 
Figure 3.9. Linear feeding profiles for fermentations conducted in chemically 
defined medium.  Three different linear feeding rates were used in the chemically 
defined medium fermentations.  In all instances, 1 L of chemically defined feed 
medium was added to 1 L of chemically defined batch medium in the bioreactor. 
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3.3.2. Growth rates 
The optical densities of the chemically defined medium fermentations are 
plotted in Figure 3.10.  The batch growth ended 12 hr after reactor inoculation.  
Regardless of fermentation condition, growth rates were identical up to 15 hr.  At this 
point, the fermentations began to diverge into different growth rates.  The 
fermentation with the high feed rate grew the fastest, followed by the fermentation 
grown at 30°C.  This is somewhat expected since glucose was the limiting reagent in 
these fermentations, and an excess of glucose should therefore lead to faster growth 
rates.  A similar phenomenon is observed with the 30°C fermentation since the cells at 
this temperature would have a slower metabolism and therefore would consume 
glucose at a slower rate than cells grown at warmer temperatures.   The fermentations 
at 37°C under low and medium feed rates had identical growth profiles.  The 
fermentation conducted at 42°C showed a decrease in cell growth rate beyond 19 hr.  
This decrease in growth rate could be explained by increased glucose consumption 
during the heat shock response. 
 
3.3.3. General trends 
The results of the statistical design using chemically defined medium are 
shown in Figures 3.11 and 3.12.  The feed rates shown in the axis are average feed 
rates per ml of final fermentation volume. 
The density profile of Syn-Melan-A IBs in chemically defined medium (Figure 
3.11) is very similar to that produced in complex medium (Figure 3.5).  There is a 
weak dependence on feed rate, where higher feeding rate results in denser IBs.  A 
much stronger dependence on growth temperature is also apparent, where lower 
temperatures result in less dense IBs and higher temperatures result in denser IBs. 
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Figure 3.10. Growth curves of Syn-Melan-A in chemically defined medium.  
Feeding began at 12 hr elapsed fermentation time.  All growth curves were identical 
until 15 hr.  Growth rates were dependent on the excess glucose in the bioreactor. 
 
The particle size influence has some commonalities with the analogous results 
from complex medium (Table 3.1).  Again, IB size increases both when temperatures 
from 37°C are decreased to 30°C or increased to 42°C.  The difference between the 
chemically defined medium results (Figure 3.11) and the complex medium results 
(Figure 3.6) is only that there is less dependence on feeding rate in the chemically 
defined medium results than in complex medium.  This discrepency may be explained 
by the fact that the range of feeding rates used in the chemically defined medium 
experiments were not as extreme those used with complex medium or that linear 
feeding rates were less harsh than constant feeding rates.  The different extremities of 
feeding methods can be seen in the respective growth profiles (Figures 3.10 and 3.7).  
The high feed rate in the complex medium experiments was high enough to suspect 
toxic acetate accumulation, as would be indicated by the rapid drop in cell growth 
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approximately 5 hr after feeding was initiated.  No such phenomenon was observed 
with the chemically defined medium.  The low feed rate in complex medium was 
limiting enough to reduce growth rate, whereas no change in growth rate was detected 
in the low feed with chemically defined medium. 
 
3.4. Summary 
 Syn-Melan-A IB size and density could be altered changing culture 
temperatures, feeding methods, and feeding rates.  The concentration of IPTG and the 
rate of IPTG introduction were not crucial parameters.  Similar results were obtained 
regardless if a complex medium or chemically defined medium was used. 
 The Syn-Melan-A IB density increased proportionately with culture 
temperature.  Density also increased slightly with an increase in constant feeding rates.  
The smallest IBs were formed when a pH-stat feeding method was used.  Larger IBs 
formed when feeding methods that did not have feedback-control were used.  When 
the growth rate of the cells was slowed down by temperature, limited feed, or acetate 
toxicity, larger IBs were formed. 
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Figure 3.11. Inclusion body density as a function of feed rate and growth 
temperature in chemically defined medium.  Vertical lines in the contour plot 
indicate that inclusion body density had a stronger dependence on temperature than 
feeding rate. 
 
Figure 3.12. Inclusion body size as a function of feed rate and growth 
temperature in chemically defined medium.  Vertical lines again indicate that the 
feeding rate was not important in determining the size of inclusion bodies produced in 
chemically defined medium.  Inclusion bodies got larger when grown temperature was 
not 37°C. 
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CHAPTER 4 
 
ADDITIONAL INCLUSION BODY INFORMATION 
 
4.1. Syn-Melan-A inclusion body structure 
Chapter 3 detailed the influence of fermentation conditions on the density and 
size of Syn-Melan-A IBs.  Although these are the most important factors involved in 
IB extraction, the shape and structure of IBs should also be considered.  All of these 
factors will influence IB separation with both centrifugation and tangential flow 
filtration. 
 
4.1.1. Syn-Melan-A inclusion body protein accessibility 
 Dry protein weights (Section 2.11) of IBs were measured to determine the 
amount of protein present.  Protein concentration estimates were also determined 
using a Bradford total protein assay.  Whereas the dry protein weight measured all of 
the protein present, the Bradford assay could only measure the protein exposed that 
could react with the Coomassie dye used in the assay.  These values could be 
compared to determine the percentage of protein accessible.  Results are shown in 
Figure 4.1. 
 The graph shows that protein accessibility changes depending on fermentation 
conditions.  General trends show that protein accessibility drops slightly as the 
fermentation temperature goes up and when feed rates go down  
Accessibility was also observed using immunochemistry on TEM samples.  
IBs produced at 30°C and 42°C were subjected to TEM analysis as described in 
Section 2.8.4.  Anti-mouse gold nanoparticles bound to a monoclonal Melan-A 
antibody.  Almost none of this antibody was able to bind to the Syn-Melan-A IB 
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produced at 42°C.  Meanwhile, the 30°C Syn-Melan-A IB was heavily labeled (Figure 
4.2).  This agrees with previous data that suggested inclusion bodies produced at 42 ºC 
were more chemically stable than the 37 ºC counterparts [121]. 
 
Figure 4.1. Protein accessibility in Syn-Melan-A inclusion bodies by Bradford.  
Accessibility was determined using a ratio of total protein determined by Bradford 
assay with the protein determined using dry weight.  Each of these assays was run in 
triplicate. 
 
Figure 4.2. Protein accessibility in Syn-Melan-A inclusion bodies by TEM.  
Inclusion bodies were labeled with 10 nm gold nanoparticles.  a) Syn-Melan-A 
inclusion body produced at 30°C.  b) Syn-Melan-A inclusion bodies produced at 42°C. 
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4.1.2. Syn-Melan-A inclusion body morphology 
When Syn-Melan-A IBs were observed on an SEM, it was found that there 
was clearly a different morphology for the IBs produced at different temperatures 
(Figure 4.4).  Syn-Melan-A IBs produced at 30°C were almost amorphous in shape, 
while the individual IBs particles produced at 37°C were much more discrete.  The 
individual 37°C IBs appear to be a cluster of smaller particles (Figure 4.3).  As an 
aside, there are typically only 1 or 2 IBs detected in a single bacterium, and this cluster 
composition makes sense since there would be initially multiple nucleation sites for 
aggregation.  The 42°C IBs were very discrete and spherical.   
These images agree with the results that suggest Syn-Melan-A IBs produced at 
lower temperatures are less dense and that Syn-Melan-A IBs produced at higher 
temperature are more dense.  These data also agree with the protein accessibility data, 
which suggests that protein in denser IBs was less accessible. 
 
Figure 4.3. SEM image of a Syn-Melan-A inclusion body at high magnification.  
Inclusion bodies were produced at 37°C using a pH-stat feeding method in complex 
medium.  The magnification was 150,000x.  Scale bar is the white dotted line.  A 
single inclusion body is circled in red. 
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Figure 4.4. SEM images of Syn-Melan-A inclusion bodies.  Scale bar is the white 
dotted line.  a) Syn-Melan-A inclusion bodies produced at 30°C viewed at 15,000x 
magnification, b) 37°C, 15,000x, c) 42°C, 15,000x, d) 30°C, 50,000x, e) 37°C, 
50,000x, f) 42°C, 50,000x 
 
4.2. Different proteins 
 As detailed in Section 1.5.2, many of the most recent IB studies have used 
GFP as a model protein.  GFP is convenient because it is a well-studied protein in 
biotechnology and its activity can be quantified using fluorescence.  It has not been 
shown, however, how IB formation mechanisms compare amongst different proteins.  
For example, the many phenomena detailed in Chapter 3 and Section 4.1 for Syn-
Melan-A may not be applicable to GFP.  Section 4.2 analyzes IBs produced at 
different temperatures for several different proteins. 
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4.2.1. Fermentation temperature effects on inclusion body density and size of 
various proteins 
 The IB density determination by cesium chloride ultracentrifugation, as 
described in Section 2.7, was highly reproducible.  When comparing IBs of Syn-
Melan-A, it was found that cultures grown at different temperatures showed the largest 
disparity in IB density.  In particular, low temperatures resulted in less dense IBs, and 
high temperatures resulted in more dense IBs.  Additional proteins were tested to 
determine if this trend was universal. 
EGFP and SSX2 were each produced at 30°C and 42°C.  Although the density 
difference in Syn-Melan-A IBs produced at these two temperatures was 50 mg/ml, it 
was only 2 mg/ml for both of these two hydrophilic proteins.  NY-ESO-1, a 
hydrophobic protein, was also subjected to this same analysis, but temperature also 
showed minimal effect on NY-ESO-1 IB density with a difference of 5 mg/ml for IBs 
produced at 30°C and 42°C.  The non-synthetic version of Melan-A was also 
investigated, and IBs produced at 30°C and 42°C also had a 5 mg/ml density 
difference.  It should be noted that in all cases, IBs produced at 42°C were denser than 
those produced at 30°C, but these density differences were trivial compared to that of 
Syn-Melan-A IBs.  These results are illustrated in Figure 4.5. 
 
4.2.2. Fermentation temperature and inclusion body morphology 
The visual morphology phenomenon observed with Syn-Melan-A (Figure 4.4) 
was not observed in the IBs of other proteins analyzed in this study (Figure 4.7).  For 
the most part, IBs produced from other proteins were all identical in morphology.  
These IBs were not as spherical as the Melan-A IBs produced at 42°C, but they were 
similar.  All of these IBs had similar densities (Figure 4.5). 
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Figure 4.5. Densities of inclusion bodies from multiple proteins produced at 
different temperatures.  Fermentations were conducted in complex medium using a 
pH-stat feeding method.  Densities were determined using cesium chloride 
ultracentrifugation gradients.  Syn-Melan-A inclusion bodies have a much more 
noticeable dependence on temperature than other proteins in this study. 
 
Figure 4.6. Size of inclusion bodies from multiple proteins produced at different 
temperatures.  Fermentations were conducted in complex medium using a pH-stat 
feeding method except for the GFP data, which was taken from literature [122]. 
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Figure 4.7. SEM images of SSX-2 inclusion bodies.  Scale bar is the white dotted 
line.  a) SSX2 inclusion bodies produced at 30°C viewed at 15,000x magnification, b) 
42°C, 15,000x.   These inclusion bodies have very similar morphologies, that are most 
similar to Syn-Melan-A inclusion bodies produced at 42°C. 
 
4.2.3. Production rates 
In terms of the density and morphology of IBs, only Syn-Melan-A seemed to 
have a dependence on fermentation temperature.  This temperature dependence was 
not a result of general hydrophobicity because NY-ESO-1 IBs did not have this 
temperature dependence.  The Syn-Melan-A results were not a result of a unique 
protein sequence because the non-synthetic version of the protein also did not exhibit 
any temperature dependence.  The primary difference between Syn-Melan-A and 
Melan-A was that the Syn-Melan-A plasmid had been altered so that more common E. 
coli DNA codons would be used to produce the exact same amino acid sequence.  
Also different is that fact that the Syn-Melan-A E. coli did not include a pRARE 
plasmid.  The presense of the pRARE plasmid alone did not account for the IB 
a)                                                       b)  
105 
temperature dependence since it was present in SSX2, NY-ESO-1, and Melan-A, but 
not EGFP or Syn-Melan-A. 
The different DNA sequence of Syn-Melan-A and Melan-A with pRARE 
plasmid did have an influence on protein production rates.  This is an important factor, 
as IBs tend to form when protein production exceeds the capacity of the protein 
folding machinery in the cell. 
Figure 4.8 shows data from Melan-A and Syn-Melan-A fermentations.  Even 
though the growth rates and feed consumed for both runs overlap, the relative protein 
productions, as determined by gel densitometry, are quite different.  The Melan-A 
fermentation produced about 30% more protein than the Syn-Melan-A fermentation.  
Although the synthetic version of the gene is designed for faster translation, the non-
synthetic version of the gene was complemented with a pRARE plasmid, which made 
this increased production possible.  
Figure 4.8. Protein production of Melan-A and Syn-Melan-A.  Data from two 
fermentations are provided.  Fermentations were conducted at 30°C using pH-stat 
feeding with complex medium.  Open symbols are for Melan-A, and closed symbols 
are for Syn-Melan-A.  Optical density (□,■), feed consumed (◊,), and protein 
produced (○, ●) are shown. 
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There are studies that examine the IB-characteristics of single point mutations.  
For human interleukin-1β, single point mutations could noticeably alter the amount of 
IB formation [123].  It has also been shown single point mutations in the fusion of 
Alzheimer-rated peptide Aβ42 to GFP can alter the protein activity found in IBs [124].  
These studies, however, focus on the effects of slightly altering a protein sequence.  
Melan-A and Syn-Melan-A are the first proteins where observing IB characteristics in 
the same proteins with different production rates via codon biases has been performed.  
It is also possible that the increase in production rate is a function of plasmid copy 
numbers in the cell, which were not determined in this study. 
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CHAPTER 5 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
5.1. Conclusions 
Industrial protein manufacturing process development is made up of 
expression, fermentation, purification, analytical, and formulation groups.  Whereas 
the goals of a purification group are clearly to produce >99% pure protein without 
contamination of endotoxin or viral particles, the goal of the fermentation group is less 
clear.  Beyond exceeding a reasonable protein titer in the fermentation broth, skilled 
fermentation scientists should be able to manipulate the characteristics of the 
intracellular protein to aid in the downstream development.  An understanding of how 
fermentation conditions influence IBs is a step towards this goal. 
In summary, this study has shown that IB characteristics are subject to 
fermentation conditions.  Syn-Melan-A IBs became denser when their respective 
production fermentations were operated at elevated temperatures or overfed glucose.  
Feeding methods that minimized glucose to starvation levels, such as the popular pH-
stat feeding method, did not have any effect on growth rate or protein production, but 
they decreased IB density.  IPTG concentrations, on the other hand, did not have an 
influence on the density of IBs produced.   
 IB sizes increased whenever the culture temperature or feed rate deviated from 
an ideal pH-stat configuration operating at 37 ºC.  Larger IBs had been obtained for 
cultures lowered to 30 ºC in previous studies [125].  IB size has also been found to 
increase for cultures when growth temperatures were increased to 42 ºC [126].  These 
separate studies initially appeared conflicting, but this study shows that the same 
results are obtained given otherwise identical culture conditions.  Likewise, the same  
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concept applied to feeding rates.  With constant feeding rates, IB size increased when 
feed rates were both increased and decreased.  In both cases, growth became inhibited, 
implying that IB size was smallest when an ideal pH-stat configuration operating at 37 
ºC is used.  The pH-stat feeding method, which constantly starves the cells of glucose, 
actually created smaller sized IBs than all of the constant feeding rates tested.  The 
fact that a severe glucose limitation created smaller inclusion bodies agrees with 
studies of TRAIL protein [127].   
 Therefore to improve extraction of Syn-Melan-A IBs from cell lysate with 
centrifugation or tangential flow filtration, an excess of glucose in the reactor culture 
is recommended.  In terms of temperature, 42 °C cultures resulted in a decrease of 
protein production, possibly through increased degradation, and 30 °C cultures created 
the largest IBs.  Therefore, these low temperatures are also recommended for 
enhanced IB extraction.  It should be noted, however, that 30 °C cultures seem to 
produce two populations of IB sizes.  These results were independently obtained from 
this study’s dynamic light scattering as well as previous studies [128]. 
 It was also important to find that this dependence on fermentation conditions 
was not applicable to all recombinant proteins.  This is in agreement with a study that 
showed the choice of the target protein would alter IB formation [129].  In fact, Syn-
Melan-A had a crucial low protein production rate that made fermentation conditions 
relevant.  For proteins produced fast enough, no extraction improvement is made by 
changing temperature.  Temperature influence on IBs is so great, that it is likely 
feeding rates would also have no influence.   
It was expected that IPTG concentration would make a large difference 
because the IB formation is ultimately determined by production rate.  Previous 
studies have suggested that decreasing IPTG creates both smaller IBs [125] and larger 
IBs [128].  A possible explanation for this is the protein dependence because each 
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protein is innately produced at a different rate.  In this study, Melan-A with a pRARE 
plasmid seemed to be produced so quickly that not even producing the protein at 30 ºC 
influenced the IB characteristics.  Syn-Melan-A was produced slowly enough that 
decreasing IPTG further did not influence the characteristics of its IBs at 37 ºC.  IPTG 
may actually have an effect on proteins that are produced faster than Syn-Melan-A. 
 Slowing down production seems to create less compact aggregates that are 
composed of more active protein.  Soluble protein yields also improve for certain 
proteins under slow production rates.  Therefore if the goal of a process is to create 
more active protein, low temperatures and limiting feed rates should be employed.   
 
5.2. Recommendations 
 An attempt was made in this study to mimic industrial E. coli fermentation 
conditions as closely as possible.  As such, the choice of E. coli strain used, as well as 
the custom-created plasmid vector could have been improved.  C41 is a direct 
derivative of BL21 and therefore still contains RecA.  A BLR strain is much more 
commonly used in industry.  Also, an unmodified commercial vector is also 
recommended.  Also, even though EGFP and GFP are very similar, an unmodified 
GFP protein should have been used for better direct comparison with literature data.  
These slight deviations were all done in this study as a matter of convenience. 
 The dynamic light scattering assay can also be improved.  Data from the 
zetasizer regularly gave numbers that were beyond the estimated range of IB size 
based on microscopy.  Either through altered sample preparations or run conditions, it 
should be possible to find conditions yielding consistent results between these two 
methods. 
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5.3. Future work 
 Aside from the recommendations listed above, this study has established many 
steps that make it worthwhile to continue this research.  Most IB studies do not use 
IBs produced under industrial conditions, particularly using HCDC.  This is an 
important factor because industrial protein production is when IB quality is the most 
significant.  Also, this study has created, to the author’s knowledge, the best protocol 
for determining IB density as well as the most detailed IB SEM images ever taken.  
The following areas can be explored using the established fermentation platform and 
assays. 
 
5.3.1. Additional process parameters 
 This study focused on feeding rates and temperatures.  The study of IPTG was 
not complete because reduced levels of IPTG needed to be tested on proteins other 
than Syn-Melan-A which already had a reduced production rate. 
In addition, other parameters that are normally controlled in an industrial 
fermentation are pH and dissolved oxygen.  Previous literature has described pH 
conditions lower than 5.5 [130].  This is very different than 7.0, but large extracellular 
pH changes are necessary since E. coli regulate their internal acidity tightly.  Some 
industrial processes are also producing proteins at minimal oxygen levels.  That is not 
to say that the fermentations are anaerobic or oxygen-limited, but oxygen levels are 
still undetectable.  A glucose spike can be used to determine adequate oxygen levels in 
these cases [131]. 
 Ultimately there are also many less conventional methods to alter cell 
metabolism.  Acetic acid, ethanol, heavy metals, antibiotics, hydrogen peroxide, and 
DTT can all be added in various levels, and their effects on IBs could be studied. 
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5.3.2. Chaperone studies  
 One of the major rules in IB formation is that IBs will form when protein 
production exceeds the cell’s folding capacity.  Folding is performed largely by DnaK 
and GroEL.  If these chaperones are coexpressed, proteins produced at relatively fast 
rates may become susceptible to changes in fermentation temperature and feeding rate.  
Commercial plasmids are available from Takara Bio (Madison, WI): pKJE7 for dnaK-
dnaJ-grpE and pGro7 for groES-groEL.  These plasmids carry an ampicillin resistance 
and are induced with arabinose.  They can be introduced into Syn-Melan-A E. coli 
with a heat shock transformation as described in Section 2.3.4.  Antibodies for these 
chaperones for western blot quantification are also commercially available. 
 
5.3.3. Inclusion body formation 
 For the sheer excessive number of samples to process, the only IB samples 
studied in detail were at the end of fermentation.  Instead of exploring many different 
fermentation conditions, it may be worthwhile to examine the IBs formed throughout 
the course of a fermentation.  A particular useful tool would be immunochemistry 
performed on cell sections in TEM.  This would allow us to visualize how IBs are 
formed.   
There may also be a protein-dependence on IB formation.  For example, Syn-
Melan-A begins forming IBs before any soluble protein is produced.  This is different 
than fusion growth hormone.  That protein was initially produced in the soluble form 
and then formed IBs as the expression level increased. 
 
5.3.4. Protease monitoring 
In order to determine the amount of actual protein production the folding 
machinery of a cell can handle, it is necessary to be able to monitor protease activity.  
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Net protein production is the difference of protein produced and the protein that is 
degraded.  SDS-PAGE analysis only provides data about net protein production, so the 
reason for reduced protein present at 42°C is not certain.  It was assumed that this 
lower protein was the result of increased protease activity at this higher temperature, 
but it is possible that protein production itself was somehow reduced. 
Although the strains of E. coli used in this study lack the Lon and OmpT 
proteases, there are still 22 other known E. coli proteases.  In addition to Lon, there are 
at least eleven more proteases located in the cytoplasm, the rest being periplasmic or 
membrane proteases [132].  In particular it has been shown that ClpP, a subunit of the 
Clp protease, can influence inclusion body degradation [133].  In addition to Clp 
protease subunits, it is possible that FtsH, although associated with the inner 
membrane, also plays a significant role in cytoplasmic protein degradation [134]. 
There are a couple of established methods for measuring protease activity.  
There is a fluorescent protease assay kit (Pierce), which is based on casein digestion.  
Specifically, casein is labeled with fluorescein isothiocyanate, and the fluorescence 
properties of this substrate will change as it is digested by proteases.  There are also 
zymogram gels (Invitrogen) that are based on the proteases ability to digest a casein or 
gelatin substrate.  These show up as clear bands on a stained gel and have the 
advantage of estimating the molecular weights of the active proteases [135].   Artifacts 
commonly caused by the gelatin can be avoided using an electroblotting procedure 
[136].   
A good preliminary experiment to perform may be to measure the rate of 
protease activity in E. coli C41(DE3) on Melan-A.  Although fast rates have been 
reported in other strains, the lack of Lon may make the remaining protease activity 
negligible.  After taking a zero timepoint sample during an active fermentation, 
protein production can be arrested in vivo using chloramphenicol [137].  In our case,  
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Figure 5.1. SEM image of AFM probe with inclusion bodies. An AFM probe was 
submerged in an inclusion body solution and washed.  A resulting finite number of 
inclusion bodies were present on the probe. 
 
we would have to operate without the pRARE plasmid or use another antibiotic, such 
as any in the macrolide class.  It should be possible to determine degradation rates by 
performing assays to detect Melan-A levels in samples at timepoints after protein 
arrest has been initiated. 
 
5.3.5. Inclusion body force measurments 
 An assay to measure inclusion body stiffness using atomic force microscopy 
was developed.  The plan was to use a custom probe that had a blunt platform, as 
shown in Figure 5.1.  This platform would be pressed against a mica surface and the 
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force would be measured.  The force would then be divided by the number of IBs on 
the platform, as can be determined with SEM. 
  116 
REFERENCES 
 
1) J. Luo, M. Leeman, A. Ballagi, A. Elfwing, Z. Su, J. Janson, K. Wahlund, Size 
characterization of green fluorescent protein inclusion bodies in E. coli using 
asymmetrical flow field-flow fractionation--- multi-angle light scattering, J. 
Chromat. A 1120 [2006] 158-164. 
2) N. Sánchez de Groot, S. Ventura, Effect of temperature on protein quality in 
bacterial inclusion bodies, FEBS Lett. 580 [2006] 6471-6476. 
3) H. Kang, A. Sun, Y. Shen, D. Wei, Refolding and structural characteristics of 
TRAIL/Apo2L inclusion bodies from different specific growth rates of 
recombinant Escherichia coli, Biotechnol. Prog. 23 [2007] 286-292. 
4) G. Margreiter, P. Messner, K. Caldwell, K. Bayer, Size characterization of 
inclusion bodies by sedimentation field-flow fractionation, J. Biotechnol. 138 
[2008] 67-73. 
5) S. Peternel, J. Grdadolnik, V. Gaberc-Porekar, R. Komel, Engineering 
inclusion bodies for non denaturing extraction of functional proteins, Microb. 
Cell Fact. 7 [2008] 1-9. 
6) L. Strandberg, S. Enfors, Factors influencing inclusion body formation in the 
production of fused protein in Escherichia coli, Appl. Environ. Microbiol. 57 
[1991] 1669-1674. 
7) J. Zawada, J. Swartz, Maintaining rapid growth in moderate-density 
Escherichia coli fermentations, Biotechnol. Bioeng. 89 [2005] 407-415. 
8) S. Harcum, W. Bentley, Response dynamics of 26-, 34-, 39-, 54-, and 80-kDa 
proteases in induced cultures of recombinant Escherichia coli, Biotechnol. 
Bioeng. 42 [1993] 675-685. 
  117 
9) A. Vera, A. Arís, M. Carrió, N. González-Montalbán, A. Villaverde, Lon and 
ClpP proteases participate in the physiological disintegration of bacterial 
inclusion bodies, J. Biotechnol. 119 [2005] 163-171. 
10) F. Baneyx, M. Mujacic, Recombinant protein folding and misfolding in 
Escherichia coli, Nat. Biotechnol. 22 [2004] 1399-1408. 
11) D. Michaud, Gel electrophoresis of proteolytic enzymes, Anal. Chim. Acta 372 
[1998] 173-185. 
12) S. Visal-Shah, T. Vrain, S. Yelle, B. Nguyen-Quoc, D. Michaud, An 
electroblotting, two-step prodcedure for the detection of proteinases and the 
study of proteinase/inhibitor complexes in gelatin-containing polyacrylamide 
gels, Electrophoresis 22 [2001] 2646-2652. 
13) A. Rozkov, T. Schweder, A. Veide, S. Enfors, Dynamics of proteolysis and its 
influence on the accumulation of intracellular recombinant proteins, Enzyme 
Microb. Technol. 27 [2000] 743-748. 
 
 
 
118 
APPENDIX 1 
 
ADDITIONAL ASSAY METHODOLOGY AND DEVELOPMENT 
 
A1.1. High performance liquid chromatography 
 A reverse phase high performance liquid chromatography (RP-HPLC) method 
was created.  The goal of this method was to characterize and quantify protein 
samples.  A Waters (Milford, MA) 1525 Binary HPLC Pump was used to load 
samples and run a gradient of mobile phase A [0.1% trifluoroacetic acid (TFA) in 
HPLC-grade water] and mobile phase B [0.09% TFA in acetonitrile] through a 
Poros® R2 10 mm 4.6mmD/50mmL stainless steel column (Applied Biosystems, 
Foster City, CA).  The column was storage in a 50:50 solution of HPLC-grade water 
and acetonitrile.  HPLC-grade water was created by filtering deioinized water through 
a 0.22 µm vacuum filter (Nalgene Labware, Rochester, NY) to remove gases and 
particulates.  Samples and buffers were sent through a Waters In-Line Degasser AF 
and guard column prior to entering the column.  Protein was detected coming off the 
column in a Waters 2996 Photodiode Array Detector.  Waters Empower Pro software 
was used to run the system. 
 A spectrophotometer, described in 2.5.2, was used to determine the optimal 
wavelength for detecting protein on the HPLC.  A purified sample of Melan-A was 
used.  The wavelength that provided the greatest absorbance value was 277 nm 
(Figure A1.1). 
The column flowrate and pressure limit was 2.0 ml/min and 2500 psi.  After 
the column was equilibrated with mobile phase A, 200 µl of protein sample was 
loaded on the column and chased with a gradient from 0% to 100% mobile phase B 
over 10 min.  Peak areas could be quantified using the Empower Pro software (Figure  
119 
Figure A1.1. Absorbance of Melan-A protein at multiple wavelengths.  The 
absorbance of a post-HIC Melan-A sample was measured at multiple wavelengths in a 
spectrophotometer.  The optimal wavelength was 277 nm. 
 
A1.2).  Bovine serum albumin (BSA) was used to calibrate the peak area.  Solutions of 
0.05, 0.10, 0.40, and 0.70 mg/ml BSA were run through the HPLC.  The load 
concentration and quantified peak area had a very linear relationship (Figure A1.3). 
Melan-A samples did not show a good resolution when run through the HPLC 
column.  In attempts to improve this, various changes to the experimental set- 
 
Figure A1.2. Chromatogram of bovine serum albumin on RP-HPLC.  BSA was 
loaded onto a reverse phase HPLC column and eluted with an increasing gradient of 
acetonitrile.  Peak area was quantified using Empower Pro software. 
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up were made.  In one case, the TFA in the mobile phases was substituted with 
heptafluorobutyric acid (HFBA).  In another case, 1% sodium dodecyl sulfate (SDS) 
was added to mobile phase A; SDS did not dissolve in mobile phase B.  A Poros® R1 
column was also used because it had different hydrophobic binding qualities as the R2 
column.  In all cases, HPLC chromatograms of Melan-A were single broad peaks 
despite having many protein impurities (Figure A1.4). 
Figure A1.3. Correlation of BSA concentration and peak area on the HPLC.  
Known protein concentrations of BSA samples were plotted against the resulting peak 
area.  Results were very linear. 
 
Figure A1.4. Chromatogram of Melan-A sample on RP-HPLC.  SDS-PAGE of 
Melan-A load (inset) show multiple impurities in the sample.  The impurities are 
indistinguishable from Melan-A on the HPLC chromatogram. 
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A1.2. Limulus amebocyte lysate Assay 
 Bacterial endotoxin has been found to react with the limulus amebocyte lysate 
(LAL) obtained from horseshoe crabs.  An Endosafe Endochrome-K kit (Charles 
River, Wilmington, MA) was used to measure the level of LAL-reactive material in 
purified protein samples.  All samples were run in triplicate on a 96-well plate.  The 
standard curve was produced with 10 ng of E. coli O55:B5 control standard endotoxin 
(Charles River).  The endotoxin was reconstituted in LAL-free water to a 
concentration of 50 EU/ml and diluted to 0.05, 0.5, and 5 EU/ml standards.   
Depending on expected endotoxin concentration, samples were diluted 5 x 103, 
2 x 104, 5 x 105, or 2 x 106 fold.  Dilutions were performed in two steps in pyrogen-
free tubes (Charles River).  A volume of 2 ml was appropriate for adequate vortexing 
of the samples.  The first step was a dilution performed in 4 M urea.  The second step 
was a 100-fold dilution into LAL-free water.  This resulted in a sample with a final 
concentration of 40 mM urea.  Removing all of the urea caused the protein to 
precipitate and created false-negative results.   
The diluted samples were pipetted into a 96-well plate in triplicate in 100 µl 
aliquots.  Each vial of LAL (Charles River) was reconstituted in 3.5 ml of water and 
100 µl was added to each sample.  The plate was read using a kinetic measurement 
over the course of five hr.  The assay provided volumetric endotoxin concentrations of 
the diluted samples.  These values were corrected for dilutions made and protein 
concentration. 
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APPENDIX 2 
 
FERMENTATION SETUP 
 
A2.1. Feed volume calculations 
 All fermentations were conducted in BioFlo units (NBSC, New Brunswick, 
NJ) controlled using Biocommand Plus software (NBSC).  The BioFlo unit had 
internal PID controllers to maintain a set agitation, temperature, and dissolved oxygen 
level.  When feed medium or base was added, arbitrary pump units were used.  The 
actual flow rates these pump rates generate depended on the type of tubing used.  
Tygon® 3350 silicone tubing (Saint-Goblain, Valley Forge, PA) was used for sodium 
hydroxide and both complex and chemically defined feed media addition.  The tubing 
dimensions were 3/32 x 7/32 for sodium hydroxide and 1/8 x 1/4 for feed medium.  
Ammonium hydroxide was added with Masterflex C-Flex® 1/8 x 1/4 tubing (Cole-
Parmer, Vernon Hills, IL) to prevent air accumulation in the tubing.  In addition to 
calculating feed rates by measuring the mass of feed reservoirs (Section 2.5.1), total 
addition volumes were also calculated in real-time by the software.  An example 
program is shown in Figure A2.1.  These programs provided a Calculated Value (.CV) 
for the base and glucose feeds. 
 
A2.2. Detailed fermentor vessel set-up 
 Incomplete complex feed medium was made in several steps.  First, 210 g of 
granulated yeast extract was dissolved into a 500 ml solution in a 1 L bottle.  
Meanwhile hot water was used to dissolve 0.1 g ferrous sulfate heptahydrate, 10.5 g 
magnesium sulfate heptahydrate, sodium citrate dihydrate, 0.6 mg manganese chloride 
tetrahydrate, and 275 ml dextrose into a separate 500 ml solution.  The second solution  
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Figure A2.1. Biocommand program for glucose and base feed calculated values.  
Based on the tubing used, a program was created to determine the cumulative addition 
of glucose and base feeds.  The program shown determines base volumes of sodium 
hydroxide. 
 
was put in a 1 L bottle with a stir bar and feeding tubing.  The feeding tubing reached 
the bottom of the bottle and led to additional tubing to a male quick connect (Cole-
Parmer, Vernon Hills, IL).  When both solutions were completely dissolved, they were 
autoclaved together for 30 min.  Should 1 L of each solution be made, they were 
autoclaved together for 45 min. 
 The sources of medium components are provided in Section 2.4.1.  Incomplete 
complex batch medium was made by dissolving 0.1 g ferrous sulfate heptahydrate, 3.0 
g sodium hexametaphosphate, 2.1 g ammonium chloride, 1.9 g citric acid 
monohydrate, 2.0 ml 30% ammonium hydroxide, and 15 g granulated yeast extract 
into a 1 L solution.  This inoculum medium was poured into a 2.5 L fermentation 
vessel, and 0.4 ml Antifoam 204 was added to the fermentor directly. 
 The pH probe was calibrated by putting the probe into fresh pH 7.0 and 4.0 
standards.  After at least 10 min of equilibration in each buffer, the BioFlo unit was 
calibrated under the Calibration screen.  The Zero was set to 7.0 and the Span was set 
to 4.0 when the probe had equilibrated in the respective buffers. 
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 The reactor was prepared by first fully inserting the baffles into the fermentor.  
A headplate was then evenly sealed on top of the fermentor with four bolts.  The 
headplate was positioned so that the inserted probes would fit in the gap in the baffles.  
O-rings were used to snuggly insert the pH and dissolved oxygen probes into the 
headplate.  Acro polytetrafluoroethylene (PTFE) 0.2 µm air filters (Pall, East Hills, 
NY) were placed on the sample port and ring sparger.  The sample port was closed, 
and the lines for the ring sparger and harvest were clamped.  Female quick connects 
(Cole-Parmer) were placed on the addition ports.  Aluminum foil was used to wrap the 
impeller, probe electrodes, air filters, quick connects, and the condenser port.  The 
condenser base and exhaust were individually wrapped in aluminum foil.  Before 
autoclaving, a coolant exhaust was placed on the fermentor’s water jacket.  The 
reactor and condenser were autoclaved for 30 min.  If two reactors were autoclaved, 
the cycle would be set for 45 min. 
 While the fermentor was still hot after being removed from the autoclave, the 
aluminum foil over the condenser base and condenser port were removed.  The 
condenser was then inserted into the headplate.  The fermentor was placed on the 
BioFlo unit and coolant return and supply lines were attached to the condenser and 
reactor water jacket.  The chiller was turned on and the Temperature was set to Prime 
mode.  After at least 1 min, the Temperature mode was set to PID with a setpoint of 
37˚C.  The temperature probe was inserted into the headplate, and the probe casing 
was filled with water.  The motor was mounted on top of the impeller, and the 
Agitation was set to PID mode at a setpoint of 1,000 rpm.  Under Calibration, the 
dissolved oxygen Zero was set to 0% prior to attaching the probe.  The pH and 
dissolved oxygen probe cables were then attached.  The dissolved oxygen cable was 
allowed to polarize the dissolved oxygen probe for a minimum of 6 hrs before Span 
calibration. 
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 A complex batch medium supplement was prepared by adding 40 ml 50% 
glucose, 1 ml 100 mg/ml kanamycin sulfate, 1 ml 34 mg/ml chloramphenicol, 1.6 ml 2 
M magnesium sulfate heptahydrate, and 0.1 ml 2 g/L manganese chloride tetrahydrate 
to a sterile 50 ml conical.  When the reactor temperature had cooled, the Gas setting 
was set at Manual, and the air flow rate was set at 2-2.5 L/min and attached to the 
vessel.  The medium supplement was then added to the fermentor. 
 When the feed medium components had cooled, 20 ml 150 g/L 
hexametaphosphate, 20 ml 150 g/L ammonium carbonate, 1 ml 100 mg/ml kanamycin 
sulfate, 1 ml 34 mg/ml chloramphenicol, and 4.5 ml of 1 M IPTG were added to the 
yeast solution.  The yeast solution was then added to the dextrose solution.  After the 
complex feed medium was mixed, the feed tubing was primed and attached to the 
bioreactor through Pump 1.  Feed 1 was set to Acid mode with a setpoint of 0.0. 
 Within a few hours of inoculation, a 5 M sodium hydroxide solution was 
attached to the bioreactor through Pump 3.  The line was primed, pH was set to PID 
mode, and the pH setpoint was slowly increased to 7.0.  Feed 3 was set to Base mode 
with a setpoint of 15.0.  The pH of a medium sample could be measured externally, 
and the pH setpoint could be readjusted accordingly. 
 The dissolved oxygen calibration Span was set to 100%.  The dissolved 
oxygen mode was set to O2, and the setpoint was set to 40%.  An oxygen tank was 
attached to the BioFlo unit that supplied pure oxygen at approximately 10 psi. 
 At inoculation, the appropriate Biocommand program was initiated. 
 
A2.3. Feeding method programs 
Most fermentations were performed using a pH-stat feeding method.  In such a 
feeding strategy, the feed medium was added as an “Acid” using the BioFlo unit’s 
internal software.  Unfortunately the C41 cells caused a pH rise prior to glucose 
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depletion in the early stage of each fermentation (see Figure 2.4).  Therefore the Set 
Point (SP) of the maximum feeding rate value of the Acid was set at 0.0 at the start of 
the run and later changed to 30.0.  The pH-stat feeding was used to control culture pH, 
and thus the base addition had to be shut off when feeding was initiated.  These 
changes were automated with the Biocommand program setup shown in Figure A2.2.   
 
Figure A2.2. Biocommand program setup for feed addition.  After a known about 
of base was added to the fermentor, the maximum feeding rate was given a value.  
After feed had been added to the fermentor, base addition was turned off. 
 
The premature pH spike only occurred when C41 E. coli cells were grown in 
the complex batch medium.  The actual pH spike caused by glucose depletion occurs 
at 6 hr elapsed fermentation time.  As shown in Figure A2.3, this pH spike did not 
occur during the early growth phase in the chemically defined batch medium.  This 
spike was also not present when BL21 and BLR strains of E. coli were used.  In these 
cases, a program, such as the one shown in Figure A2.2, was not used. 
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Figure A2.3. Dissolved oxygen and pH profiles of fermentations in complex and 
chemically defined media.  C41 E. coli cells grown in complex medium generate a 
pH spike during early batch phase.  This pH spike is not present in the early batch 
phase of the same cells grown in a chemically defined medium. 
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For constant feeding rate strategies, the feed medium addition was manually 
set in “Manual” mode at the culture’s pH spike.  For linear feed rates, an automated 
program was used based on elapsed fermentation time (EFT).  Feeding began at 
glucose depletion, which occurred after 12 hr EFT when chemically defined batch 
medium was used.  The slope of the linear feed rate was changed by altering the 
constant value the EFT value was divided by.  The actual feed rates that these setpoint 
values represent were determined in Section 2.5.1.  An example of a linear feed 
program used in a chemically defined medium culture is shown in Figure A2.4. 
 
Figure A2.4. Biocommand program for linear feed rate addition.  Feeding began 
when glucose was depleted in chemically defined medium fermentations at 12 hr 
elapsed fermentation time.  The feeding rate could be increased by decreasing the 
value of the Const number. 
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A2.4. Chemically defined medium metals 
 The trace metals in the feed medium added to the chemically defined medium 
cultures were prepared in sulfuric acid.  This highly acidic solution made it impossible 
to implement the pH-stat feeding method.  An attempt to reduce the acidity of the 
trace metals was attempted.  The trace metals in sulfuric acid have a pH of 0.7 and will 
precipitate if the pH is increased above 2.5. 
Copper, cobalt, zinc, borate, and calcium salts appeared to readily dissolve in 
water.  Calcium chloride could be dissolved with the other metals, but it would then 
form a precipitate after an extended period of time.  Sodium molybdate would 
precipitate in the presence of manganese chloride or ferrous sulfate.  It was omitted 
because molybdate is primarily used for nitrate uptake, and there was no nitrate in the 
medium.  Ferric sulfate [Fe2(SO4)3 · nH2O] could not be dissolved in water, and 
ferrous sulfate [FeSO4 · 7H2O] could stay in solution in water for only an appreciable 
amount of time, possibly because of the high concentration used.  The trace metal 
solution without molybdate or iron had an innate pH of 4.6 in water.  Adding all 
metals together in water created a pH 3.4 solution with heavy precipitation.   
 Since the metals require a low pH, the amount added to the feed medium was 
decreased to minimize the acidity in the chemically defined feed medium.  
Unfortunately, even with no metals in the feed medium, the glucose and magnesium 
solutions alone were able to sharply decrease the reactor pH and result in inadequate 
feeding with the pH-stat method.  Ultimately, linear feed rates were used to ensure a 
successful high cell density culture with chemically defined medium. 
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A2.5. Temperature shift programs 
All cultures were run at 37ºC in batch mode until a pH spike indicated glucose 
depletion.  If temperatures were to be changed to a different set point for the 
production phase, this change was automatically initiated after feeding was initiated, 
as shown in Figure A2.5. 
 
Figure A2.5. Biocommand program for temperature shift.  When at least 1 ml of 
feed medium was added to the reactor, temperature could be shifted.  The example 
program shown downshifted vessel temperature to 30ºC during the production phase. 
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APPENDIX 3 
 
SM14 PROCESS DEVELOPMENT 
 
A3.1. Sm14 introduction 
Sm14-C62V antigen is a potential vaccine for schistosomiasis, a condition 
caused by the parasite Schistosoma mansoni that is found in unclean waters of 
undeveloped countries.  The World Health Organization ranks schistosomiasis as the 
second most important infectious disease after malaria.  An initial fermentation and 
purification process was developed by Dr. Leonardo Damasceno (now at Sanofi 
Pasteur, Swiftwater, PA).  The purification process was based a procedure used to 
purify a single-chain antibody for A33 glycoprotein fragment [138]. 
 
A3.2. Supernatant processing 
The Pichia pastoris supernatant that contained Sm14 was washed using 
tangential flow filtration over a 3 kDa cassette (Pall) to remove the salts from the 
fermentation medium prior to an anion exchange column.  On the manufacturing 
scale, most of the protein precipitated on the cassette (Figure A3.1a), and the final 
purification yield was 26.5 mg.   
 
A3.3. Direct hydrophobic interaction chromatography 
Since hydrophobic interaction chromatography (HIC) is not affected by 
conductivity, the supernatant was loaded onto a Phenyl FF column at 1.00 and 1.25 M 
ammonium sulfate.  At 1.25 M ammonium sulfate, no Sm14 protein was detected in 
the flowthrough fraction.  This was not the case with the sample at 1.00 M ammonium 
sulfate, and the Sm14 was able to be partially purified over a 20 column volume (CV) 
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gradient from 1.25 to 0 M ammonium sulfate (Figure A3.1b).  Silver-stained gels were 
loaded and run in the same way as SDS-PAGE, as described in Section 2.5.3, and then 
stained with a SilverQuest staining kit (Invitrogen).  
Figure A3.1. SDS-PAGE of Sm14 after TFF or HIC purification. Lane 1, 4: See 
Blue Plus 2 molecular weight standard (Invitrogen, Carlsbad, CA), Lane 2: Sm14 
supernatant, Lane 3: Sm14 retentate, Lane 5: 1.25 M ammonium sulfate Sm14 
flowthrough, Lane 6: 1.00 M ammonium sulfate SM14 flowthrough, Lane 7-16: Sm14 
fractions off a Phenyl column at 1, 3, 5, 7, 9, 11, 13, 15, 17, and 19 CV.  The Sm14 
protein band is labeled with a red arrow. 
 
A3.4. Direct anion exchange chromatography 
Sm14 supernatant could be purified on a Q XL anion exchange column 
(Invitrogen, Carlsbad, CA) if it was diluted three-fold in Loading Buffer [20 mM Tris, 
pH 8.0] prior to loading.  Although purification could be achieved, it was not 
straightforward because the Sm14 would not tightly bind to the Q XL resin.  For 
example, only 9 ml of diluted protein could be loaded per ml of resin.  If the load 
volume was tripled, Sm14 would elute off of the column before the loading was 
completed.  This was not a conductivity issue because the protein would elute off the 
column while it was still loading even if diluted 20-fold to the same conductivity as 
the Loading Buffer, 0.75 mS/cm.  Even a 5 mM sodium chloride step gradient would 
immediately elute Sm14 off a column with many higher molecular weight 
contaminants.  Increasing the pH of the load material up to 9.00 did not seem to 
a)  1   2      3    b)   4   5  6  7 8  9 10111213141516 
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improve binding, but tight binding did occur if a pH 10.00 ethanolamine buffer was 
used. 
Using pH 8.0 Tris buffers, the original anion exchange process used a gradient 
that went from 0 to 186 mM sodium chloride over 13 CV.  It was found that many 
higher molecular weight contaminants could be removed without loss of Sm14 
recovery if the gradient was kept at 100 mM sodium chloride.  A final major 
contaminant could be removed by running a gradient from 0 to 8.4 mM sodium 
chloride over 35 CV and then increasing the gradient to 10m mM sodium chloride 
over the next 10 CV (Figure A3.2).   
 
Figure A3.2. Silver stain of Sm14 after anion exchange purification.  a) Sm14 
recovered after original anion exchange process.  b) Sm14 recovered after modified 
anion exchange process.  A longer initial gradient removed a major contaminant 
(Lanes 3-5).  Very pure Sm14 was separated (Lanes 7-12).  High molecular weight 
contaminants were removed by decreasing the highest gradient concentrations (Lane 
14-15).  Marker is See Blue Plus 2 (Invitrogen).  Sm14 protein is labeled with a red 
arrow. 
 
These modifications were implemented during the third manufacturing run. 
The second manfacturing run increased total protein yields from 26.5 mg to 66.2 mg, 
but the product had more impurities.  The third manufacturing run produced the purest 
material to date with a total protein yield of 138.5 mg (FigureA3.3). 
a)        1    2         b)    3    4   5          6   7   8   9   10  11  12  13  14 15 
134 
Figure A3.3. SDS-PAGE of Sm14 produced at the manufacturing scale.  SDS-
PAGE of Sm14 recovered after manufacturing runs #3 (Lanes 1, 2), #2 (Lanes 3, 4), 
and #1 (Lanes 5, 6).  Odd lanes contain 10 mg of protein and even lanes contain 5 mg 
of protein.  The Sm14 protein band is labeled with a red arrow. 
 1      2      3     4     5     6 
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APPENDIX 4 
 
NY-ESO-1 PROCESS DEVELOPMENT 
 
A4.1. NY-ESO-1 process development introduction 
The original NY-ESO-1 fermentation and purification processes were 
developed by Dr. Todd Vannelli (now at Adnexus Therapeutics, Waltham, MA).  This 
appendix describes contributions made to improve this process. 
 
A4.2. NY-ESO-1 inclusion body wash 
After cell lysis, NY-ESO-1 inclusion bodies were originally washed by 
pelleting the insoluble protein and resuspending it in the wash solution described in 
Section 2.6.  This process did not scale up well when 10 L of fermentation lysate was 
sent through a Carr Powerfuge Pilot Centrifuge (Pneumatic Scale Angelus, Cuyahoga 
Falls, OH).  Although the Powerfuge is advertised to reach speeds of 20,000 rcf, it was 
not able to efficiently pellet the inclusion bodies that would pellet in a Sorvall RC-5B 
Superspeed Centrifuge (Thermo Fisher Scientific, Waltham, MA) under the same 
gravitational force (Fighure A3.1). 
Instead of using the Powerfuge, a Millipore Proflux M-30 (Billerica, MA) was 
used to wash the inclusion bodies using tangential flow filtration (TFF).  In the final 
process, the cell lysate was circulated parallel to a 0.2 µm Centrasette II cassette (Pall 
Corporation, East Hills, NY).  The diafiltration buffer (50 mM Tris, 1 mM 
ethylenediaminetetraacetic acid (EDTA), 200 mM sodium chloride, pH 8.0) of five-
fold the initial lysate volume was used to wash the inclusion bodies.  No Tween-20 
was used in this wash buffer because it would create an artifact on SDS-PAGE (Figure 
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Figure A4.2).  β-mercaptoethanol was also removed from the wash buffer because its 
absence had no detectable changes. 
 
Figure A4.1. SDS-PAGE of NY-ESO-1 lysate fractions through a continuous 
centrifuge.  Lane 1: Multimark molecular weight standard (Invitrogen), Lane 2-4: cell 
lysate, Lane 5, 6, 8: powerfuge flowthrough, Lane 10: powerfuge pellet.  NY-ESO-1 is 
indicated by the red arrow.   
Figure A4.2. SDS-PAGE of tangential flow filtration fractions using a Tween-20 
wash buffer.  NY-ESO-1 inclusion bodies were sent through a 0.22 µm filter and 
retained using a 10 kDa filter.  Tween-20 is visible as a blue shading below the 3 kDa 
marker and appears as a larger artifact in higher concentrations. 
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 An immobilized metal affinity chromatography (IMAC) column was 
equilibrated with IMAC A buffer (4 M urea, 100 mM sodium phosphate, pH 7.5).  The 
TFF retentate was diluted eight-fold in solubilization buffer (8.57 M urea, 100 mM 
sodium phosphate, pH 7.5) to a final urea concentration of 7.5 M.  The solubilized 
inclusion bodies were loaded onto the IMAC column and chased off the column with 
IMAC A buffer.  The protein was then washed and eluted with IMAC A buffer 
containing 75 and 500 mM imidazole, respectively.  In comparison to the 
centrifugation-washed material, the material washed using tangential flow filtration 
showed a much larger absorbance peak during the 75 mM imidazole wash and a much 
smaller peak during 500 mM imidazole elution (Figure A4.3).  
 
Figure A4.3. IMAC chromatography profiles of NY-ESO-1.  Each profile contains 
a flowthrough, low imidazole wash, and elution peak.  NY-ESO-1 washed using 
centrifugation resuspensions (top) had a sharper elution peak.  The material washed 
using tangential flow filtration (bottom) had more material in the low imidazole wash.  
Blue lines are ultraviolet absorbance at 280 nm.  Green lines are column pressure.  The 
wash peaks are labeled with arrows. 
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A4.3. NY-ESO-1 protein precipitation during ion exchange chromatography 
 NY-ESO-1 in the high imidazole fraction was buffer exchanged to [4 M urea, 
50 mM Tris, pH 8.0] to remove salts.  The original NY-ESO-1 purification process 
sent this material through a Q XL column without binding.   
 Upon scale-up, the NY-ESO-1 precipitated on the Q XL column and could not 
be removed with up to 1 M sodium chloride or 1% deoxycholate detergent.  One of the 
changes made to the process upon scale-up was the change of urea manufacturer.  The 
small scale process had used a granular urea (Mallinckrodt Baker, Phillipsburg, NJ), 
and the manufacturing process used bead urea (EMD Biosciences, San Diego, CA).  
Buffers using both types of urea were tested on a 5 ml HisTrap FF and a 5 ml HiTrap 
Q XL column (GE Healthcare).  Both buffers produced 0.3 mg/ml IMAC elution 
fractions and 0.26 mg/ml Q XL loads  In both cases, there was also an undetectable 
level of protein in the Q XL flowthrough and subsequent 1 M sodium chloride wash.  
It was determined that the type of urea used did not affect the purification of NY-ESO-
1, and there was another cause for its precipitation on the Q XL column.   
 NY-ESO-1 irreversibly bound to the Q XL column, which implied that it had 
precipitated.  Several buffers were screened to determine which one would prevent the 
Q XL load from precipitating on the column.  An aliquot of the NY-ESO-1 Q XL load 
was buffer exchanged to the respective buffer prior to loading on a 5 mL HiTrap Q XL 
column (GE Healthcare) in each of these cases.  It was determined that a phosphate 
buffer instead of a Tris buffer at a lower pH solved this problem (Table A4.1).  
Changing the buffer base from Tris to sodium phosphate had the greatest influence.  A 
buffer of [4 M urea, 50 mM Tris, pH 7.5] was also attempted, but the NY-ESO-1 
solution become cloudy during the buffer exchange.  It was concluded that NY-ESO-1 
has a poor solubility in Tris buffer that caused protein loss through precipitation. 
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Table A4.1. Recovery of NY-ESO-1 through a Q XL column using different 
buffers.  NY-ESO-1 was buffer exchanged into various buffers and flowed through a 
Q XL column.  No protein was recovered when a Tris buffer was used. 
 
 
 
 
 
A4.4. NY-ESO-1 protein precipitation during hydrophobic interaction 
chromatography 
 The Q XL flowthrough fraction was composed of NY-ESO-1 protein in [4 M 
urea, 100 mM sodium phosphate, pH 7.5].  Originally, this material was diluted 1:1 in 
[4 M urea, 100 mM sodium phosphate, 2 M ammonium sulfate, pH 7.5] to a final 
concentration of 1 M ammonium sulfate.  This resulted in a cloudy precipitate of the 
NY-ESO-1 protein that would be lost in 0.5 µm pre-column filtration or on the 
hydrophobic interaction chromatography (HIC) column itself. 
 The ammonium sulfate concentration was reduced to 0.95 M.  Protein yields 
were increased from 0.340 to 0.415 mg of protein.  Further studies are now 
determining the improved NY-ESO-1 yields achieved by lowering ammonium sulfate 
levels. 
 
A4.5. NY-ESO-1 endotoxin removal 
 
A4.5.1. NY-ESO-1 endotoxin removal during ion exchange chromatography 
 A scouting study was performed to determine if altering the pH in the anion 
exchange chromatography step could improve endotoxin removal.  The protein was 
Buffer pH urea recovery 
50 mM Tris 8.0 4 M 0.0% 
100 mM Na Phos 8.0 4 M 62.1% 
100 mM Na Phos 7.5 4 M 71.5% 
100 mM Na Phos 7.5 8 M 91.3% 
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buffer exchanged into and sent through the column without binding using a [4 M urea, 
100 mM sodium phosphate] buffer.  The tested pH’s of this buffer were 6.5, 7.0, and 
7.5.  Q XL load retain from a manufacturing run was loaded in 7.5 ml aliquots on both 
equilibrated 1ml and 5 ml HiTrap Q XL column (GE Healthcare) and washed off with 
5 ml of buffer.  Protein recovered from each pH was identical.  The load endotoxin 
concentration was 280 EU/µg.  Endotoxin values were 84.5, 160, and 158  EU/µg off 
the 1 mL columns and 9.1, 7.0, and 4.9 EU/µg off the 5 ml columns for pH 6.5, 7.0, 
7.5, respectively.  So although the pH range tested did not have much influence on the 
endotoxin level, the use of additional Q XL resin helped significantly.   
 A more elaborate study [139] showed that up to 900,000 endotoxin units (EU) 
could be loaded onto 1 ml of Q XL resin.  For future manufacturing runs, the amount 
of Q XL resin used was quintupled. 
 
A4.5.2. NY-ESO-1 endotoxin removal during nickel chromatography 
 A detergent-based endotoxin removal step was based off of a successful 
literature study [140].  NY-ESO-1 cell pellets were resuspended back to 1 L and 
washed on a 0.2 µm TFF unit with 5 L of EDTA Buffer [100 mM sodium phosphate, 
500 mM sodium chloride, 13.2 mM EDTA, pH 7.5].  The EDTA was removed by 
washing with 5 L of Phosphate Buffer [100 mM sodium phosphate, 200 mM sodium 
chloride, 100 mM potassium chloride, pH 7.5].  The retentate was concentrated to 500 
mL and diluted to 4 L with Triton Buffer [100 mM sodium phosphate, 200 mM 
sodium chloride, 100 mM potassium chloride, 10 mM imidazole, 1.0% Triton X-114, 
8 M urea, pH 7.5].  The solution was allowed to solubilize overnight. 
 An IMAC column was equilibrated with 5 CV of Triton Buffer and was loaded 
with the solubilized NY-ESO-1.  Triton buffer was then used to wash off the 
endotoxin.  It took 15 CV of a Urea Buffer [100 mM sodium phosphate, 4 M urea, pH 
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7.5] to wash out the triton, as detected with an online UV280 monitor.  The column 
was then washed for 5 CV with [Urea Buffer + 75 mM imidazole] and eluted with 4 
CV of [Urea Buffer + 500 mM imidazole]. 
Although the Reichelt study only used 0.1% Triton X-114, our studies found 
that 1.0% Triton X-114 would result in better endotoxin removal.  Triton X-114 would 
typically form a cloudy solution at room temperature, but the Triton Buffer, which 
contained 8 M urea, was clear at room temperature.  Temperature studies were 
performed to confirm that the Triton Buffer did not need to be kept at 4 ºC, as was also 
done in the Reichelt study.  The Triton Buffer would freeze if it was kept in ice, so the 
buffer could only be maintained at 10 ± 2 ºC during the course of a run that jacketed 
the IMAC column with ice.  A 4 ºC study was performed manually in a cold room 
with syringes.  The Reichelt study also used a 50 CV wash of Triton Buffer.  The 
triton concentration, buffer temperature, and wash volumes were evaluated using 5 mL 
HisTrap columns (GE Healthcare). 
 
Table A4.2. Endotoxin removal during IMAC under different triton 
concentrations, temperatures, and wash volumes.  Temperature was not important, 
but 1% triton-X114 and high wash volumes were necessary for endotoxin removal. 
Run Triton Temp Wash EU/µg 
1 0.0% 10˚C 50CV 13.90 
2 0.1% 10˚C 50CV 1.32 
3 0.1% 4˚C 50CV 2.77 
4 1.0% 10˚C 50CV 0.14 
5 1.0% 10˚C 50CV 0.06 
6 1.0% 10˚C 10CV 0.73 
7 1.0% 20.5˚C 50CV 0.06 
8 1.0% 20.5˚C 5CV 1.64 
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 After establishing the merits of using 1.0% triton-X114 and determining that 
temperature was not a significant factor, another study evaluated the use of different 
load volumes and wash volumes.  The results are summarized in Figure A4.4.  
Increasing the wash volumes from 20 to 40 CV did slightly reduce the endotoxin 
concentration in the IMAC elution from 2.40 to 0.07 EU/µg.  It also turned out that 
overloading the column did not result in increased protein yield and instead resulted in 
endotoxin levels as high as 29.8 EU/µg.  It was later shown that by adding 1.0% 
deoxycholate buffer to the Triton Buffer, the endotoxin level could be reduced to 0.05 
EU/µg with only a 5 CV wash after loading. 
Figure A4.4. Endotoxin removal during IMAC under different protein load 
volumes and wash volumes of triton buffer.  Overloading the nickel column 
resulted in an order of magnitude higher level of endotoxin in the IMAC elution.  At 
the lowest load tested, wash volumes close to 50 CV were necessary to keep endotoxin 
levels below 1.0 EU/mg. 
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A4.5.3. Additional NY-ESO-1 endotoxin removal attempts 
Endotoxin removal was attemped using Endotrap Red (Cambrex, Charles City, 
IA) and Detoxigel (Thermo Fisher Scientific, Waltham, MA).  Columns were drained 
of storage solution and flushed with Cambrex regeneration buffer and equilibration 
buffer.  Q XL load retain from a manufacturing run was loaded and the protein 
concentration and endotoxin values of the flowthrough were compared with that of the 
load.  The load sample had a protein concentration of 9.0 mg/ml and the flowthrough 
samples through the Endotrap Red and Detoxigel columns had protein concentrations 
of 0.7 and 0.5 mg/ml, respectively.  Most of the protein was lost on these columns, and 
there was no improvement in endotoxin removal. 
An increase of sodium chloride and EDTA was attempted to remove endotoxin 
during the tangential flow filtration (TFF) wash.  A NY-ESO-1 cell pellet was 
resuspended to 1 L and washed with 5 L of [100 mM sodium phosphate, 770 mM 
sodium chloride, 120 mM EDTA, pH 7.5].  This process was unable to remove 
enough endotoxin to warrant its use. 
 Endotoxin removal was also attempted on the HIC column by changing the 
denaturant.  A 2x dilution buffer was used to bring the ammonium sulfate 
concentration of the HIC load material to 1 M.  As such, the most soluble dilution 
buffer used was [5 M guanidine hydrochloride, 2 M ammonium sulfate, 100 mM 
sodium phosphate, pH 7.5] resulting in a HIC load of concentrations [2.5 M guanidine 
hydrochloride, 4 M urea, 1 M ammonium sulfate, 100 mM sodium phosphate, pH 
7.5].  This change had no effect on protein recovery or endotoxin removal. 
 
A4.6. Purification of soluble NY-ESO-1 
There was very little NY-ESO-1 in the soluble fraction.  The chloramphenicol 
acetyltransferase (CAT) protein was produced by the pRARE plasmid, and it showed 
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up at 26 kDa.  Although NY-ESO-1 was 19 kDa, it ran at approximately the same size 
as CAT.  Purification of the soluble fraction of NY-ESO-1 could only be evaluated 
with a western blot. 
Using a [100 mM sodium phosphate, pH 7.5] buffer, soluble NY-ESO-1 could 
be found in the flowthrough and elution fractions of the IMAC column.  Samples 
flowed through and did not bind to Q XL and Q FF anion exchange columns.  
Different ammonium sulfate concentrations were evaluated for the HIC column.  
Soluble NY-ESO-1 did not bind to a Phenyl column when 0.34 M ammonium sulfate 
was used.  A little bound to the column at 0.63 M and most bound at 0.87 M.   
 
146 
REFERENCES 
 
139) R. Chen, C. Huang, B. Newton, G. Ritter, L. Old, C. Batt, Factors affecting 
endotoxin removal from recombinant therapeutic proteins by anion exchange 
chromatography, Prot. Expr. Purif. 64 [2009] 76-81. 
140) P. Reichelt, C. Schwartz, M. Donzeau, Single step protocol to purify 
recombinant proteins with low endotoxin contents, Prot. Expr. Purif. 46 
[2006] 483-488. 
 
147 
APPENDIX 5 
 
NY-ESO-1 PROCESS FLOWCHARTS 
Process Overview 
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r
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Fermentation Harvest
Powerfuge
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(aka resuspension buffer)
Microfluidizer
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3. CELL LYSIS
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Cassette
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r
washed inclusion bodies
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b
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to solubilization
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5. SOLUBILIZATION & CAPTURE
washed inclusion bodies
Solubilization Buffer
1.2 µm 0.5 µm BPG column
Phosphate imidazole bufferPhosphate buffer
a
b
c
flowthru
low imidazole
High Imidazole
Fraction
HOLD STEP 3
6. DOWNSTREAM PURIFICATION
IMAC 
Elution TFF 
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pr
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b
Phosphate NaCl buffer
salt wash
AXC flowthrough
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HIC Buffer A
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flowthru
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7. POST-HIC PROCESSING
HIC elution
Bulk formulation buffer
TFF 
Cassette
pr
FILTERED FINAL BULK PURIFIED NY-ESO-1
a
b
HOLD STEP 6
0.2 µm
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APPENDIX 6 
 
MELAN-A EXPRESSION PROCESS DEVELOPMENT 
 
A6.1. Melan-A research cell bank screening 
The initial Melan-A plasmid was constructed by Dr. Todd Vannelli.  The 
Melan-A sequence was: 
mgsshhhhhhssglvprgshmpredahfiygypkkghghsyttaeeaagigiltvilgvllligcwycrrrngyralm
dkslhvgtqcaltrrcpqegfdhrdskvslqekncepvvpnappayeklsaeqspppysp 
The custom-made 9a24a plasmid containing the Melan-A sequence was transformed 
into competent C41 cells (see Section 2.3.4).  The colonies were screened by 
suspending single colonies in 1 ml aliquots of complex batch medium (see Section 
2.4.1).  Eight different cultures were grown in 50 ml conical tubes.  After agitation at 
room temperature overnight, the culture optical densities (OD600) were 15.1, 11.0, 9.8, 
12.9, 6.0, 5.0, 3.3, and 9.5.  Cultures were diluted to an optical density of 0.2 in 5 ml 
of complex batch medium and placed in a 37 ºC shaker.   
Induction was performed with the addition of 2 µl of 1 M IPTG to reach a final 
concentration of 0.4 mM IPTG when the culture OD600 were 1.68, 1.18, 1.23, 1.50, 
1.12, 0.98, 0.88, and 0.97.  A preinduction sample was taken from culture #5 before 
IPTG was added.  After four hr, the OD600 were 4.16, 3.40, 3.80, 3.76, 4.02, 4.00, 
3.84, and 3.64.  Cell pellets were made from (1.3/OD) ml of broth.  Protein was 
separated into soluble and insoluble fractions (see 2.5.3).  A western blot of these 
samples (Figure A6.1) showed equal Melan-A production in all cultures.  Culture #8 
was selected to be made into the research cell bank (2.3.4).   
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Figure A6.1. Western blot of Melan-A production in transformed cells.  Lane 1 is 
a Multimark standard (Invitrogen, Carlsbad, CA).  Lane 2 is a preinduction sample 
that shows negligible Melan-A production.  Lanes 3-10 are Melan-A production in 
eight cultures after four hr of IPTG induction.  A red arrow indicates the Melan-A 
monomer band. 
 
A6.2. Melan-A genetic stability study 
A single 100-fold dilution was performed by mixing 10 µl of culture into a 1 
ml aliquot of phosphate buffer saline (PBS).  The fermentation inoculum culture was 
diluted 106-fold with three 100-fold dilutions in series.  The harvest culture was 
diluted 108-fold by conducting four 100-fold dilutions.  Aliquots of 50 µl of these 
dilutions were plated on plates with and without kanamycin and chloramphenicol.  
Plates were made using 20 g/L APS Luria broth and 15 g/L agar.  The autoclaved 
solution was poured into petri dishes in 40 ml aliquots under sterile conditions.  
Colonies were allowed to form over a two day period at room temperature.   
Performed in triplicate, the inoculum culture formed 49 ± 3 and 46 ± 7 
colonies on plates with and without antibiotic, respectively.  Also performed in 
triplicate, harvest cultures formed 32 ± 2 and 264 ± 50 colonies on plates with and 
without antibiotic, respectively.  Even though kanamycin was included in the feed 
medium, this study shows that the culture had 100% antibiotic resistance in the 
inoculum stage, but it lost most of this resistance by the end of the fermentation.  In 
TEM images of the harvest cells (Figure 2.12), very few cells also appear to be 
1   2    3    4    5    6    7   8   9   10 
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producing inclusion bodies.  This is possible because C41 cells are not RecA negative.  
Under stress, cells are able to lose their protein-producing plasmid.  The cells that do 
not need to produce the protein and replicate the plasmid have a growth advantage and 
overtake the remaining the cells in the culture. 
  
A6.3. Melan-A production in BLR E. coli 
 BLR cells were transformed with the pET9a24a Melan-A plasmid using the 
same techniques in Section 2.3.4.  A double transformation was performed to add a 
pRARE plasmid.  From western blot analysis, it was determined that Melan-A 
expression in the BLR strain was improved compared to the C41 strain.  It was also 
concluded that the pRARE plasmid was necessary for acceptable Melan-A expression 
(Figure A6.2). 
 
Figure A6.2. Western blot of Melan-A produced from different strains of E. coli.  
Lane 1: Multimark, Lane 2: BLR preinduction, Lane 3: BLR harvest, Lane 4: BLR 
pRARE harvest, Lane 5: C41 preinduction, Lane 6: C41 harvest.  Red arrows indicate 
the Melan-A monomer bands. 
 
It was recommended that the production cell line be change to BLR E. coli to 
possibly prevent genetic stability and improve process yields.  The BLR strain is also 
1    2    3     4    5    6 
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more commonly used for industrial production of recombinant proteins.  It was not 
changed in the process because the NY-ESO-1 fermentation process had set 
precedence for using C41 E. coli in the Cornell University – Ludwig Institute for 
Cancer Research productions. 
 
A6.4. Synthetic Melan-A production 
The Melan-A sequence was changed to: 
mpredahfiygypkkghghsyttaeeaagigiltvilgvllligcwycrrrngyralmdkslhvgtqcaltrrcpqegfdh
rdskvslqekncepvvpnappayeklsaeqspppysphhhhhh 
Codons for the Melan-A sequence were changed so that the frequency of codon usage 
would match the codons naturally found in E. coli (Section 2.3.1).  Compared to the 
original sequence (Section A6.1), the His-tag has been moved to the C-terminus and 
extraneous amino acids not part of the Melan-A protein were removed.  This change 
created a smaller protein (Figure A6.3).  Changing the position of the His-tag did not 
seem to alter any fermentation or purification yields. 
 
Figure A6.3. SDS-PAGE and western blot of Melan-A and Syn-Melan-A.  a) SDS-
PAGE and b) western blot of the previously produced Melan-A and the modified 
sequence.  Syn-Melan-A is in the rightmost lanes.  The former version had additional 
amino acids that were removed.  See Blue Plus 2 molecular weight standard 
(Invitrogen) was used.  Red arrows indicate the monomer bands. 
 
a)                           b)  
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A6.5. GroEL co-expression in Syn-Melan-A production 
 A pGro7 plasmid (Takara, Madison, WI) was transformed into Syn-Melan-A 
C41 cells.  These cells were cultured in 5 ml of complex fermentation batch medium 
in 50 ml conical tubes.  Different cultures were supplemented with a 20% arabinose 
solution to a final concentration of 0.2%, 0.6%, 1.0%, 2.0%, and 4.0% (v/v).  
Induction was performed with a final IPTG concentration of 2 mM.  Although a 
western blot run with an anti-GroEL antibody (EMD Biosciences, San Diego, CA) 
confirmed the increased production of GroEL (Figure A6.4), no improvement in 
Melan-A expression or solubility was detected.  Relative levels of GroEL and Melan-
A produced were determined using ImageJ densitometry software. 
 
Figure A6.4. Relative GroEL expression in Syn-Melan-A Gro7 cultures.  A Syn-
Melan-A culture without the pGro7 plasmid was run as a control.  Increasing 
arabinose up to 1% (v/v) more than tripled the expression of GroEL in the culure. 
 
A6.6. Harvesting Conditions 
 After high cell density E. coli fermentations of NY-ESO-1 and Syn-Melan-A, 
cells were harvested prior to centrifugation and lysis.  Particularly on the 
manufacturing scale, the cells would be glucose-depleted and without pH, DO, and 
temperature control.  A 2 L fermentation for each protein was evaluated in complex 
medium with and without the addition of 50 ml feed medium and with and without 
cooling the cells to 4 ºC.  Cells that did not receive cooling were removed from the 
  Control    0.0%     0.2%       0.6%       1.0%       2.0%      4.0% 
 
SE   IB    SE  IB    SE   IB    SE  IB    SE   IB   SE   IB   SE  IB 
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reactor and placed in a 37 ºC incubator for 40 min.  Cells that did receive cooling were 
brought down to 20 ºC in the fermentor, which took 20 min, and placed in a 4 ºC 
refrigerator for an additional 20 min.  The two-step cooling procedure was used 
because cooling cells below the cloud point of Antifoam 204 would cause foaming in 
the reactor.  In every combination of these harvest conditions, protein yields were 
identical as seen on SDS-PAGE (Figure A6.5). 
 
Figure A6.5. SDS-PAGE of NY-ESO-1 and Syn-Melan-A under different 
harvesting conditions.  Soluble (S) and insoluble (I) fractions are indicated for a) 
NY-ESO-1 and b) Syn-Melan-A lysate samples.  Condition A: feed added, no cooling, 
Condition B: no feeding, no cooling, Condition C: no feeding, 4 ºC cooling, Condition 
D: feed added, 4 ºC cooling.  Red arrows indicate the respective bands. 
 
A6.7. Melan-A secretion in Pichia pastoris 
An attempt to produce Melan-A in Pichia pastoris was attemped.  P. pastoris 
is a methylotrophic yeast that can reach high cell densities and secrete some proteins.  
If Melan-A could be secreted in P. pastoris, purification of the protein would be 
greatly simplified. 
YPD (yeast extract peptone dextrose) plates were made using 1 M sorbitol and 
15 g/L agar.  Zeocin was added as the antibiotic to final concentrations of 100, 250, 
and 500 µg/ml.  The pPICzαA plasmid was linearized by adding a 10 µl aliquot to 2 
µl PmeI restriction enzyme, 0.5 µl 100x BSA, 5 µl Buffer 4, and 33 µl water.  The 
DNA was precipitated with the addition of 5 µl 4 ºC NaOAC and 100 µl of -20 ºC 
ethanol.  This mixture was divided into two aliquots and left at -20 ºC overnight. 
A         B         C          D              A     B    C     D a)                                   b)
S     I    S     I    S    I    S    I         S   I  S  I  S  I  S  I 
158 
The precipitated DNA was centrifuged at 12,000 rcf for 15 min.  Both pellets 
were each resuspended in 400 µl of -20 ºC 70% ethanol.  After another centrifugation 
for 5 min, the supernatants were placed at 42 ºC.  X33 and Km71 P. pastoris cell 
banks were thawed, and 80 µl aliquots were added to each washed DNA pellet.  Each 
mixture was incubated in an electroporation cuvette for 5 min.  Electroporation 
occurred using a BioRad Gene Pulser (Bio-Rad, Hercules, CA) at 1.50 kV, 200 Ω, and 
25 µFD.  The mixture was then left at 30 ºC for 2 hrs. 
Plating was performed by adding a 50 ml drop of YPD and the transformed 
cell mixture onto sorbitol plates.  For the Km71 cells, histidine was also added to the 
plate.  BMM (buffered minimal methanol) plates were made by adding 50 ml 1 M 
potassium phosphate buffer pH 6.0, 50 ml 10x YNB (yeast nitrogen base), 1 ml 500x 
biotin, and 50 ml 10x (5%) methanol to a cooled, autoclaved solution of 345 ml water 
and 7 g agar.  BMMH plates were BMM plates that also contained histidine.  The 
BMM and BMMH plates were topped with a nitrocellulose membrane (Schleicher & 
Schuell, Keene, NH).  Cells were lifted off of the YPD plates, imprinted on the BMM 
and BMMH plates, and incubated at 30 ºC.   
 The nitrocellulose membranes were developed using western breeze reagents 
with an α-Melan-A antibody.  The Km71 cells did not secrete any Melan-A, and in 
future studies Km71H cells should be used instead for simplicity.  The X33 cells did 
seem to produce some Melan-A (Figure A6.6a), so a select number of colonies were 
grown in liquid YPD medium.  Methanol was added to induce protein production, and 
the cultures grew overnight at 16 ºC.  To analyze the intracellular fraction, glass beads 
in a breaking buffer were used.  The secreted protein was precipitated with 
trichloroacetic acid (TCA) and ethanol ether and run on SDS-PAGE (Figure A6.6b,c).  
No Melan-A was found in either fraction.  
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Figure A6.6. Melan-A expression in Pichia pastoris.  a) Dot blot of Melan-A 
produced by X33 Pichia cells.  Colonies were arranged in a matrix pattern on BMM 
plates.  b) SDS-PAGE of intracellular Melan-A from Pichia.  c) SDS-PAGE of 
extracellular Melan-A from Pichia. 
a)                          b)                       c) 
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APPENDIX 7 
 
MELAN-A PURIFICATION PROCESS DEVELOPMENT 
 
A7.1. Melan-A clarification and solubilization  
 
A7.1.1. Homogenization 
Cell pellets were resuspended to their original volume.  The buffers used are 
described below.  Pellets were thawed in a 37ºC water bath for 10 min.  If cell pellets 
were thawed in a 55ºC water bath, they would become more viscous and difficult to 
resuspend.  The cell pellets were then blended for several min at a speed low enough 
to prevent foaming.  Lysate was created by sending the resuspended cell pellet through 
a homogenizer, as described in Section 2.6.  The preparation of insoluble protein was 
evaluated for three different methods. 
 
A7.1.2. Insoluble protein preparation 1: pellet wash 
Cells pellets were resuspended in [50 mM Tris, 100 mM sodium chloride, pH 
8.0].  The soluble protein fraction was separated from the insoluble protein fraction 
with a Sorvall centrifuge, described in Section 2.4.3.  A GSA rotor was operated at 
20,000 rcf.  Insoluble protein pellets were resuspended and re-pelleted with [50 mM 
Tris base, 1% Tween-20, 0.5 M sodium chloride, 1 mM EDTA, pH 8.0] three times.  It 
was assumed that the washed insoluble fraction consisted of only inclusion bodies 
(IBs).  Unless otherwise specified, centrifugation-washed inclusion bodies were 
solubilized in [6 M guanidine hydrochloride, 4 M urea, 50 mM sodium phosphate, pH 
7.5].  The solubilized inclusion bodies were centrifuged at 20,000 rcf once more to 
remove cell debris.  The entire centrifugation-wash step could not be scaled-up, but 
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most of the Melan-A purification development work was performed with this starting 
material. 
 
A7.1.3. Insoluble protein preparation 2: tangential flow filtration 
 Cell pellets were resuspended in [50 mM sodium phosphate, 0.5 M sodium 
chloride, pH 7.5].  After lysis, the crude lysate was subject to a tangential flow 
filtration (TFF) wash, as performed with NY-ESO-1 (Section A4.2) with a 0.45 µm 
membrane (Pall).  The removal of Tween-20 from the wash buffer was being 
considered. 
 Melan-A inclusion bodies washed in [20 mM Tris, 300 mM sodium chloride, 1 
mM EDTA] did not readily go through a 0.45 µm membrane.  If 1% Tween-20 was 
added to this buffer, inclusion bodies would still be retained.  If 10 psi of back 
pressure was applied, however, a fraction of the inclusion bodies would cross the 
membrane.  Additionally, if Tween-20 was added to the buffer while back pressure 
was being applied, additional Melan-A would pass through the filter (Figure A7.1). 
Figure A7.1. SDS-PAGE of Melan-A fractions during tangential flow filtration.  
Lane 1: Multimark, Lane 2: load, Lane 3: neutral permeate, Lane 4: permeate with 
back pressure, Lane 5: permeate with back pressure and Tween-20, Lane 6: retentate, 
Lane 7: permeate with Tween-20 only.  A red arrow indicates the Melan-A band. 
 
 1   2  3   4   5   6  7 
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Unless otherwise specified, TFF-washed inclusion bodies were diluted in 
eight-fold in [8 M urea, 100 mM sodium phosphate, pH 7.5].  After an overnight 
solubilization, the protein was filtered through a 0.5 µm Milligard Low Protein 
Binding (LPB) capsule filter (Millipore, Billerica, MA).   
 
A7.1.4. Insoluble protein preparation 3: denaturant lysis 
 Unless otherwise specified, denaturant lysis was performed by resuspending 
cell pellets in [7.5 M guanidine hydrochloride, 100 mM sodium chloride, pH 7.2].  
Homogenization was conducted as normal.  DNA and cell debris were pelleted using 
centrifugation at 4,000 rcf, in a SH-3000 rotor as described in Section 2.4.3.  This low-
force centrifugation could be scaled-up to the Powerfuge (Section A4.2).  A gelatinous 
precipitate was removed, and the solubilized protein was filtered through a 0.5 µm 
Milligard LPB capsule filter (Millipore).  
 
A7.2. Melan-A imobilized metal affinity chromatography 
 
A7.2.1. Introduction 
The immobilized metal affinity chromatography (IMAC) column consisted of 
chelating sepharose FF resin (GE Healthcare, Piscataway, NJ) charged with a 2 M 
nickel sulfate solution.  The two running buffers used for this column were IMAC A 
buffer [4 M urea, 50 mM sodium phosphate, 0.5 M sodium chloride, pH 7.5] and 
IMAC B buffer [4 M urea, 50 mM phosphoric acid, 0.5 M sodium chloride, 0.5 M 
imidazole, pH 7.5].  IMAC B buffer was diluted with IMAC A buffer in different 
proportions to gradually increase the imidazole concentration in the running buffer.   
 
 
163 
A7.2.2. Soluble Melan-A capture attempts 
Initial IMAC runs attempted to purify the soluble fraction of Melan-A protein. 
In these cases, no urea was added to either IMAC buffer.  The column was 
equilibrated with 2 column volumes (CV) of urea-less IMAC A buffer and loaded with 
2 ml of solubilized IBs per ml total column resin.  A 1 ml prepacked HisTrap column 
(GE Healthcare, Piscataway, NJ) was used.  The loaded column was flushed with 8 
CV of urea-less IMAC buffer A and then washed with 2.5 CV each of 10%, 20%, 
30%, and 100% urea-less IMAC B buffer.  Based on Bradford, it was found the 
protein that flowed through the column during the loading stage had a concentration of 
34.0 mg/ml.  A 3.2 mg/ml protein solution left the column during the 10% B wash, a 
0.7 mg/ml solution left during the 20% B wash, and no protein left the column in the 
30% and 100% washes.  A more refined step gradient washed the bound protein with 
2.5 CV each of 1%, 2%, 3%, 4%, 5%, and 20% urea-less IMAC B buffer.  The protein 
concentrations leaving the column during the 1%, 2%, and 3% washes were 0.7, 3.3, 
and 2.4 mg/ml, respectively.  No protein was found in any of the latter buffer washes. 
This inconsistency of the protein concentrations during the imidazole washes 
and the low concentrations of imidazole needed for these washes suggests that the 
eluted protein was only weakly attached with non-specific binding.  As seen by SDS-
PAGE, Melan-A did not bind to the IMAC column and was found only in the 
flowthrough fraction (FigureA7.2).  The most possible explanation for this is that the 
folded Melan-A may bury its His tag.  Changing the terminus where the His tag is 
located may prevent this phenomenon. 
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Figure A7.2. SDS-PAGE of soluble Melan-A capture attempt on a nickel column.  
Lane 1: Multimark, Lane 3: load, Lane 4: flowthrough, Lane 5: chase, Lane 6: pre-
elution, Lane 7: 50 mM imidazole wash, Lane 8: 100 mM imidazole wash, Lane 9: 
150 mM imidazole wash.  Melan-A is indicated by the red arrow. 
 
A7.2.3. Insoluble Melan-A capture 
Using the same protocol as for the soluble Melan-A (Section A6.2.2) with the 
centrifugation-washed inclusion bodies (Section 6.1.2), total protein concentrations of 
the elution were 1.31, 0.64, 0.07 mg/ml during 33%, 66%, and 100% washes of IMAC 
B buffer with urea.  A linear gradient was used to determine the optimal dilution of 
IMAC B buffer in IMAC A buffer to elute the Melan-A protein.  It was estimated that 
Melan-A could be retained on the column using a 40% IMAC B buffer wash.   
Using a 50 ml self-packed column, three separate runs were performed to 
determine the effectiveness of using a 30%, 40%, and 50% IMAC B buffer low 
imidazole wash.  It was determined with SDS-PAGE that some Melan-A was lost in 
the 40% and 50% washes, but none was lost in the 30% wash (Figure A7.3).  Total 
protein concentrations of the elutions from the 30%, 40%, and 50% runs were 1.11, 
0.86, and 0.40 mg/ml, respectively.  This indicated that a 30% wash was advantageous 
over higher washes in maintaining higher protein yields. 
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Figure A7.3. SDS-PAGE of insoluble Melan-A capture on a nickel column.  Both 
gels are labeled with a Multimark (Invitrogen) standard and show flowthrough, low 
imidazole wash, and elution fractions.  The a) 150 mM low imidazole wash run was 
able to lose less Melan-A than the b) 200 mM low imidazole wash run in the low 
imidazole wash fraction.  Melan-A is indicated by the red arrow. 
 
When further wash studies were performed and analyzed using a western blot, 
it was determined that a 15% IMAC B buffer low imidazole wash was needed in the 
low imidazole wash to prevent any detectable loss of Melan-A (Figure A7.4).  A 
chromatogram with this final process change is shown in Figure A7.5. 
Figure A7.4. Western blot of low imidazole washes of Melan-A on a nickel 
column.  Lane 1: load, Lane 2-9: eluates of increasing imidazole concentrations – 25, 
50, 75, 100, 125, 150, 175, 200 mM.  A faint band can be detected at 125 mM. 
 
flowthru  wash    elution flowthru  wash   elution 
a)                                                     b) 
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Figure A7.5. Chromatogram of Melan-A on a nickel column.  The flowthrough, 
low imidazole, and imidazole peaks are shown at approximately 150, 310 and 375 ml, 
respectively.  Solid blue line shows the ultraviolet absorbance measured at 280 nm.  
The dotted pink line is the percentage of IMAC buffer B in the inlet buffer.  Baseline 
absorbance increases post-elution because of imidazole’s innate UV absorbance. 
 
 Since the centrifugation step for this initial Melan-A development could not be 
scaled-up, a tangential flow filtration step was used (Section A7.1.3).  Mimicking the 
NY-ESO-1 process (Section A4.2), a [8 M urea, 100 mM sodium phosphate buffer] 
was attempted used for Melan-A solubilization, and almost no Melan-A was recovered 
post-IMAC.  It was found that Melan-A IMAC recovery was very dependent on high 
levels of strong denaturing agents.  To maximize denaturing agent, the cell pellet was 
resuspended directly in solubilization buffer (Section A7.1.4).  In general, protein 
yields could be maximized by using higher levels of guanidine and avoiding the 
inclusion body wash steps (Figure A7.6).  Although some contaminating proteins were 
removed during the wash steps, the final purity of the IMAC elution was the same 
regardless of load preparation method. 
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Figure A7.6. Melan-A recovery on nickel column with different load 
preparations.  Load material was either washed using TFF and filtered, washed with 
centrifugation, or lysed in denaturant and filtered.  Higher concentrations of denaturant 
were possible with the latter method and improved Melan-A recovery. 
 
A7.2.4. Melan-A Refolding 
Refolding was attempted in the IMAC column by loading the column and 
washing it with 2 CV of buffers containing 2.0, 1.0, and 0.5 M urea.  As with previous 
runs, some of the protein flowed through the column during loading.  Very little 
protein was found in the elution fractions.  Bradford determined the total protein 
concentration of the elution fraction to be 0.10 mg/ml.  It is possible that protein bled 
off of the column in undetectable concentrations while the protein was being refolded. 
 In a related study, Melan-A inclusion bodies were solubilized in [3 M urea, 
100 mM sodium phosphate, 0.5 M sodium chloride, pH 7.5].  The total protein 
concentration of the load was 27.6 mg/ml.  The flowthough and wash concentrations 
were 11.9 and 2.5 mg/ml, respectively.  The elution concentration was 0.1 mg/ml.  
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Most of the recovered Melan-A band was in the flowthrough fraction (Figure A7.7).  
The implication is that Melan-A must be in high concentrations of chaotropic agents to 
bind and stay bound to the IMAC column. 
 
Figure A7.7. SDS-PAGE of Melan-A capture on nickel column in 3 M urea.  Lane 
1: Multimark (Invitrogen), Lane 2: load, Lane 3-4: flowthrough, Lane 5: wash, Lane 6: 
pre-elution, Lane 7: elution.  Melan-A is indicated by the red arrow. 
 
A7.2.5. Cobalt column 
 Instead of using nickel, the chelating sepharose FF resin could also be charged 
using cobalt.  A 50 ml column was charged and purification was performed on 
solubilized Melan-A inclusion bodies.  Melan-A did bind and elute off the cobalt 
column very similarly as it had done with the nickel column.  Since there was no 
obvious advantage (Figure A7.8), this method was not investigated any further. 
 
Figure A7.8. SDS-PAGE of Melan-A purified on a cobalt column.  Lane 1: load, 
Lane 2: chase, Lane 3: pre-elution, Lane 4: elution.  A red arrow indicates Melan-A. 
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A7.3. Melan-A ion exchange chromatography 
Since the isoelectric point (pI) of Melan-A with a His-tag was calculated to be 
8.65, it was decided to use a 10.5 carbonate buffer to bind the protein to an anion 
exchange (AXC) column and a 6.0 phosphate buffer to bind the protein to a cation 
exchange (CXC) column.  The Ion Exchange (IEX) A buffer was [4 M urea, 20 mM 
carbonate, pH 10.5]; IEX B buffer was [4 M urea, 20 mM carbonate, 1 M sodium 
chloride, pH 10.5];  IEX C buffer was [4 M urea, 20 mM sodium phosphate, pH 6.3]; 
IEX D buffer was [4 M urea, 20 mM sodium phosphate, 1 M sodium chloride, pH 
6.3].  A diafiltration step was performed using a 10 kDa Minimate cassette (Millipore, 
Billerica, MA) to buffer exchange the IMAC elution to IEX A or IEX C buffer. 
Q HP and SP HP (GE Healthcare, Piscataway, NJ) columns were used for 
AXC and CXC, respectively.  As expected, Melan-A in IEX A buffer bound to the Q 
HP column and Melan-A in the IEX C buffer bound to the SP HP column.  
Interestingly, the Melan-A in IEX C buffer at pH 6.3 also bound to the Q HP column.  
In all cases, some Melan-A was lost in the flowthrough fraction.  The bound Melan-A 
could be eluted by changing the buffer pH, such as by increasing the IEX A to IEX C 
ratio on a SP HP column (Figure A7.9a).  Bound Melan-A could also be eluted by 
increasing the salt concentration, such as increasing the IEX D to IEX C buffer ratio 
on a Q HP column (Figure A7.9b, Figure A7.10).   
 Q XL chromatography was later developed to be an endotoxin removal step for 
Melan-A [141].  A pH of 9.3 was necessary to dissociate the endotoxin from the 
positive charge of the Melan-A protein.  The SP HP column could not be used for this 
process because the endotoxin would bind and elute off the column with the protein. 
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Figure A7.9. SDS-PAGE of Melan-A purified on ion exchange columns.  a)  
Melan-A at pH 6.3 was eluted off a SP HP column with increasing pH.  Lane 1: load, 
Lane 2-4: flowthrough, Lane 5-10: pH 6.85, 7.32, 7.86, 8.35, 8.79, 9.33, 10.37 washes.  
Lane 12: 1 M sodium chloride wash.  b) Melan-A at pH 6.3 was eluted off a Q HP 
column with increasing salt at constant pH.  Lane 1: load, Lane 2-7: flowthrough, 
Lane 8-12: 10, 15, 25, 30, 40 mM sodium chloride washes.  The Melan-A band is 
indicated by a red arrow. 
 
 
Figure A7.10. Chromatogram of Melan-A on an ion exchange column. Melan-A at 
pH 6.3 was eluted off of an ion exchange column with a single step gradient of salt.  
The solid blue line shows the eluate absorbance at 280 nm.  The dotted pink line is the 
conductivity of the eluate.  Protein is both lost in the flowthough and eluted with the 
salt.   
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A7.4. Melan-A hydrophobic interaction chromatography 
Hydrophobic interaction chromatography (HIC) was investigated for use with 
Melan-A.  A 500 g/L ammonium sulfate solution was made.  This solution was added 
to the Melan-A IMAC elution to entice the exposure of hydrophobic groups while 
Melan-A was being loaded onto a Phenyl HP column (GE Healthcare).  The protein 
was eluted using a gradient that removed the ammonium sulfate.  All buffers 
contained [4 M urea, 100 mM sodium phosphate, 0 to 1 M ammonium sulfate, pH 
7.5].  Even though loading with a 0.40 M ammonium sulfate concentration allowed 
Melan-A to bind to the Phenyl column and no protein was detected in the flowthrough 
on SDS-PAGE, increasingly better yields were obtained in the elution when 0.56, 
0.63, and 0.76 M ammonium sulfate was used.  At 0.87 M ammonium sulfate, there 
was visible cloudiness in the load material from precipitated protein, and protein 
yields were lower.  Therefore the optimum ammonium sulfate concentration for 
Melan-A was estimated to be approximately 0.75 M (Figure A7.11).  Unfortunately 
there was no improvement in Melan-A purity after binding and eluting to the Phenyl 
column. 
Figure A7.11. Ammonium sulfate dependence of Melan-A binding on a Phenyl 
column.  Increasing concentrations of ammonium sulfate increased Melan-A 
recovery, but protein precipitation resulted in worse recovery at 0.87 M. 
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Sodium chloride was added to the Melan-A protein instead of ammonium 
sulfate in one case.  A 5.17 M solution of sodium chloride was added to Melan-A until 
it precipitated.  This occurred at 3.10 M sodium chloride.  A successful HIC step was 
performed using a final concentration of 2.58 M sodium chloride.  Again, the Melan-A 
protein could be bound and eluted off the Phenyl column, but it did not get separated 
from any of the contaminating proteins.  
For purification of the cancer antigen SSX2, eluting with a 30 colume volumes 
(CVs) gradient was able to separate the protein of interest from its impurities [142].  
Melan-A was eluted using 30 CVs, but no purification advantage was gained (Figure 
A7.12).   
 
Figure A7.12. SDS-PAGE of Melan-A purified on phenyl column. M: Sharp 
molecular weight standard (Invitogen), L: load, Lane 15-24: fractions taken from 15-
24 CV of the elution gradient.  A red arrow indicates the Melan-A band. 
 
A7.5. Melan-A size exclusion chromatography 
Size exlusion chromatography (SEC) was also attempted to purify Melan-A 
after IMAC capture.  A Superdex 200 PG (GE Healthcare) column was used.  The 
loading buffer was [4 M urea, 50 mM sodium phosphate, 0.15 M sodium chloride].  
Sodium chloride was added upon the manufacturer’s recommendation to prevent 
M   L 15 16 1718 19 20 21 22 23 24 
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nonspecific binding.  Melan-A eluted early and did not gain any purity (Figure A7.13), 
suggesting that it was aggregated with the higher molecular weight contaminants.  
These results are consistent with results of HPLC analysis (Section A1.1). 
 
 
Figure A7.13. SDS-PAGE of Melan-A fractions through IMAC and SEC.  Lane 1: 
Multimark, Lane 2-3: solubilized inclusion bodies, Lane 4: wash, Lane 5: IMAC 
elution, Lane 6: SEC eluate.  The Melan-A band is indicated by a red arrow. 
 
A7.6. Identification of contaminating proteins 
 Some of the higher molecular weight protein contaminants of both Melan-A 
and NY-ESO-1 were isolated by SDS-PAGE and submitted to the Cornell 
Biotechnology Resource Center (BRC) for mass spectrometry identification.  The 
contaminants included dimers of the respective proteins, elongation factor thermo 
unstable (EF-Tu), 50S ribosomal protein L2, glutamine synthetase, β-galactosidase, 
ClpB, and DnaK. 
 It was somewhat expected to find chaperone proteins associated with the 
proteins.  DnaK, GroEL, and EF-Tu are the three most abundant proteins in E. coli.  
Chaperones bind to the protein while it is forming into inclusion bodies.  DnaK and 
GroEL have been imaged on the peripheral and middle of inclusion bodies, 
1   2     3     4    5     6 
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respectively [143].  EF-Tu is a DnaK substrate also very commonly found in inclusion 
bodies [144] and ClpB works with DnaK to disassemble these aggregates.  β-
galactosidase was also normal because its activity is induced by IPTG. 
Western blotting was performed to confirm the presence of DnaK and GroEL 
in both purified Melan-A, NY-ESO-1, and SSX2.  DnaK was detected in the final 
purified product of all three proteins.  GroEL was only found in the final Melan-A and 
NY-ESO-1 products.  According to western blotting, the GroEL in the SSX2 inclusion 
bodies was removed during the SSX2 HIC step [142].  Melan-A and NY-ESO-1 are 
hydrophobic proteins, so the chaperones are more likely to interact tightly with them.   
 
Figure A7.14. SDS-PAGE of higher molecular contaminants in bulk Melan-A 
and NY-ESO-1 drug substance.  Most proteins were identified with mass 
spectroscopy.  Proteins labeled within parenthesis were identified using a western blot.
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A7.7. Influence of reducing agent 
 Melan-A has five cysteine residues and thus is capable of forming disulfide 
bonds with itself and other proteins with free cysteine groups.  Disulfide bonds cannot 
be formed in reducing conditions, such as in the presence of dithiothreitol (DTT) or β-
mercaptoethanol.  To make free cysteine groups inaccessible for bond formation, 
iodoacetamide can be used.  Using an established protocol [145], a set of proteins 
including Melan-A were separately incubated in 20 mM DTT and 100 mM 
iodoacetamide.  Samples were left at 65 ºC for 1 hr.  SDS-PAGE analysis shows that 
all of the proteins tested were far more aggregated in the presence of no reducing 
agent (Figure A7.15a).  The presence of iodoacetamide, which is confirmed by a slight 
increase in molecular weight of conjugated samples, was not necessary.  The level of 
reducing agent also did not seem to make a difference (Figure A7.15b). 
 
Figure A7.15. SDS-PAGE of cancer antigens with and without reducing agent.  a) 
NY-ESO-1, Melan-A, and MAGE were run on an SDS-PAGE A) with no reducing 
agent, B) with 20 mM DTT, C) with 20 mM DTT and 100 mM iodoacetamide.  b) 
Melan-A was loaded on a gel with increasing concentrations of β-mercaptoethanol and 
DTT.  Lane 2: no reducing agent, Lane 3-7: 10 mM, 100 mM, 5%, 20%, 45% β-
mercaptoethanol, Lanes 8-11: 1 mM, 10 mM, 100 mM, 45% DTT.  
 
 
NY-ESO-1   Melan-A     MAGE                                 Melan-A 
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A7.8. Additives to improve Melan-A purification 
Detergents were used in an attempt to separate the hydrophobic interactions 
between Melan-A and its protein contaminants.  In two separate cases, 1% Tween-20 
or Triton-100 was added to the IMAC running buffers.  The addition of 1% Tween-20 
was also performed on an ion exchange column.  In all cases, there was no noticeable 
difference compared to operating with the original buffers that did not contain 
detergent.  This is consistent with the addition of SDS to the HPLC Melan-A load and 
running buffer (Section A1.1). 
The use of reducing agents was also evaluated.  The addition of 1 mM β-
mercaptoethanol in all of the running buffers was ineffective in improving purity 
during the TFF wash or IMAC, IEX, or HIC columns.  The β-mercaptoethanol 
concentration was increased to 10 mM in the HIC buffers, but this did not have any 
noticeable effect.  Using 5 mM DTT was also ineffective in improving Melan-A purity 
during ion exchange.  Using 5 mM DTT in the IMAC buffers was not possible 
because the reducing agent precipitated the nickel and turned the column black. 
The addition of EDTA was also evaluated.  During IEX, 40 mM EDTA was 
added to the load and running buffers.  Likewise, the addition of 10 mM EDTA to the 
HIC buffers was not effective.  Using 10 mM EDTA in the IMAC buffers was not 
possible because this low concentration of EDTA was enough to strip the nickel off of 
the column.   
 
A7.9. Final Melan-A purification process 
 In summary, Melan-A cell pellets were lysed in [7.5 M guanidine 
hydrochloride, 100 mM sodium phosphate, pH 7.2] and centrifuged to remove DNA 
and cell debris.  The material was filtered through a 0.5 µm filter (Millipore) and 
loaded onto an IMAC column with [4 M urea, 100 mM sodium phosphate, 0-500 mM 
177 
imidazole, pH 7.2].  Ammonium sulfate was added, and the protein was eluted off of a 
HIC column.  The product was then buffer exchanged into [4 M urea, 100 mM sodium 
phosphate, pH 9.3] and sent through a Q XL column.   
 A 2 L fermentation was conducted for a prototype run.  The packing flow rates 
of the columns were 650, 750, and 580 ml/min for a 10 cm column for chelating 
sepharose fast flow, Phenyl sepharose high performance, and Q sepharose fast flow 
resins.  Packing rates were scaled down using constant linear flowrates.  Total protein 
yields per liter of fermentation broth were 329, 167, and 156 mg after the IMAC, HIC, 
and Q XL columns, respectively.  The protein fractions are visualized in Figure A7.16. 
 
Figure A7.16.  SDS-PAGE and western blot of Syn-Melan-A during final 
purification process.  Lane 1, 7: See Blue Plus 2 Marker (Invitrogen), Lane 2: IMAC 
imidazole wash, Lane 3: IMAC elution, Lane 4: HIC flowthrough, Lane 5, 8: HIC 
elution, Lane 6, 9: Q XL flowthrough.
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APPENDIX 8 
 
MELAN-A SECONDARY STRUCTURE 
 
A8.1. Predicted secondary structure 
 The Melan-A amino acid sequence was used to predict the protein’s secondary 
structure using the Advanced Protein Secondary Structure Prediction Server 
(Chandigarh, India).  Most of the protein was predicted to be a random coil, but the 
main hydrophobic region of the sequence was predicted to be an alpha helix.  In the 
sequence shown, the highlighted, bold amino acid residues were predicted to be part of 
an alpha helix: 
mpredahfiygypkkghghsyttaeeaagigiltvilgvllligcwycrrrngyralmdkslhvgtqcaltrrcpqegfd
hrdskvslqekncepvvpnappayeklsaeqspppyspaaalehhhhhh 
 
A8.2. Sample preparation 
 Syn-Melan-A lysate was washed using tangential flow filtration.  The retentate 
was kept as a representative sample of the inclusion bodies.  The inclusion bodies 
were pelleted at 12,000 rcf and resuspended in Dialysis Buffer [20 mM sodium 
phosphate, pH 7.1].  This first sample was representative of Syn-Melan-A inclusion 
bodies. 
After solubilization and purification through an IMAC column, the Syn-
Melan-A in [4 M urea, 100 mM sodium phosphate, 0.5 M imidazole, pH 7.5] was 
subject to dialysis using a 20 kDa Slide-A-Lyzer® unit (Thermo Fisher Scientific, 
Waltham, MA) into Dialysis Buffer.  Only 0.75 ml of IMAC elution sample was 
dialysed in 4 L of Dialysis Buffer that was gently mixed with a stir bar overnight.  
This second sample was representative of refolded Syn-Melan-A. 
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A8.3. Circular Dichroism 
 Circular dichroism (CD) was performed on Syn-Melan-A samples using a CD 
spectrophotometer (Aviv Biomedical, Lakewood, NJ).  CD-400 software was used to 
operate the system.  Samples were diluted to 0.02-0.2 mg/ml to accommodate the 
system.  The spectra of Syn-Melan-A inclusion bodies and refolded protein were 
measured. 
 The characteristic curve for an alpha helix has minima at approximately 208 
and 225 nm during CD.  The characteristic curve for a beta sheet has a minimum at 
217 nm.  Although the two minima for an alpha helix are not visible, the curve shown 
in Figure A8.1 does have an extended minimum which is not at 217 nm.  It was 
suspected that both Syn-Melan-A inclusion bodies and refolded protein formed alpha 
helices. 
Figure A8.1. Circular dichroism spectra of Syn-Melan-A inclusion bodies and 
refolded protein.  CD spectra were measured from 200 to 250 nm.  The broad minima 
of the spectra suggest both Syn-Melan-A samples contained alpha helices. 
 
A8.4. Fourier transform infrared spectroscopy 
Fourier transform infrared spectroscopy (FTIR) was also used to determine the 
secondary structure of Syn-MelanA.  A Vertex80V FTIR spectrophotometer (Brunker 
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Optics, Billerica, MA) was used to measure the FTIR spectra of Syn-Melan-A 
inclusion bodies and refolded protein from 400 to 4,000 nm (Figure A8.2).  A 1 ml 
aliquot of each sample was loaded into a liquid cell.  The spectrum of water taken and 
subtracted from all measured spectra. 
 
Figure A8.2. FTIR spectra of Syn-Melan-A inclusion bodies and refolded protein.  
FTIR spectra were determined from 400 to 4,000 nm.  All samples were blanked with 
the spectrum from water. 
 
As seen in Figure A8.3, both Syn-Melan-A samples have a minimum at 1650 nm.  
Minima from 1620 to 1640 nm typically suggest beta sheet structures, but minima 
from 1650 to 1658 nm suggest alpha helices.  The FTIR data therefore also suggested 
that the secondary structure of Syn-Melan-A inclusion bodies and refolded protein 
were both alpha helices. 
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Figure A8.3. FTIR spectra of Syn-Melan-A inclusion bodies and refolded protein, 
enlarged.  Both Syn-Melan-A samples had a minimum at 1650 nm, suggesting that 
they contained alpha helices. 
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APPENDIX 9 
 
QUORUM SENSING STUDY  
 
A9.1. Introduction to autoinducer 2 
Process development at the cellular level aims at increasing expression of the 
inserted plasmid.  Cell-to-cell communication becomes an important factor because 
gene transcription is strongly regulated with intercellular signal molecules.  The 
relevant bacterial phenomenon that occurs at high cell density is quorum sensing.  
Quorum sensing refers to the effect that the presence an individual cell has on its 
neighbors.  The chemical signals involved in quorum sensing have been named 
autoinducers.  Since every cell regularly secretes these signals, the autoinducer 
concentration in growth medium has been described as the bacteria’s biological 
measure of cell density.  As with a number of bacterial species, E. coli has been found 
to use a furanoysl borate diester known as autoinducer 2 (AI-2) as a primary signal in 
quorum sensing [146]. 
After its discovery in E. coli, studies were performed to determine the factors 
that regulated AI-2 secretion.  To uncouple effects of density from growth conditions, 
experiments were performed in a chemostat process.  The results showed that AI-2 
production was not density-dependent but instead shadowed changes in growth rate 
[147].  Another feature during fermentations is that AI-2 levels rapidly decrease and 
remain at minimum detection once the cells have been induced and enter stationary 
phase [148].   
The drop of AI-2 levels at slower rates of metabolism is not fully understood.  
There is insufficient data about degradation or catabolism of the compound.  The most 
recent data suggest that the drop may largely be an issue of AI-2 uptake into the cell.  
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A study has shown that the drop upon induction is not the result of production ceasing 
because LuxS, the synthase for AI-2, continues to be active during these phases [149].  
Salmonella enterica serovar Typhimurium uptakes AI-2 by a Lsr (luxS regulated) 
transport system.  E. coli has a homolog of this transport system, designated as the 
b1513 operon, which is induced by AI-2.  These transporters have been found to be 
susceptible to catabolite repression [150].  This means that in a glucose-rich 
environment, such as fresh growth medium, the transporters are not transcribed so that 
external levels of AI-2 can accumulate.  Then in glucose-limited situations, common 
in HCDC, the transporter quickly intakes this accumulated AI-2. 
AI-2 serves as a signal of the growth potential in a cell’s environment.  
Adverse conditions therefore result lower concentrations.  When a heat shock stress is 
induced, for example, AI-2 production ceases.  Similar results have been obtained 
through ethanol and oxidative stresses, and all poststress AI-2 levels decrease at a 
faster rate than controls.  An induced stringent response, caused by serine 
hydroxamate addition, also results in lower AI-2 production [147].  A stringent 
response, which is the lack of cellular resources to produce protein [151], is also 
caused by expression of foreign protein upon induction [152].  Induction itself, already 
stated to cause an AI-2 depletion, first triggers a global stress response [153].  All 
these stresses would be expected to lead to AI-2 depletion simply by the fact that they 
also slow down the metabolic processes of the cell [147].   
There is evidence to show that AI-2 has a direct effect on a cell’s ability to 
produce protein.  Conditioned medium is cell-free medium that cells have already 
grown in, which will include standard levels of AI-2.  LacZ fusions have been used to 
show that conditioned medium activates a σ38 alternative sigma factor [154].  
Microarray analysis has shown that conditioned medium also triggers a σ54 homolog 
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of LuxO activation in V. harveyi [155].  Stress responses similarly activate specific 
sigma factors and will typically result in lower protein production levels [156].   
Initial work on the addition of AI-2 to cultures has shown that the presence of 
AI-2 alone was able to increase production levels of foreign protein.  Earlier studies 
have shown that the addition of conditioned medium, which is assumed to contain 
autoinducers, can increase a culture’s ability to produce particular proteins of interest 
[157, 158].  More recently, an E. coli mutant without the ability to synthesize AI-2 
specifically was used.  These cells were shown to produce 3-4 fold less target protein 
than a second mutant that corrected for the AI-2 removal [159].   
Previous studies regarding the effect of AI-2 have almost all relied on the 
addition of conditioned medium.  Conditioned medium has been deemed nonideal for 
such experiments because contaminating by-products of cellular metabolism affect 
cell growth and behavior [160].  The AI-2 synthase LuxS has also been co-expressed 
in E. coli cells.  It would be preferred, however, to instead add pure AI-2 to a culture 
since this does not place an extra burden on the cells and provides more flexibility in 
experiments.  Conversely, studies have been performed with LuxS deletion mutants, 
but LuxS is an important part of the activated methyl cycle in bacteria [160]. 
If the presence of AI-2 does cause changes improvements in recombinant 
protein expression, it can added to the fermentation during a culture.  There are now 
methods to synthesize and purify AI-2 in vitro using a method based on 
biosynthetically-produced enzymes [161, 162] and additional organic chemical 
synthesis methods [163, 164, 165].    
If the presence of AI-2 is deleterious to protein expression, then it can be 
destroyed or blocked.  Acyl-homoserine lactonase has been used in vivo to cleave and 
eliminate the effects of AI-1 in a virulent strain of bacteria [166].  Although a similar 
substance to cleave AI-2 has yet to be discovered, there exists a furanose additive that 
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has been shown to inhibit AI-2 activity in E. coli by 26,600 fold without any effects of 
toxicity [167].  This creates a preferred method of effective AI-2 decrease instead of 
using a luxS mutant because AI-2 levels can be stoichiometrically reduced and not 
completely eliminated. 
 
A9.2. Chemical synthesis attempt of autoinducer 2 
 The Semmelhack chemical synthesis was attempted because its publication 
included nuclear magnetic resonance (NMR) spectra of five chemical intermediates 
and the final product in the article supplement.  Its synthesis was attempted by Dr. 
Aaron Strickland. 
 All reagents were obtained from Sigma-Aldrich (St. Louis, MO).  L-gulonic 
acid g-lactone (20.02 g) and p-toluene sulfonic acid monohydrate (0.203 g) were 
mixed in 100 ml N,N-dimethylformamide.  An addition of 1,1-dimethoxycyclohexane 
(28.1 g) was made, and the solution was left mixing for 48 hr.  Triethylamine (100 ml) 
was added and mixing was continued for another hr.  The reaction was then 
concentrated at 60ºC under a vacuum.  Toluene (500 ml) was added and the solution 
was left at -20ºC for 24 hr.  The precipitate was collected, washed in toluene, and 
dried under vacuum for 24 hr at room temperature, resulting in 10 g of material.  A 
portion of this first intermediate product (5.05 g) was then added to a mixture of 
potassium periodate (100 g) and potassium bicarbonate (100 g) in 28 ml water.  
Dichloromethane (50 ml) was added and the reaction was left to mix for 18 hr.  More 
dichloromethane (50 ml) was added and a saturated sodium chloride solution was 
gradually added to a final addition volume of 30 ml over 3 hr.  Some gelatinous 
precipitation gradually formed and was removed.  The aqueous layer was mixed with 
water and the second intermediate product was extracted with dichloromethane. 
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 NMR was performed using a Varian (Palo Alto, CA) instrument to confirm the 
accuracy of the intermediates.  The spectra of the first intermediate made matched the 
spectra from the Semmelhack supplement.  The second intermediate contained 
impurities.  This is suspected because the volume of and mixing time after sodium 
chloride addition were not precise and the precipitation in the reaction never formed 
an expected gel layer.  More information or trial work was necessary to complete the 
second step of the chemical synthesis. 
 
A9.3. The Vibrio harveyi organism  
Comprehensive work involving AI-2 has been performed in Vibrio harveyi.  Its 
two autoinducers, AI-1 and AI-2, cause measurable self-bioluminescence to occur 
[168].  Since one of these autoinducers is the same AI-2 produced from multiple 
bacterial species, V. harveyi can be used to quantify AI-2 concentrations in 
conditioned media from E. coli fermentations.  The BB170 strain developed for this 
assay [169] cannot detect AI-1 and was acquired from Dr. Anthony Hay (Cornell) 
with the permission of Dr. Bonnie Bassler (Princeton).  Cells were transferred on a 
plate of commercial marine broth. 
The identity of V. harveyi was confirmed by sequencing 16s rRNA and 
matching this with the AM183755 locus publically available from the National Center 
for Biotechnology Information (NCBI).  Genomic DNA was isolated using a kit 
(Qiagen, Germantown, MD) and the desired gene fragment was amplified using a 
polymerase chain reaction (PCR).  Briefly, cells were grown up in a shake flask to an 
optical density of 4.0.  A 0.5 ml aliquot was removed, pelleted, and resuspended in 
tissue lysis buffer (ATL buffer).  A 3 hr incubation was performed at 55ºC after 20 µl 
of proteinase K was added.  After a 200 µl addition of AL buffer, the mixture was 
incubated at 70ºC for 10 min, and then 200 µl of cold ethanol was added.  Genomic 
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DNA was bound, washed, and eluted off of a DNeasy spin column at a volume of 100 
µl and a concentration of 96 ng/µl.  The primers used in the PCR were 5’ – GAA AGC 
CAC GGC TCA AGG CCA – 3’ and 5’ – TTA ACA CAT GCA AGT CGA GCG G – 
3’.  Each primer was added in 2.5 µl aliquots to 0.5 µg DNA, 25 µl 2x biomix 
(Bioline, Taunton, MA), and 15 µl of water.  The Biomix contained the Taq 
polymerase necessary for PCR.  A 1% agarose gel in TAE (tris acetate EDTA) buffer 
was used to confirm a successful PCR of the 456 ng/µl 821 base pair region (Figure 
A9.1a).  The amplified product was purified using Wizard DNA purification kit 
(Promega, Madison, WI).  Briefly, the product was captured on a column and washed 
with 80% isopropanol.  Diluting the concentration below 100 ng/ml, 0.4 ml of PCR 
product, 0.8 ml of primer were mixed in 16.8 ml of water and sent to Cornell 
Biotechnology Resource Center (BRC) for sequencing.  The extracted sequence 
matched NCBI sequence (Figure A9.1b), compared using Vector NTI software 
(Invitrogen). 
 
Figure A9.1. Agarose gel and sequence evaluation of V. harveyi 16s rRNA.  a) 
Lane 1: Hyperladder marker (Bioline), Lane 2: V. harveyi genomic DNA, Lane 3: 
Amplified V. harveyi 16s rRNA.  b) Partial comparison of amplified 16s rRNA 
sequence with database sequence. 
 
a)                         b) 
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A9.4. Autoinducer 2 detection assay 
The AI-2 detection assay is a bioassay that measures the relative luminescence 
of a V. harveyi culture that is exposed to the AI-2 molecule.  Experimental samples are 
compared to a control group since the sensor strain does have the ability to produce 
AI-2 by itself. 
 The autoinducer bioassay medium was [0.3 M sodium chloride, 0.05 M 
magnesium sulfate, 0.2% casamino acids, 10 mM potassium phosphate, 1 mM L-
arginine, 20 ml/L glycerol, 4 µg/ml riboflavin, 40 µg/ml thiamine, pH 7.5].  When 10 
µl of cell bank was grown in 125 ml of autoinducer bioassay medium at 30ºC, it took 
17 hr to reach an optical density of 0.8.  At this density, the cells were bioluminescent.   
 The assay requires that the cells are diluted to stop the bioluminescence and the 
addition of 10% (v/v) conditioned medium.  To make conditioned medium, a bacterial 
culture sample was centrifuged, and the supernatant was filtered through a 0.2 µm 
filter.  If this filtration was not performed, trace cells in the supernatant would 
interfere with the sensitive assay.  A 10 µl aliquot of conditioned medium was added 
to 100 µl of V. harveyi culture in autoinducer bioassay medium at an optical density of 
0.8.  Samples were loaded in 96-well plates, white with clear bottom (Corning Inc., 
Corning, NY).  Measurements were performed in a Lumicount luminescence 
microplate reader (Packard, United Kingdom) with a PMT value of 600.  The emission 
spectra of the V. harveyi was measured by Dr. Byung-Ryool Hyun (Figure A8.2). 
 Initial measurements were performed with the addition of conditioned medium 
of undiluted V. harveyi cultures at O.D. 0.8.  Responses to the conditioned medium 
were detected in various dilutions of the V. harveyi culture.  Higher dilutions of the 
cells delayed luminescence peaks, and the addition of 10% (v/v) conditioned medium 
activated luminescence earlier (Figure A9.3a).  If only 5% (v/v) conditioned medium 
was added, luminescence would occur sooner than when 10% (v/v) conditioned 
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medium was added.  The addition of 20% (v/v) conditioned medium as only slightly 
better than the 10% (v/v) addition (Figure A9.3b). 
 
Figure A9.2. Emission spectra of V. harveyi luminescence.  Measurement of the 
emission of a V. harveyi culture over time was conducted by Dr. Byung-Ryool Hyun.  
Intensity dropped over time, but the peak intensity was constantly detected at 
approximately 490 nm. 
 
Figure A9.3.  Luminescence of V. harveyi culture with conditioned medium.  a) V. 
harveyi culture with and without 10% conditioned medium at different cell dilutions.  
b) Different amounts of conditioned medium were added to a diluted culture of V. 
harveyi.  Blank medium was added as a negative control. 
 
A9.5. Autoinducer 2 detection assay with glucose 
If blank complex E. coli fermentation medium was added, the luminescence 
would rise and fall, creating a luminescence peak.  This peak occurred earlier if 
conditioned medium from an early stage E. coli culture was added (Figure A8.4).  The 
0
500
1000
1500
2000
2500
3000
5 7 9 11 13
Time (hours)
Bi
o
lu
m
in
es
ce
n
ce
10^3 control
10^3 conditioned
10^4 control
10^4 conditioned
10^5 control
10^5 conditioned 
200
400
600
800
1000
9.5 9.7 9.9 10.1 10.3 10.5
Time (hours)
Bi
o
lu
m
in
es
ce
n
ce
cells
+ medium
+ 5ul cond.
+ 10ul cond.
+ 20ul cond.
a)                                                              b) 
cell dilution 
  191 
percentage of luminescence increased was measured at the 8 hr timepoint for 
consistency.  For example, in Figure A9.4, the culture with conditioned medium was 
at 486 luminescence units at 8 hr, the culture with blank medium was at 69 
luminescence units at this same time, and the conditioned medium therefore created a 
7.04-fold increase in luminescence.  Modifications needed to be made to the assay for 
fermentation samples in late-stage growth when glucose was at undetectable levels. 
 
Figure A9.4. Luminescence curves from diluted V. harveyi cultures with 
fermentation samples.  Blank fermentation medium created a luminescence peak.  
Conditioned medium caused this luminescence to occur earlier.  The percentage of 
increased luminescence was measured at 8 hr. 
 
 A very important detail about the AI-2 detection assay is that the luminescence 
of the V. harveyi culture is greatly influenced by the presence of glucose, which is 
very commonly used in E. coli fermentation media recipes.  The V. harveyi bioassay is 
influenced by pH, DNA damaging reagents, arginine, salt, glucose, oxygen tension, 
borate, and possibly iron.  The original autoinducer bioassay medium consisted of 
potassium phosphate, arginine, salt, and glycerol [170].  It is logical that while the 
phosphate salt control the pH, arginine and salt were added to saturate any inhibitory 
effects.  Meanwhile, glucose was replaced with glycerol, and this assay cannot be used 
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with any media that contains glucose.  Literature regarding this effect of glucose is 
inconsistent (Table A9.1).   
 
 
Table A9.1. Summary of glucose effects on AI-2 bioassay from literature.  
Conflicting observations have been made on the influence of small concentrations of 
glucose on the autoinducer 2 bioassay. 
 
The effect of adding only glucose and glucose plus a glucose-rich conditioned 
medium sample to the V. harveyi detector culture was determined.  While low 
concentrations of glucose promote initial luminescence, high concentrations of 
glucose are inhibitory during later phases of luminescence (Figure A9.5).  These 
results perhaps help to explain the inconsistent observations in the literature.  It is 
important to note that the initial luminescence of the same conditioned medium 
sample does not change when extra glucose is added (Figure A9.5b).  Since only the 
early luminescence of the cultures is used in the detection assay, a surplus of glucose 
normalizes luminescence (Figure A9.6).  This modification permitted the use of 
fermentation samples in the AI-2 bioassay.  The quantitative results agree with 
Group Observed luminescence Glucose concentration 
Nealson, 1972 inhibited > 28 mM 
DeLisa, 2001 2.5x increase 
6.3x increase 
5 mM 
50 mM 
De Keersmaecker, 2003 “complete” inhibition > 2 mM 
Turovskiy, 2006 20x increase 0.44 mM 
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previous studies that show high levels of AI-2 during exponential growth phase and 
depleted levels during stationary phase (Figure A9.7). 
 
Figure A9.5. Influence of glucose addition to autoinducer 2 bioassay.  a) 
Increasing concentrations of glucose were added to the V. harveyi culture.  Any 
addition of glucose increased the start time of luminescence.  Higher levels of glucose 
decreased late levels of luminescence.  b) For a glucose-rich conditioned medium 
sample, the addition of glucose had no effect. 
 
Figure A9.6.  Effect of glucose on V. harveyi luminescence from conditioned 
medium.  Without the addition of glucose, early fermentation samples created 
luminescence peaks and later fermentation samples did not settle.  With the addition of 
glucose, luminescence peaks were well-behaved. 
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Figure A9.7. Autoinducer 2 levels during a high cell density fermentation.  
Conditioned medium samples were acquired for various time points during a high cell 
density E. coli fermentation.  Their relative level of AI-2 was determined using a V. 
harveyi bioassay.  The dotted blue line is the optical density, and the solid pink line is 
the relative AI-2 intensity. 
 
A9.6. Intracellular autoinducer 2 measurements 
 AI-2 levels drop in an E. coli culture as the cells enter stationary phase [171].  
It is hypothesized that the cells consume the autoinducer to create this drop.  The 
internal AI-2 levels within an E. coli culture were then measured to determine if the 
molecule accumulated within the cells. 
 Samples of 40 ml were taken from a high cell density culture at regular time 
points.  The OD600 of the samples was measured (Section 2.5.2), and the cells were 
pelleted at 8,000 rcf in a SLA-600TC rotor in the ultracentrifuge described in Section 
A4.2.   The cells were then washed and resuspended in water before being lysed in a 
high pressure homogenizer, as described in Section 2.6.  The lysate samples were 
assayed with a V. harveyi culture (Section A9.5) and their luminescence-stimulation 
was compared to that of water.  Values were normalized for cell density to determine 
specific levels of AI-2 per cell.  There was no accumulation of the AI-2 molecule in 
the cells found (Table A9.2). 
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Table A9.2. Intracellular autoinducer 2 levels of a high cell density E. coli 
fermentation.  Samples from a high cell density fermentation were sampled, and the 
AI-2 of the lysate was measured.  AI-2 levels were normalized by the cell density in 
the first sample to determine any trends in specific internal AI-2 levels. 
 
 
 
 
 
 
 
 
 
A9.7. LuxS deletion mutants 
 The ygaG gene is a 516 base pair sequence that codes for LuxS, the synthase 
of AI-2.  Its removal was performed by Chung-Jr Huang in C41 E. coli cells to create 
a negative control for the AI-2 experiments.  To do this, FY and RY fragments were 
created.  These fragments were 500 base pairs on the bacterial chromosome upsteam 
and downstream of the ygaG gene.  They were created using PCR with a set of 
primers for each fragment.  The fragments were ligated together to form a FYRY 
sequence, and this ligation product was PCR-amplified using the primers from the 
non-ligated ends.  The goal was to delete the ygaG sequence by replacing the FY-
ygaG-RY sequence with FYRY.   
FYRY was purified and extracted from an agarose gel and ligated into a 
pKNG1-FY vector.  The plasmid was transformed into SRM cells, and successful 
transformants were screened using streptomycin resistance.  SRM and C41 cells were 
individually grown to optical densities of 0.5 without any antibiotics.  The cells were 
then combined, pelleted, and resuspended in 100 µl of 0.9% sodium chloride.  The 
EFT (hrs) Luminescence
raw by mass
1 135% 135%
1.5 139% 96%
3 160% 77%
4.5 170% 68%
5.45 191% 61%
5.45 178% 47%
6.7 190% 41%
10.45 206% 35%
12.75 185% 32%
15.22 195% 30%
18 190% 26%
20.2 192% 25%
22.36 200% 24%
24.71 186% 22%
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mixture was left unmixed on a plate overnight to promote conjugation.  Cells were 
then grown on a chloramphenicol plate with 10% sucrose to induce recombination. 
The genome of the LuxS mutant and of a control C41 organism were 
individually PCR amplified using the FYRY primers for the unligated ends.  An 
agarose gel stained with ethidium bromide shows that the control organism has, as 
expected, a 1,500 base pair fragment, and the LuxS mutant has a 1,000 base pair 
fragment (Figure A9.8).  The mutant, unfortunately, did not fail to stimulate 
luminescence in the AI-2 detection assay.  The mutants were grown in the complex 
fermentation batch medium to an OD600 of 4.5 and LB medium, and the conditioned 
media’s luminescence stimulation was compared to the respective blank media.  It 
should be noted that no AI-2 signal should be detected when LB medium is used 
without glucose supplementation [146]. 
 
Figure A9.8. Agarose gel of FY-ygaG-RY and FYRY fragments.  The LuxS mutant 
lacked the ygaG gene.  When amplified with FY and RY primers, its fragment (Lane 
5) was smaller than the control organism (Lane 3). 
 
A9.8. Lag phase studies 
 Cells typically repeat a lag in their growth phase when they are inoculated into 
fresh medium, even if the medium composition and operating conditions are identical.  
1     2     3     4    5 
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It was therefore hypothesized that the cells operate under the control of a quorum 
sensing factor.  Both E. coli and V. harveyi cells would enter exponential growth phase 
faster when supplemented with their respective conditioned medium.  Studies were 
conducted with 5 ml cultures in 50 ml conical tubes.  After exponential growth was 
initiated, the cells grew at the same specific growth rate.  The results of using various 
concentrations of conditioned medium for E. coli are shown in Figure A9.9.  Cells 
would not grow in 100% conditioned medium.  When conditioned medium was added 
from different growth phases of fermentation, it was found that the conditioned 
medium with the highest level of AI-2 increased lag phase and conditioned medium 
with almost no AI-2 decreased the lag phase (Figure A9.10).  These results suggested 
that AI-2 was not responsible for conditioned medium’s ability to decrease lag phase.  
The reason increasing blank medium addition from 5% to 10% was able to decrease 
lag phase is unknown. 
 
Figure A9.9. Growth curves of E. coli fermentations supplemented with 
conditioned medium.  Although the addition of water was not able to change the 
growth pattern of E. coli, the addition of conditioned medium decreased lag phase 
proportionately. 
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Figure A9.10. Autoinducer 2 levels in conditioned medium and their effect to 
decrease lag phase.  Water, blank medium, conditioned medium from exponential 
growth phase, and conditioned medium from stationary growth phase were added in 
5% and 10% (v/v) to E. coli cultures.  The conditioned medium with the greatest AI-2 
level did not result in the shortest lag time. 
 
The results of this study are supported by another study that showed 
conditioned medium from E. coli with high AI-2 levels could not reduce the lag phase 
in growth for Listeria innocua [172].  Yet another group was able to decrease lag 
phase using conditioned medium from stationary growth phase.  Their classification of 
the growth-stimulating substance suggest it is a small, non-proteinaceous, non-ionic 
organic molecule [173].  In other work, it was determined that the transition from 
exponential phase to stationary phase is through cell signaling and not a nutrient 
limitation [174]. 
 
A9.9. Discussion 
 AI-2’s inability to reduce the lag phase in bacterial growth is not the only 
example where AI-2 could not explain quorum sensing phenomenon.  One study 
showed that pure AI-2 was responsible for increased biofilm formation [175], but 
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multiple studies that also used pure AI-2 did not support this conclusion [176].  
Although it had been suspected that AI-2 was responsible for virulence in 
Enterohemorrhagic E. coli O157:H7 pathogenicity [177], repeated experiments with 
pure AI-2 [178] disproved this theory.  Similar to the growth-stimulating substance, 
the pathogenicty-stimulating substance has not been identified. 
AI-2 was originally suspected to be a quorum sensing molecule because it was 
able to activate luminescence in V. harveyi.  In order for this to happen, the AI-2 
produced from interspecies bacteria, such as E. coli, actually had to undergo a 
conformational change that included the incorporation of a borate group [179].   
Considering this molecular change, the AI-2 produced by E. coli and the AI-2 used as 
a quorum sensing signal in V. harveyi are quite different.   
During a high cell density E. coli fermentation, AI-2 is produced when glucose 
is plentiful and consumed when glucose has been depleted, much like acetate and 
other metabolites.  It has been suspected that AI-2 is nothing more than an un-
preferential carbon source for E. coli [160, 176].  Most experiments that suggested AI-
2 was a quorum sensing factor for E. coli were conducted with conditioned medium.  
Among the experiments that use pure AI-2, many show that the molecule does not 
have any quorum sensing effect on E. coli.  If AI-2 is to be considered as a quorum 
sensing molecule for E. coli, more evidence is now needed to support this theory. 
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